ğ‹‡ Â¦severeÂ¦ Â¦ac uteÂ¦ Â¦respiratoryÂ¦ Â¦sy nd r omeÂ¦ Â¦coronavirusÂ¦ Â¦2Â¦ â–( ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ )â– Â¦isÂ¦ Â¦aÂ¦ Â¦no ve lÂ¦ Â¦virusÂ¦ ,â– Â¦firstÂ¦ Â¦isol atedÂ¦ Â¦fromÂ¦ Â¦threeÂ¦ Â¦peopleÂ¦ Â¦withÂ¦ Â¦p ne um o niaÂ¦ Â¦con n ectedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦cl us terÂ¦ Â¦ofÂ¦ Â¦ac uteÂ¦ Â¦respiratoryÂ¦ Â¦ ill nessÂ¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡Â¦w uhanÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦th ur s dayÂ¦ ,â– Â¦theÂ¦ Â¦totalÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦casesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦coronavirusÂ¦ Â¦infectionsÂ¦ Â¦sur p as sedÂ¦ Â¦oneÂ¦ Â¦millionÂ¦ Â¦wor l d w ideÂ¦ ,â– ğ‹‡ Â¦jo h nsÂ¦ ğ‹‡Â¦h op k insÂ¦ ğ‹‡Â¦universityÂ¦ Â¦dataÂ¦ Â¦ind ic atedÂ¦ .
ğ‹‡ Â¦beforeÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦isol ationÂ¦ Â¦ofÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - Â¦2 2 9 ğ‹‡ eÂ¦ Â¦str ainÂ¦ ğ‹‡Â¦b 8 1 4Â¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦n as alÂ¦ Â¦dis c har geÂ¦ Â¦ofÂ¦ Â¦patientsÂ¦ Â¦whoÂ¦ Â¦hadÂ¦ Â¦contr actedÂ¦ Â¦comm onÂ¦ Â¦co ldÂ¦ ,â– Â¦differentÂ¦ ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦isol atedÂ¦ Â¦inÂ¦ Â¦variousÂ¦ Â¦infectedÂ¦ Â¦ani m alsÂ¦ ,â– Â¦includingÂ¦ Â¦ tur ke yÂ¦ ,â– Â¦mo useÂ¦ ,â– Â¦co wÂ¦ ,â– Â¦ pi gÂ¦ ,â– Â¦c atÂ¦ Â¦andÂ¦ Â¦do gÂ¦ .
ğ‹‡ Â¦fe lineÂ¦ Â¦coronavirusÂ¦ â–( ğŠ£ Â¦f cğŠ¼ o ğ‹‡ vÂ¦ )â– Â¦cau sesÂ¦ Â¦mi ldÂ¦ Â¦en teri ti sÂ¦ Â¦inÂ¦ Â¦ca tsÂ¦ Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦severeÂ¦ ğ‹‡ Â¦fe lineÂ¦ Â¦in fe ct iousÂ¦ Â¦per it o niti sÂ¦ â–( Â¦otherÂ¦ Â¦v ari a ntsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦virusÂ¦ ).
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦governmentÂ¦ ' Â¦sÂ¦ Â¦se ni orÂ¦ Â¦medicalÂ¦ Â¦ad v is erÂ¦ ğ‹‡Â¦z h ongÂ¦ ğ‹‡Â¦na ns hanÂ¦ Â¦ar g u edÂ¦ Â¦thatÂ¦ â–" Â¦itÂ¦ Â¦couldÂ¦ Â¦beÂ¦ Â¦overÂ¦ Â¦byÂ¦ ğ‹‡Â¦j uneÂ¦ "â– Â¦ifÂ¦ Â¦allÂ¦ Â¦countriesÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦mo bi li zedÂ¦ Â¦toÂ¦ Â¦follow Â¦ Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ ' Â¦sÂ¦ Â¦ad v iceÂ¦ Â¦onÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦sto pÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦surveillanceÂ¦ Â¦isÂ¦ Â¦exp ectedÂ¦ Â¦toÂ¦ Â¦monit orÂ¦ Â¦epi dem io log icalÂ¦ Â¦tre ndsÂ¦ ,â– Â¦rapidlyÂ¦ Â¦det ectÂ¦ Â¦newÂ¦ Â¦casesÂ¦ ,â– Â¦andÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦thisÂ¦ Â¦informationÂ¦ ,â– Â¦provideÂ¦ Â¦epi dem io log icalÂ¦ Â¦informationÂ¦ Â¦toÂ¦ Â¦conduc tÂ¦ Â¦riskÂ¦ Â¦ass ess mentÂ¦ Â¦andÂ¦ Â¦guid eÂ¦ Â¦diseaseÂ¦ Â¦pre par ed nessÂ¦ .
ğ‹‡ Â¦basedÂ¦ Â¦onÂ¦ Â¦clinicalÂ¦ Â¦stud iesÂ¦ Â¦reportedÂ¦ Â¦th usÂ¦ Â¦farÂ¦ ,â– Â¦theÂ¦ Â¦follow ingÂ¦ Â¦fa ct orsÂ¦ Â¦mayÂ¦ Â¦a ff ectÂ¦ Â¦orÂ¦ Â¦beÂ¦ Â¦associ atedÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦pro g no sisÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦patientsÂ¦ â–( ğ‹‡Â¦t ableÂ¦ â– â€‹ ( ğ‹‡Â¦t ab le 3 3Â¦ ) :
ğ‹‡ Â¦givenÂ¦ Â¦suchÂ¦ Â¦rap idÂ¦ Â¦pro gr essÂ¦ Â¦inÂ¦ Â¦researchÂ¦ Â¦onÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦severalÂ¦ Â¦cr iticalÂ¦ Â¦issu esÂ¦ Â¦rem ainÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦s ol vedÂ¦ ,â– Â¦asÂ¦ Â¦follow sÂ¦ :
ğ‹‡Â¦onÂ¦ Â¦1 3Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦heÂ¦ Â¦dec l aredÂ¦ Â¦aÂ¦ Â¦n ationalÂ¦ Â¦emergencyÂ¦ ,â– Â¦whichÂ¦ Â¦madeÂ¦ Â¦f ed er alÂ¦ Â¦f u ndsÂ¦ Â¦availableÂ¦ Â¦toÂ¦ Â¦respon dÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦crisisÂ¦ .
ğ‹‡Â¦chineseÂ¦ Â¦clinicalÂ¦ Â¦trialsÂ¦ Â¦inÂ¦ ğ‹‡Â¦w uhanÂ¦ Â¦andÂ¦ ğ‹‡Â¦sh en z h enÂ¦ Â¦clai medÂ¦ Â¦toÂ¦ Â¦sho wÂ¦ Â¦thatÂ¦ Â¦fa vi pi ra virÂ¦ Â¦wasÂ¦ â–" Â¦cle ar lyÂ¦ Â¦effectiveÂ¦ " .
ğ‹‡Â¦ma u ri z i oÂ¦ ğ‹‡Â¦m as s ar iÂ¦ ,â– ğ‹‡Â¦ita lyÂ¦ ' Â¦sÂ¦ Â¦a mb as s a d orÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğŠ£ Â¦e uÂ¦ğŠ¼ ,â– Â¦saidÂ¦ Â¦thatÂ¦ â–" ğ‹‡ Â¦onlyÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦respon dedÂ¦ Â¦b il at er allyÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦canÂ¦ Â¦k illÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦30Â¦ %â– Â¦ofÂ¦ Â¦thoseÂ¦ Â¦infectedÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦andÂ¦ Â¦someÂ¦ Â¦areÂ¦ Â¦rel ati ve lyÂ¦ Â¦ har m l essÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦comm onÂ¦ Â¦co ldÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦ uÂ¦ . ğ‹‡Â¦sÂ¦ .â– Â¦administrationÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦do na ldÂ¦ ğ‹‡ Â¦tr um pÂ¦ Â¦hasÂ¦ Â¦ ref er r edÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦asÂ¦ â–" ğ‹‡Â¦chineseÂ¦ Â¦virusÂ¦ "â– Â¦orÂ¦ â–" ğ‹‡Â¦w uhanÂ¦ Â¦virusÂ¦ "â– Â¦sa yingÂ¦ Â¦thatÂ¦ ğ‹‡Â¦chinaÂ¦ ' Â¦sÂ¦ â–" Â¦ce ns or s hi pÂ¦ Â¦su p er c har gedÂ¦ Â¦aÂ¦ Â¦virusÂ¦ Â¦thatÂ¦ Â¦hasÂ¦ Â¦nowÂ¦ Â¦ tur nedÂ¦ Â¦intoÂ¦ Â¦aÂ¦ Â¦g lobalÂ¦ Â¦pandemicÂ¦ " ,â– Â¦whichÂ¦ Â¦hasÂ¦ Â¦inÂ¦ Â¦ tur nÂ¦ Â¦beenÂ¦ Â¦c ri ti ci zedÂ¦ Â¦byÂ¦ Â¦someÂ¦ Â¦c rit icsÂ¦ Â¦asÂ¦ Â¦r ac is mÂ¦ Â¦andÂ¦ â–" Â¦dis tr actÂ¦ [ Â¦ ingÂ¦ ] â– Â¦fromÂ¦ Â¦hisÂ¦ Â¦administrationÂ¦ ' Â¦sÂ¦ Â¦fa il ureÂ¦ Â¦toÂ¦ Â¦cont ainÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ " .
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ Â¦toÂ¦ Â¦rep lic a tingÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦l ow erÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦canÂ¦ Â¦e ffic ie ntlyÂ¦ Â¦rep lic ateÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦u pp erÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦andÂ¦ Â¦cau sesÂ¦ Â¦mi ldÂ¦ Â¦orÂ¦ Â¦noÂ¦ Â¦symptomsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦phaseÂ¦ Â¦ofÂ¦ Â¦infectionÂ¦ ,â– Â¦simil arÂ¦ Â¦toÂ¦ Â¦otherÂ¦ ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦thatÂ¦ Â¦causeÂ¦ Â¦comm onÂ¦ Â¦c ol dsÂ¦ .
ğ‹‡Â¦c lu st eredÂ¦ Â¦o ns etÂ¦ Â¦o f tenÂ¦ Â¦happ e nsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦familyÂ¦ Â¦orÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦ga th eringÂ¦ Â¦orÂ¦ Â¦ve h ic leÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦c ru iseÂ¦ Â¦s hi pÂ¦ .
ğ‹‡Â¦au th or itiesÂ¦ Â¦wor l d w ideÂ¦ Â¦haveÂ¦ Â¦respon dedÂ¦ Â¦byÂ¦ Â¦imple m en tingÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ ,â– Â¦qu ara nt inesÂ¦ ,â– Â¦cur fe wsÂ¦ ,â– Â¦wor k p l aceÂ¦ Â¦ha z ardÂ¦ Â¦contr olsÂ¦ ,â– Â¦andÂ¦ Â¦facil ityÂ¦ Â¦closuresÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦moreÂ¦ Â¦rec entÂ¦ Â¦studyÂ¦ ,â– Â¦asÂ¦ Â¦d es c rib edÂ¦ Â¦ab o veÂ¦ ,â– Â¦ dem on stra tesÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦inc ub ationÂ¦ Â¦periodÂ¦ Â¦wasÂ¦ Â¦4Â¦ . Â¦8Â¦ â–( Â¦3Â¦ . Â¦ 0Â¦ - Â¦7Â¦ . Â¦2Â¦ )â– Â¦daysÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦ dem o g rap hyÂ¦ Â¦ofÂ¦ Â¦8Â¦ , Â¦8 6 6Â¦ Â¦casesÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦severeÂ¦ Â¦casesÂ¦ ,â– Â¦patientsÂ¦ Â¦qu ic k lyÂ¦ Â¦pro g res sedÂ¦ Â¦toÂ¦ Â¦develop Â¦ Â¦ac uteÂ¦ Â¦respiratoryÂ¦ Â¦sy nd r omeÂ¦ ,â– Â¦se p ticÂ¦ Â¦sh oc kÂ¦ ,â– Â¦me t ab ol icÂ¦ Â¦ac id o sisÂ¦ ,â– Â¦andÂ¦ Â¦co a g ul op at hyÂ¦ .
ğ‹‡ Â¦supp r ess ionÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦p ref er r edÂ¦ Â¦butÂ¦ Â¦nee dsÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦ma in ta inedÂ¦ Â¦forÂ¦ Â¦asÂ¦ Â¦longÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦c ir c u la tingÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦humanÂ¦ Â¦populationÂ¦ â–( Â¦orÂ¦ Â¦un ti lÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦b ec om esÂ¦ Â¦availableÂ¦ ,â– Â¦ifÂ¦ Â¦thatÂ¦ Â¦com esÂ¦ Â¦firstÂ¦ ),â– Â¦asÂ¦ Â¦transmissionÂ¦ Â¦o th er w iseÂ¦ Â¦qu ic k lyÂ¦ Â¦re b ou ndsÂ¦ Â¦whenÂ¦ Â¦measuresÂ¦ Â¦areÂ¦ Â¦re la x edÂ¦ .
ğ‹‡Â¦p res um ab lyÂ¦ ,â– Â¦itÂ¦ Â¦hasÂ¦ Â¦al rea dyÂ¦ Â¦beenÂ¦ Â¦ad ap tedÂ¦ Â¦toÂ¦ Â¦anotherÂ¦ Â¦h ostÂ¦ Â¦cl oseÂ¦ Â¦toÂ¦ Â¦hum ansÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦thisÂ¦ Â¦studyÂ¦ ,â– Â¦weÂ¦ Â¦ass essÂ¦ Â¦theÂ¦ Â¦tre ndsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦c um u la tiveÂ¦ Â¦in ci denceÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦inÂ¦ Â¦eachÂ¦ ğ‹‡Â¦e ur op e anÂ¦ ğ‹‡Â¦unionÂ¦ / ğ‹‡Â¦e ur op e anÂ¦ ğ‹‡ Â¦econom icÂ¦ ğ‹‡ Â¦areaÂ¦ â–( ğŠ£ Â¦e uÂ¦ / Â¦e ea Â¦ğŠ¼ )â– Â¦countryÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡ Â¦ki ng d omÂ¦ â–( ğŠ£Â¦ukÂ¦ğŠ¼ )â– Â¦andÂ¦ Â¦comp areÂ¦ Â¦themÂ¦ Â¦toÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ ğ‹‡Â¦h ub e iÂ¦ ğ‹‡ Â¦pro vi nceÂ¦ ,â– ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦twoÂ¦ Â¦typ esÂ¦ Â¦ofÂ¦ Â¦can ineÂ¦ Â¦coronavirusÂ¦ â–( ğŠ£Â¦c cğŠ¼ o ğ‹‡ vÂ¦ ) â–( Â¦oneÂ¦ Â¦ca us ingÂ¦ Â¦en teri ti sÂ¦ ,â– Â¦theÂ¦ Â¦otherÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦respiratoryÂ¦ Â¦dis easesÂ¦ ).
ğ‹‡Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ Â¦wereÂ¦ Â¦ea sedÂ¦ Â¦inÂ¦ ğ‹‡Â¦h ub e iÂ¦ ,â– Â¦ ap artÂ¦ Â¦fromÂ¦ ğ‹‡Â¦w uhanÂ¦ ,â– Â¦twoÂ¦ Â¦monthsÂ¦ Â¦afterÂ¦ Â¦theÂ¦ Â¦lockdownÂ¦ Â¦wasÂ¦ Â¦imposedÂ¦ . ğ‹‡Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ ğ‹‡Â¦ministryÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦fo re i g nÂ¦ ğ‹‡Â¦a ff a ir sÂ¦ Â¦announcedÂ¦ Â¦onÂ¦ Â¦2 6Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ Â¦thatÂ¦ Â¦en tryÂ¦ Â¦forÂ¦ Â¦v is aÂ¦ Â¦orÂ¦ Â¦re si denceÂ¦ Â¦p erm itÂ¦ Â¦h ol dersÂ¦ Â¦wouldÂ¦ Â¦beÂ¦ Â¦susp e ndedÂ¦ Â¦fromÂ¦ Â¦2 8Â¦ ğ‹‡Â¦marchÂ¦ Â¦on w ar dsÂ¦ ,â– Â¦withÂ¦ Â¦noÂ¦ Â¦speci ficÂ¦ Â¦de ta il sÂ¦ Â¦onÂ¦ Â¦whenÂ¦ Â¦thisÂ¦ Â¦po lic yÂ¦ Â¦willÂ¦ Â¦ endÂ¦ .
ğ‹‡Â¦d a ma geÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦g lobalÂ¦ Â¦econom yÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦f el tÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ :â– Â¦accordingÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦mediaÂ¦ Â¦reportÂ¦ Â¦onÂ¦ Â¦1 6Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦theÂ¦ Â¦econom yÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦wasÂ¦ Â¦veryÂ¦ Â¦h ardÂ¦ Â¦h itÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦twoÂ¦ Â¦monthsÂ¦ Â¦ofÂ¦ Â¦2020Â¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦measuresÂ¦ Â¦takenÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦governmentÂ¦ Â¦toÂ¦ Â¦cur t ai lÂ¦ Â¦virusÂ¦ Â¦spreadÂ¦ ,â– Â¦andÂ¦ Â¦re t ai lÂ¦ Â¦sa lesÂ¦ Â¦pl un gedÂ¦ Â¦20Â¦ . Â¦5Â¦ % .
ğ‹‡Â¦theÂ¦ Â¦2019Â¦ Â¦no ve lÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ â–( Â¦2019Â¦ - Â¦n ğ‹‡ co ğ‹‡ vÂ¦ ),â– Â¦whichÂ¦ Â¦hasÂ¦ Â¦sub se que ntlyÂ¦ Â¦beenÂ¦ Â¦re na medÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ,â– Â¦isÂ¦ Â¦theÂ¦ Â¦ca us a tiveÂ¦ Â¦ag entÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦o ng o ingÂ¦ Â¦epi demicÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦diseaseÂ¦ Â¦2019Â¦ â–( ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ),â– Â¦whichÂ¦ Â¦hasÂ¦ Â¦clai medÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦3Â¦ , Â¦1 2 0Â¦ Â¦li vesÂ¦ Â¦andÂ¦ Â¦infectedÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦9 1Â¦ , Â¦000Â¦ Â¦peopleÂ¦ Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦marchÂ¦ Â¦3Â¦ ,â– Â¦2020Â¦ .
ğ‹‡Â¦p res um ab lyÂ¦ ,â– Â¦theÂ¦ Â¦inter medi ateÂ¦ Â¦ani malÂ¦ Â¦hos tsÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦amongÂ¦ Â¦theÂ¦ Â¦w il d li feÂ¦ Â¦speci esÂ¦ Â¦so ldÂ¦ Â¦andÂ¦ Â¦ki lledÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡Â¦h u an anÂ¦ ğ‹‡Â¦s ea f o odÂ¦ ğ‹‡Â¦w h ol es a leÂ¦ ğ‹‡ Â¦marke tÂ¦ ,â– Â¦withÂ¦ Â¦whichÂ¦ Â¦manyÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦initi alÂ¦ Â¦casesÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦wereÂ¦ Â¦associ atedÂ¦ ,â– Â¦ind ic a tiveÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦pro b ableÂ¦ Â¦ani malÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦e v entÂ¦ .
ğ‹‡Â¦s outhÂ¦ ğ‹‡Â¦k o re aÂ¦ ' Â¦sÂ¦ Â¦pro gr am meÂ¦ Â¦isÂ¦ Â¦consid eredÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦aÂ¦ Â¦s uc c essÂ¦ Â¦inÂ¦ Â¦cont ro llingÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦d esp iteÂ¦ Â¦notÂ¦ Â¦qu ar an ti ningÂ¦ Â¦ent ireÂ¦ Â¦c itiesÂ¦ . ğ‹‡Â¦theÂ¦ ğ‹‡Â¦s outhÂ¦ ğ‹‡Â¦k o re anÂ¦ Â¦s oc ie tyÂ¦ Â¦wasÂ¦ Â¦initi allyÂ¦ Â¦pol ari zedÂ¦ Â¦onÂ¦ ğ‹‡ Â¦presidentÂ¦ ğ‹‡ Â¦mo onÂ¦ ğ‹‡Â¦j a eÂ¦ - Â¦inÂ¦ ' Â¦sÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦crisisÂ¦ .
ğ‹‡Â¦ne ver th el essÂ¦ ,â– Â¦theÂ¦ Â¦fe at uresÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦includingÂ¦ Â¦itsÂ¦ Â¦trans m is sib ilityÂ¦ ,â– Â¦p at ho g en ic ityÂ¦ Â¦andÂ¦ Â¦s us ta in ableÂ¦ Â¦sprea dingÂ¦ Â¦afterÂ¦ Â¦pas s a gesÂ¦ Â¦inÂ¦ Â¦hum ansÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦inf lu enti alÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦ ul tim ateÂ¦ Â¦f ateÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦o ng o ingÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡ Â¦mo re o verÂ¦ ,â– Â¦theÂ¦ Â¦highÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦re ac tiveÂ¦ Â¦oxygenÂ¦ Â¦speci esÂ¦ â–( ğŠ£Â¦r os Â¦ğŠ¼ )â– Â¦gen er atedÂ¦ Â¦fromÂ¦ Â¦highÂ¦ Â¦me t ab ol icÂ¦ Â¦ac tiv ityÂ¦ Â¦ofÂ¦ Â¦ba tsÂ¦ Â¦couldÂ¦ Â¦bothÂ¦ Â¦supp r essÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ Â¦rep lic ationÂ¦ Â¦andÂ¦ Â¦a ff ectsÂ¦ Â¦pro o f rea dingÂ¦ Â¦byÂ¦ Â¦ex o rib on uc le aseÂ¦ ,â– Â¦th usÂ¦ Â¦pro vi dingÂ¦ Â¦theÂ¦ Â¦se le ctionÂ¦ Â¦pr ess ureÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦gen er ationÂ¦ Â¦ofÂ¦ Â¦virusÂ¦ Â¦stra insÂ¦ Â¦high lyÂ¦ Â¦p at ho g en icÂ¦ Â¦whenÂ¦ Â¦in tr od uc edÂ¦ Â¦intoÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦h ostÂ¦ .
ğ‹‡ Â¦severalÂ¦ Â¦tr ainÂ¦ Â¦st ationsÂ¦ Â¦andÂ¦ Â¦f er r yÂ¦ Â¦ por tsÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦closedÂ¦ .
ğ‹‡Â¦co ro na vi rusesÂ¦ Â¦v aryÂ¦ Â¦si gni fic a ntlyÂ¦ Â¦inÂ¦ Â¦riskÂ¦ Â¦fa ctorÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦cl ar ityÂ¦ ,â– Â¦theÂ¦ Â¦currentÂ¦ Â¦kno w l ed geÂ¦ Â¦onÂ¦ Â¦ani malÂ¦ Â¦o ri g insÂ¦ Â¦ofÂ¦ Â¦knownÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ Â¦isÂ¦ Â¦s um m ari zedÂ¦ Â¦inÂ¦ ğ‹‡ Â¦fi g ureÂ¦ â– â€‹ Â¦1Â¦ Â¦andÂ¦ ğ‹‡Â¦t ableÂ¦ Â¦2Â¦ .
ğ‹‡Â¦inÂ¦ Â¦bothÂ¦ Â¦casesÂ¦ ,â– Â¦theÂ¦ Â¦hos tsÂ¦ Â¦areÂ¦ Â¦n atur allyÂ¦ Â¦infectedÂ¦ Â¦andÂ¦ Â¦areÂ¦ Â¦theÂ¦ Â¦n atur alÂ¦ Â¦hos tsÂ¦ Â¦ofÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ Â¦orÂ¦ Â¦itsÂ¦ Â¦par en talÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ ,â– Â¦2 1 5Â¦ ğ‹‡Â¦ca na di ansÂ¦ â–( Â¦1 7 6Â¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦pl aneÂ¦ ,â– Â¦andÂ¦ Â¦3 9Â¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦secondÂ¦ Â¦pl aneÂ¦ Â¦ch art eredÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦ uÂ¦ . ğ‹‡Â¦sÂ¦ .â– Â¦governmentÂ¦ )â– Â¦wereÂ¦ Â¦e v ac u atedÂ¦ Â¦fromÂ¦ ğ‹‡Â¦w uhanÂ¦ Â¦toÂ¦ ğŠ£Â¦c f b Â¦ğŠ¼ ğ‹‡ Â¦tre nt onÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦qu ara nt inedÂ¦ Â¦forÂ¦ Â¦twoÂ¦ Â¦weeksÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦pol y p ro te inÂ¦ Â¦hasÂ¦ Â¦itsÂ¦ Â¦ ownÂ¦ Â¦prot easesÂ¦ Â¦whichÂ¦ Â¦cl ea veÂ¦ Â¦theÂ¦ Â¦pol y p ro te inÂ¦ Â¦intoÂ¦ Â¦m ul ti p leÂ¦ Â¦no ns tr uc tur alÂ¦ Â¦prote insÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦b har ati yaÂ¦ ğ‹‡Â¦j an at aÂ¦ ğ‹‡ Â¦par tyÂ¦ ' Â¦sÂ¦ ğ‹‡Â¦stateÂ¦ Â¦un itÂ¦ Â¦presidentÂ¦ Â¦inÂ¦ ğ‹‡Â¦w estÂ¦ ğ‹‡ Â¦be ng alÂ¦ ğ‹‡Â¦di li pÂ¦ ğ‹‡Â¦ gh os hÂ¦ Â¦st atedÂ¦ Â¦thatÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦hadÂ¦ Â¦d est ro y edÂ¦ Â¦n at ureÂ¦ Â¦andÂ¦ â–" Â¦thatÂ¦ ' Â¦sÂ¦ Â¦w hyÂ¦ Â¦theÂ¦ ğ‹‡Â¦g odÂ¦ Â¦to okÂ¦ Â¦re v en geÂ¦ Â¦againstÂ¦ Â¦themÂ¦ ."
ğ‹‡ Â¦stud iesÂ¦ Â¦haveÂ¦ Â¦foundÂ¦ Â¦thatÂ¦ Â¦anÂ¦ Â¦u nc ov eredÂ¦ Â¦c ou g hingÂ¦ Â¦canÂ¦ Â¦le adÂ¦ Â¦toÂ¦ Â¦dr op le tsÂ¦ Â¦tra ve llingÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦4Â¦ . Â¦5Â¦ Â¦me tr esÂ¦ â–( Â¦15Â¦ Â¦fe etÂ¦ )â– Â¦toÂ¦ Â¦8Â¦ . Â¦2Â¦ Â¦me tr esÂ¦ â–( Â¦2 7Â¦ Â¦fe etÂ¦ ).
ğ‹‡Â¦inÂ¦ Â¦ch ic ke nsÂ¦ ,â– Â¦theÂ¦ Â¦in fe ct iousÂ¦ Â¦b ro nc hi ti sÂ¦ Â¦virusÂ¦ â–( ğŠ£Â¦i b v Â¦ğŠ¼ ),â– Â¦aÂ¦ Â¦coronavirusÂ¦ ,â– Â¦t ar ge tsÂ¦ Â¦notÂ¦ Â¦onlyÂ¦ Â¦theÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦butÂ¦ Â¦alsoÂ¦ Â¦theÂ¦ Â¦u ro ge ni talÂ¦ Â¦tr actÂ¦ .
ğ‹‡ Â¦inter es ti ng lyÂ¦ ,â– Â¦theÂ¦ Â¦n uc le o t ideÂ¦ Â¦a na log ueÂ¦ ğ‹‡ Â¦rem desivirÂ¦ Â¦isÂ¦ Â¦knownÂ¦ Â¦toÂ¦ Â¦supp r essÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ Â¦rep lic ationÂ¦ Â¦throughÂ¦ Â¦in hi b itionÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦ex o rib on uc le aseÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦r na Â¦ğŠ¼ - Â¦dep e nd entÂ¦ ğŠ£Â¦r na Â¦ğŠ¼ Â¦pol y mer aseÂ¦ .
ğ‹‡ Â¦takingÂ¦ Â¦overÂ¦ - Â¦theÂ¦ - Â¦c oun terÂ¦ Â¦co ldÂ¦ Â¦medic ationsÂ¦ ,â– Â¦dr in kingÂ¦ Â¦f lu i dsÂ¦ ,â– Â¦andÂ¦ Â¦res tingÂ¦ Â¦mayÂ¦ Â¦helpÂ¦ Â¦al le vi ateÂ¦ Â¦symptomsÂ¦ .
ğ‹‡Â¦th usÂ¦ ,â– Â¦ifÂ¦ Â¦nee dedÂ¦ ,â– Â¦s te ro i dsÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦usedÂ¦ Â¦atÂ¦ Â¦lowÂ¦ Â¦d os a geÂ¦ Â¦andÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦sh ortÂ¦ Â¦timeÂ¦ Â¦inÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦patientsÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦se p te mberÂ¦ Â¦201 2Â¦ ,â– Â¦aÂ¦ Â¦newÂ¦ Â¦typ eÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦wasÂ¦ Â¦ id enti fiedÂ¦ ,â– Â¦initi allyÂ¦ Â¦calledÂ¦ ğ‹‡ Â¦no ve lÂ¦ ğ‹‡ Â¦coronavirusÂ¦ Â¦201 2Â¦ ,â– Â¦andÂ¦ Â¦nowÂ¦ Â¦offi ci allyÂ¦ Â¦na medÂ¦ ğ‹‡Â¦m id d leÂ¦ ğ‹‡ Â¦ea stÂ¦ Â¦respiratoryÂ¦ Â¦sy nd r omeÂ¦ Â¦coronavirusÂ¦ â–( ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ).
ğ‹‡Â¦aÂ¦ ğŠ£Â¦c n n Â¦ğŠ¼ Â¦reportÂ¦ Â¦ind ic atedÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦co mb inationÂ¦ Â¦ofÂ¦ ğ‹‡Â¦ita lyÂ¦ ' Â¦sÂ¦ Â¦largeÂ¦ Â¦el d er lyÂ¦ Â¦populationÂ¦ Â¦andÂ¦ Â¦in ab ilityÂ¦ Â¦toÂ¦ Â¦testÂ¦ Â¦allÂ¦ Â¦whoÂ¦ Â¦haveÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦toÂ¦ Â¦d ateÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦cont rib u tingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦highÂ¦ Â¦f at alityÂ¦ Â¦rateÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦januaryÂ¦ Â¦20Â¦ ,â– Â¦theÂ¦ Â¦infectionÂ¦ Â¦ofÂ¦ Â¦healthÂ¦ - Â¦careÂ¦ Â¦pro vi dersÂ¦ Â¦wasÂ¦ Â¦reportedÂ¦ ,â– Â¦su gg es tingÂ¦ Â¦thatÂ¦ Â¦humanÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦wasÂ¦ Â¦possibleÂ¦ .
ğ‹‡ Â¦sur g icalÂ¦ Â¦masksÂ¦ Â¦areÂ¦ Â¦recomme ndedÂ¦ Â¦forÂ¦ Â¦thoseÂ¦ Â¦whoÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦infectedÂ¦ ,â– Â¦asÂ¦ Â¦we ar ingÂ¦ Â¦aÂ¦ Â¦maskÂ¦ Â¦canÂ¦ Â¦li m itÂ¦ Â¦theÂ¦ Â¦v o lu meÂ¦ Â¦andÂ¦ Â¦travelÂ¦ Â¦distanceÂ¦ Â¦ofÂ¦ Â¦exp ir atoryÂ¦ Â¦dr op le tsÂ¦ Â¦dis p er sedÂ¦ Â¦whenÂ¦ Â¦t al kingÂ¦ ,â– Â¦s n ee z ingÂ¦ ,â– Â¦andÂ¦ Â¦c ou g hingÂ¦ .
ğ‹‡Â¦weÂ¦ Â¦alsoÂ¦ Â¦re v iewÂ¦ Â¦theÂ¦ Â¦tr endÂ¦ Â¦ofÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ Â¦e v o lu tionÂ¦ Â¦inÂ¦ Â¦whichÂ¦ Â¦theÂ¦ Â¦increaseÂ¦ Â¦inÂ¦ Â¦trans m is sib ilityÂ¦ Â¦o f tenÂ¦ Â¦com esÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦d ecre aseÂ¦ Â¦inÂ¦ Â¦p at ho g en ic ityÂ¦ .
ğ‹‡ Â¦sinceÂ¦ Â¦casesÂ¦ Â¦haveÂ¦ Â¦soÂ¦ Â¦farÂ¦ Â¦c lu st eredÂ¦ Â¦inÂ¦ Â¦c er t ainÂ¦ Â¦regi onsÂ¦ Â¦inÂ¦ ğŠ£ Â¦e uÂ¦ / Â¦e ea Â¦ğŠ¼ Â¦countriesÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦ukÂ¦ğŠ¼ ,â– Â¦andÂ¦ Â¦hospitalsÂ¦ Â¦andÂ¦ Â¦int en siveÂ¦ Â¦careÂ¦ Â¦u ni tsÂ¦ Â¦us u allyÂ¦ Â¦ser veÂ¦ Â¦aÂ¦ Â¦de f inedÂ¦ Â¦regi onalÂ¦ Â¦c at ch mentÂ¦ Â¦populationÂ¦ ,â– Â¦informationÂ¦ Â¦aboutÂ¦ Â¦casesÂ¦ Â¦andÂ¦ Â¦int en siveÂ¦ Â¦careÂ¦ Â¦bedsÂ¦ Â¦shouldÂ¦ Â¦p ref er ab lyÂ¦ Â¦beÂ¦ Â¦madeÂ¦ Â¦availableÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡ Â¦no me nc l at ureÂ¦ Â¦ofÂ¦ Â¦ter rit o ri alÂ¦ Â¦u ni tsÂ¦ Â¦forÂ¦ Â¦st ati st icsÂ¦ Â¦2Â¦ â–( ğŠ£ Â¦n ut s Â¦ğŠ¼ - Â¦2Â¦ )â– Â¦levelÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦the ref oreÂ¦ Â¦notÂ¦ Â¦to oÂ¦ Â¦sur p r is ingÂ¦ Â¦thatÂ¦ Â¦ba tsÂ¦ Â¦mi ghtÂ¦ Â¦trans m itÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - Â¦2 2 9 ğ‹‡ eÂ¦ Â¦toÂ¦ Â¦hum ansÂ¦ Â¦dire ctlyÂ¦ .
ğ‹‡ Â¦threeÂ¦ Â¦maj orÂ¦ Â¦riskÂ¦ Â¦fa ct orsÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦wereÂ¦ Â¦se xÂ¦ â–( Â¦ma leÂ¦ ),â– Â¦ageÂ¦ â–( â‰¥ Â¦6 0Â¦ ),â– Â¦andÂ¦ Â¦severeÂ¦ Â¦p ne um o niaÂ¦ .
ğ‹‡Â¦accordingÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦humanÂ¦ Â¦v ol un te erÂ¦ Â¦studyÂ¦ ,â– Â¦heal t hyÂ¦ Â¦in di v id u alsÂ¦ Â¦infectedÂ¦ Â¦withÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - Â¦2 2 9 ğ‹‡ eÂ¦ Â¦developedÂ¦ Â¦mi ldÂ¦ Â¦comm onÂ¦ Â¦co ldÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦ art istsÂ¦ Â¦haveÂ¦ Â¦exp l or edÂ¦ Â¦wa ysÂ¦ Â¦toÂ¦ Â¦continueÂ¦ Â¦toÂ¦ Â¦produc eÂ¦ Â¦andÂ¦ Â¦sh areÂ¦ Â¦workÂ¦ Â¦overÂ¦ Â¦theÂ¦ Â¦intern etÂ¦ Â¦asÂ¦ Â¦anÂ¦ Â¦al t er na tiveÂ¦ Â¦toÂ¦ Â¦tra di ti onalÂ¦ Â¦li veÂ¦ Â¦per for ma nceÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦li veÂ¦ Â¦st re am ingÂ¦ Â¦conc er tsÂ¦ Â¦orÂ¦ Â¦c rea tingÂ¦ Â¦we b Â¦ - Â¦basedÂ¦ â–" Â¦f es tiv alsÂ¦ "â– Â¦forÂ¦ Â¦ art istsÂ¦ Â¦toÂ¦ Â¦per for mÂ¦ ,â– Â¦dist rib uteÂ¦ ,â– Â¦andÂ¦ Â¦p ub li ci z eÂ¦ Â¦theirÂ¦ Â¦workÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦18Â¦ ,â– Â¦2020Â¦ ,â– ğ‹‡Â¦b ol iÂ¦ ğ‹‡Â¦z h an gÂ¦ Â¦andÂ¦ Â¦c ow or k ersÂ¦ Â¦p ub lish edÂ¦ Â¦aÂ¦ Â¦studyÂ¦ Â¦toÂ¦ Â¦comp areÂ¦ Â¦w est ernÂ¦ Â¦medic ineÂ¦ â–( ğŠ£ Â¦w m Â¦ğŠ¼ )â– Â¦treatmentÂ¦ Â¦al oneÂ¦ Â¦withÂ¦ Â¦co mb inedÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ ğŠ£ Â¦w m Â¦ğŠ¼ Â¦andÂ¦ ğŠ£ Â¦t c m Â¦ğŠ¼ .
ğ‹‡Â¦theÂ¦ Â¦casesÂ¦ Â¦mo st lyÂ¦ Â¦hadÂ¦ Â¦l in ksÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡Â¦h u an anÂ¦ ğ‹‡Â¦s ea f o odÂ¦ ğ‹‡Â¦w h ol es a leÂ¦ ğ‹‡ Â¦marke tÂ¦ Â¦andÂ¦ Â¦soÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦th oughtÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦ z o o no ticÂ¦ Â¦o ri g inÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦ex o rib on uc le aseÂ¦ Â¦no ns tr uc tur alÂ¦ Â¦prote inÂ¦ ,â– Â¦forÂ¦ Â¦ins ta nceÂ¦ ,â– Â¦prov id esÂ¦ Â¦ex tr aÂ¦ Â¦f id el ityÂ¦ Â¦toÂ¦ Â¦rep lic ationÂ¦ Â¦byÂ¦ Â¦pro vi dingÂ¦ Â¦aÂ¦ Â¦pro o f rea dingÂ¦ Â¦f un ctionÂ¦ Â¦whichÂ¦ Â¦theÂ¦ ğŠ£Â¦r na Â¦ğŠ¼ - Â¦dep e nd entÂ¦ ğŠ£Â¦r na Â¦ğŠ¼ Â¦pol y mer aseÂ¦ Â¦l ac ksÂ¦ . ğ‹‡ Â¦oneÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦m ainÂ¦ Â¦f u nc tionsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦comple xÂ¦ Â¦isÂ¦ Â¦toÂ¦ Â¦rep lic ateÂ¦ Â¦theÂ¦ Â¦v iralÂ¦ Â¦gen omeÂ¦ .
ğ‹‡Â¦se v enÂ¦ Â¦trialsÂ¦ Â¦wereÂ¦ Â¦e v a lu a tingÂ¦ Â¦rep ur p osedÂ¦ Â¦d ru gsÂ¦ Â¦al rea dyÂ¦ Â¦approvedÂ¦ Â¦toÂ¦ Â¦t reatÂ¦ Â¦m al ari aÂ¦ ,â– Â¦includingÂ¦ Â¦fourÂ¦ Â¦stud iesÂ¦ Â¦onÂ¦ Â¦hy d ro x y ch lo ro qu ineÂ¦ Â¦orÂ¦ Â¦ch lo ro qu ineÂ¦ Â¦ph os p h ateÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦rapidlyÂ¦ Â¦increasingÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦p ub lic ationsÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦e mer g ingÂ¦ Â¦diseaseÂ¦ ,â– Â¦thisÂ¦ Â¦ art ic leÂ¦ Â¦att e mp tsÂ¦ Â¦toÂ¦ Â¦provideÂ¦ Â¦aÂ¦ Â¦ ti me lyÂ¦ Â¦andÂ¦ Â¦comp re h en siveÂ¦ Â¦re v iewÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦sw i f t lyÂ¦ Â¦develop ingÂ¦ Â¦researchÂ¦ Â¦sub j ectÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦dire ctlyÂ¦ Â¦inv ol vedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦rep lic ationÂ¦ Â¦andÂ¦ Â¦trans c ri p tionÂ¦ Â¦ofÂ¦ ğŠ£Â¦r na Â¦ğŠ¼ Â¦fromÂ¦ Â¦anÂ¦ ğŠ£Â¦r na Â¦ğŠ¼ Â¦str andÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦epi demicÂ¦ Â¦resul tedÂ¦ Â¦inÂ¦ Â¦8Â¦ , Â¦ 0 9 6Â¦ Â¦reportedÂ¦ Â¦casesÂ¦ Â¦withÂ¦ Â¦7 7 4Â¦ Â¦deathsÂ¦ ,â– Â¦sprea dingÂ¦ Â¦acrossÂ¦ Â¦manyÂ¦ Â¦countriesÂ¦ Â¦andÂ¦ Â¦con ti ne ntsÂ¦ .
ğ‹‡ Â¦mostÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ Â¦o ri g in atedÂ¦ Â¦fromÂ¦ Â¦ba tsÂ¦ Â¦whereÂ¦ Â¦theyÂ¦ Â¦areÂ¦ Â¦n onÂ¦ - Â¦p at ho g en icÂ¦ .
ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦al thoughÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦severalÂ¦ Â¦b atÂ¦ Â¦coronavirusÂ¦ Â¦speci esÂ¦ ,â– Â¦appe ar sÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦di ver gedÂ¦ Â¦fromÂ¦ Â¦theseÂ¦ Â¦severalÂ¦ Â¦c en tur iesÂ¦ Â¦ag oÂ¦ .
ğ‹‡ Â¦ph y s icalÂ¦ Â¦dis ta ncingÂ¦ Â¦measuresÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦recomme ndedÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦transmissionÂ¦ . ğ‹‡Â¦manyÂ¦ Â¦go ver n mentsÂ¦ Â¦haveÂ¦ Â¦res tric tedÂ¦ Â¦orÂ¦ Â¦ad vi sedÂ¦ Â¦againstÂ¦ Â¦allÂ¦ Â¦n onÂ¦ - Â¦essentialÂ¦ Â¦travelÂ¦ Â¦toÂ¦ Â¦andÂ¦ Â¦fromÂ¦ Â¦countriesÂ¦ Â¦andÂ¦ Â¦areasÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦theÂ¦ Â¦situationÂ¦ Â¦isÂ¦ Â¦rapidlyÂ¦ Â¦e v ol vingÂ¦ ,â– Â¦theÂ¦ Â¦fin alÂ¦ Â¦sc op eÂ¦ Â¦andÂ¦ Â¦se ver ityÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦rem ainÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦det erm inedÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ ,â– Â¦overÂ¦ Â¦2 4 4Â¦ Â¦thousandÂ¦ Â¦coronavirusÂ¦ Â¦casesÂ¦ Â¦wereÂ¦ Â¦rec or dedÂ¦ ,â– Â¦l in kingÂ¦ Â¦toÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦5Â¦ , Â¦9 00Â¦ Â¦deathsÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦st ar kÂ¦ Â¦cont ra stÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦r b d ğŠ¼ sÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦andÂ¦ ğ‹‡Â¦ra ğŠ£ t g ğŠ¼ 1 3Â¦ Â¦areÂ¦ Â¦moreÂ¦ Â¦di ver g entÂ¦ ,â– Â¦al b e itÂ¦ Â¦aÂ¦ Â¦higherÂ¦ Â¦de g re eÂ¦ Â¦ofÂ¦ Â¦se que nceÂ¦ Â¦h om o logyÂ¦ Â¦gen omeÂ¦ - Â¦w ideÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦earlyÂ¦ ğ‹‡Â¦aprilÂ¦ Â¦2020Â¦ ,â– Â¦1 0 3Â¦ Â¦ca nd id ateÂ¦ Â¦the rap e ut icsÂ¦ Â¦wereÂ¦ Â¦inÂ¦ Â¦pr ec l in icalÂ¦ Â¦orÂ¦ Â¦aÂ¦ Â¦sta geÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦phaseÂ¦ ğ‹‡Â¦iÂ¦ - ğŠ£Â¦i v Â¦ğŠ¼ Â¦developmentÂ¦ ,â– Â¦withÂ¦ Â¦tri alÂ¦ Â¦resul tsÂ¦ Â¦forÂ¦ Â¦2 9Â¦ Â¦drugÂ¦ Â¦ca nd id a tesÂ¦ Â¦exp ectedÂ¦ Â¦duringÂ¦ ğ‹‡Â¦aprilÂ¦ .
ğ‹‡Â¦b atÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ - ğŠ£Â¦h k u ğŠ¼ 4Â¦ Â¦andÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦u ti li z eÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦h ostÂ¦ Â¦re ce pt orÂ¦ ,â– Â¦di p e pt id y lÂ¦ Â¦p e pt id aseÂ¦ Â¦4Â¦ â–( ğŠ£ Â¦d pp ğŠ¼ 4Â¦ ),â– Â¦forÂ¦ Â¦virusÂ¦ Â¦en tryÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– ğ‹‡Â¦coğ‹‡vÂ¦ Â¦canÂ¦ Â¦in hi b itÂ¦ ğ‹‡ Â¦tÂ¦ Â¦c ellÂ¦ Â¦f u nc tionsÂ¦ Â¦byÂ¦ Â¦ind uc ingÂ¦ Â¦a po pt o sisÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦tÂ¦ Â¦ce llsÂ¦ .
ğ‹‡Â¦theyÂ¦ Â¦areÂ¦ Â¦en v el op edÂ¦ Â¦vi rusesÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦positiveÂ¦ - Â¦s en seÂ¦ Â¦sing leÂ¦ - Â¦stra ndedÂ¦ ğŠ£Â¦r na Â¦ğŠ¼ Â¦gen omeÂ¦ Â¦andÂ¦ Â¦aÂ¦ Â¦n uc le oc ap s idÂ¦ Â¦ofÂ¦ Â¦h el icalÂ¦ Â¦sy m me tryÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦theÂ¦ Â¦high estÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦f at al itiesÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦dayÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦e vi denceÂ¦ Â¦toÂ¦ Â¦d ateÂ¦ Â¦isÂ¦ Â¦thatÂ¦ Â¦c aÂ¦ Â¦8 0Â¦ %â– Â¦ofÂ¦ Â¦in di v id u alsÂ¦ Â¦withÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦mi ldÂ¦ Â¦diseaseÂ¦ ,â– Â¦ iÂ¦ . Â¦ eÂ¦ .â– Â¦aÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦infectionÂ¦ Â¦withÂ¦ Â¦orÂ¦ Â¦withoutÂ¦ Â¦p ne um o niaÂ¦ ,â– Â¦andÂ¦ Â¦mostÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦reco verÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦14Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦aÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ - Â¦l edÂ¦ ğ‹‡ Â¦jo in tÂ¦ ğ‹‡Â¦ missionÂ¦ ğ‹‡Â¦t ea mÂ¦ Â¦withÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦wasÂ¦ Â¦ac tiv atedÂ¦ Â¦toÂ¦ Â¦provideÂ¦ Â¦intern ationalÂ¦ Â¦andÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦expertsÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦gr oun dÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦toÂ¦ Â¦as si stÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦d om es ticÂ¦ Â¦ma na ge mentÂ¦ Â¦andÂ¦ Â¦e v a lu ateÂ¦ â–" Â¦theÂ¦ Â¦se ver ityÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦trans m is sib ilityÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ "â– Â¦byÂ¦ Â¦hos tingÂ¦ Â¦wor k s ho psÂ¦ Â¦andÂ¦ Â¦m ee ti ngsÂ¦ Â¦withÂ¦ Â¦ ke yÂ¦ Â¦n ationalÂ¦ - Â¦levelÂ¦ Â¦in st itu tionsÂ¦ Â¦andÂ¦ Â¦toÂ¦ Â¦conduc tÂ¦ Â¦f ieldÂ¦ Â¦vi si tsÂ¦ Â¦toÂ¦ Â¦ass essÂ¦ Â¦theÂ¦ â–" Â¦imp actÂ¦ Â¦ofÂ¦ Â¦responseÂ¦ Â¦ac tiv itiesÂ¦ Â¦atÂ¦ Â¦prov in cialÂ¦ Â¦andÂ¦ Â¦c oun tyÂ¦ Â¦le v elsÂ¦ ,â– Â¦includingÂ¦ Â¦ ur b anÂ¦ Â¦andÂ¦ Â¦ruralÂ¦ Â¦se t ti ngsÂ¦ " . ğ‹‡Â¦onÂ¦ Â¦2 5Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦dec l aredÂ¦ Â¦thatÂ¦ â–" Â¦theÂ¦ Â¦worldÂ¦ Â¦shouldÂ¦ Â¦doÂ¦ Â¦moreÂ¦ Â¦toÂ¦ Â¦pre p areÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦possibleÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ , "â– Â¦sta tingÂ¦ Â¦thatÂ¦ Â¦whileÂ¦ Â¦itÂ¦ Â¦wasÂ¦ Â¦stillÂ¦ Â¦to oÂ¦ Â¦earlyÂ¦ Â¦toÂ¦ Â¦c allÂ¦ Â¦itÂ¦ Â¦aÂ¦ Â¦pandemicÂ¦ ,â– Â¦countriesÂ¦ Â¦shouldÂ¦ Â¦no ne th el essÂ¦ Â¦beÂ¦ â–" Â¦inÂ¦ Â¦aÂ¦ Â¦phaseÂ¦ Â¦ofÂ¦ Â¦pre par ed nessÂ¦ " .
ğ‹‡ Â¦casesÂ¦ Â¦beg anÂ¦ Â¦toÂ¦ Â¦r iseÂ¦ Â¦s har p lyÂ¦ ,â– Â¦whichÂ¦ Â¦pro mp tedÂ¦ Â¦theÂ¦ ğ‹‡Â¦ita li anÂ¦ Â¦governmentÂ¦ Â¦toÂ¦ Â¦susp endÂ¦ Â¦allÂ¦ Â¦f li gh tsÂ¦ Â¦toÂ¦ Â¦andÂ¦ Â¦fromÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦andÂ¦ Â¦dec l areÂ¦ Â¦aÂ¦ Â¦stateÂ¦ Â¦ofÂ¦ Â¦emergencyÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦v ar ie tyÂ¦ Â¦ofÂ¦ Â¦ z o o no ticÂ¦ ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦areÂ¦ Â¦c ir c u la tingÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦wi ldÂ¦ .
ğ‹‡ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦experie nceÂ¦ Â¦fromÂ¦ ğ‹‡Â¦ita lyÂ¦ ,â– Â¦countriesÂ¦ ,â– Â¦hospitalsÂ¦ Â¦andÂ¦ Â¦int en siveÂ¦ Â¦careÂ¦ Â¦u ni tsÂ¦ Â¦shouldÂ¦ Â¦increaseÂ¦ Â¦theirÂ¦ Â¦pre par ed nessÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦sur geÂ¦ Â¦ofÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦whoÂ¦ Â¦willÂ¦ Â¦requir eÂ¦ Â¦heal th c areÂ¦ ,â– Â¦andÂ¦ Â¦inÂ¦ Â¦part icul arÂ¦ Â¦int en siveÂ¦ Â¦careÂ¦ .
ğ‹‡ Â¦toÂ¦ Â¦conc lu deÂ¦ ,â– Â¦weÂ¦ Â¦h op eÂ¦ Â¦moreÂ¦ Â¦d ir ectÂ¦ Â¦e vi denceÂ¦ Â¦com ingÂ¦ Â¦upÂ¦ Â¦andÂ¦ Â¦c allÂ¦ Â¦forÂ¦ Â¦rea dersÂ¦ Â¦toÂ¦ Â¦provideÂ¦ Â¦theirÂ¦ Â¦com mentsÂ¦ .
ğ‹‡ Â¦in di v id u alsÂ¦ Â¦mayÂ¦ Â¦app lyÂ¦ Â¦socialÂ¦ Â¦dis ta ncingÂ¦ Â¦me t ho dsÂ¦ Â¦byÂ¦ Â¦sta yingÂ¦ Â¦atÂ¦ Â¦homeÂ¦ ,â– Â¦li mi tingÂ¦ Â¦travelÂ¦ ,â– Â¦avo i dingÂ¦ Â¦crow dedÂ¦ Â¦areasÂ¦ ,â– Â¦usingÂ¦ Â¦noÂ¦ - Â¦contactÂ¦ Â¦gr ee ti ngsÂ¦ ,â– Â¦andÂ¦ Â¦ph y s icallyÂ¦ Â¦dis ta ncingÂ¦ Â¦the m s el vesÂ¦ Â¦fromÂ¦ Â¦o thersÂ¦ .
ğ‹‡Â¦di a gn os ingÂ¦ Â¦theÂ¦ Â¦confirmedÂ¦ Â¦caseÂ¦ Â¦shouldÂ¦ Â¦b aseÂ¦ Â¦onÂ¦ Â¦susp ectedÂ¦ Â¦caseÂ¦ Â¦withÂ¦ Â¦anyÂ¦ Â¦oneÂ¦ Â¦i te mÂ¦ Â¦ofÂ¦ Â¦p at ho g en icÂ¦ Â¦orÂ¦ Â¦se ro log icalÂ¦ Â¦e vi denceÂ¦ Â¦asÂ¦ Â¦follow ingÂ¦ : â–( Â¦1Â¦ )â– Â¦re alÂ¦ - Â¦timeÂ¦ ğŠ£Â¦p crÂ¦ğŠ¼ Â¦testÂ¦ Â¦positiveÂ¦ Â¦forÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ; â–( Â¦2Â¦ )â– Â¦v iralÂ¦ Â¦w ho leÂ¦ Â¦gen omeÂ¦ Â¦se que ncingÂ¦ Â¦sh owingÂ¦ Â¦highÂ¦ Â¦h om o ge ne ityÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦knownÂ¦ Â¦no ve lÂ¦ Â¦coron a vi rusesÂ¦ ; â–( Â¦3Â¦ )â– Â¦positiveÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦speci ficÂ¦ ğ‹‡Â¦i g ğ‹‡ mÂ¦ Â¦antib o dyÂ¦ Â¦andÂ¦ ğ‹‡Â¦i g ğ‹‡ gÂ¦ Â¦antib o dyÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦inÂ¦ Â¦ser umÂ¦ Â¦testÂ¦ ;â– Â¦orÂ¦ Â¦aÂ¦ Â¦chan geÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ - Â¦speci ficÂ¦ ğ‹‡Â¦i g ğ‹‡ gÂ¦ Â¦antib o dyÂ¦ Â¦fromÂ¦ Â¦ne ga tiveÂ¦ Â¦toÂ¦ Â¦positiveÂ¦ ,â– Â¦orÂ¦ Â¦ ti terÂ¦ Â¦r is ingÂ¦ â– â‰¥ Â¦4Â¦ Â¦ timesÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦reco veryÂ¦ Â¦phaseÂ¦ Â¦ab o veÂ¦ Â¦thatÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦ac uteÂ¦ Â¦phaseÂ¦ .
ğ‹‡Â¦e i ghtÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦doctorsÂ¦ ,â– Â¦includingÂ¦ ğ‹‡Â¦l iÂ¦ ğ‹‡Â¦w en li an gÂ¦ ,â– Â¦wereÂ¦ Â¦ad m on ish edÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦policeÂ¦ Â¦forÂ¦ Â¦sprea dingÂ¦ Â¦f al seÂ¦ Â¦r um o ur sÂ¦ ,â– Â¦andÂ¦ Â¦anotherÂ¦ ,â– ğ‹‡Â¦a iÂ¦ ğ‹‡Â¦f enÂ¦ ,â– Â¦wasÂ¦ Â¦rep ri ma ndedÂ¦ Â¦byÂ¦ Â¦h erÂ¦ Â¦su p e ri orsÂ¦ Â¦forÂ¦ Â¦ra is ingÂ¦ Â¦theÂ¦ Â¦al ar mÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦wasÂ¦ Â¦in formedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ .
ğ‹‡Â¦whenÂ¦ Â¦thisÂ¦ Â¦ch estÂ¦ Â¦p ainÂ¦ Â¦startedÂ¦ ?
ğ‹‡Â¦s hi aÂ¦ Â¦sh r inesÂ¦ Â¦inÂ¦ ğ‹‡Â¦ q omÂ¦ Â¦re ma inedÂ¦ Â¦openÂ¦ Â¦toÂ¦ Â¦p il g ri msÂ¦ Â¦un ti lÂ¦ Â¦1 6Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ . ğ‹‡Â¦ ir anÂ¦ Â¦b ec a meÂ¦ Â¦aÂ¦ Â¦c en tr eÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦afterÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦duringÂ¦ ğ‹‡Â¦februaryÂ¦ .
ğ‹‡ Â¦longÂ¦ - Â¦ter mÂ¦ Â¦int erv entionÂ¦ Â¦toÂ¦ Â¦supp r essÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦cau sesÂ¦ Â¦socialÂ¦ Â¦andÂ¦ Â¦econom icÂ¦ Â¦c os tsÂ¦ .
ğ‹‡Â¦iÂ¦ ' Â¦ veÂ¦ Â¦veryÂ¦ Â¦conc er nedÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦ch estÂ¦ Â¦p ainÂ¦
ğŠ£Â¦us Â¦ğŠ¼ Â¦a u th or itiesÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦acc u sedÂ¦ Â¦ofÂ¦ Â¦di ver tingÂ¦ Â¦a idÂ¦ Â¦me antÂ¦ Â¦forÂ¦ Â¦otherÂ¦ Â¦n ationsÂ¦ Â¦toÂ¦ Â¦theirÂ¦ Â¦ ownÂ¦ Â¦countryÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦de te ctionÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ğŠ£Â¦r na Â¦ğŠ¼ Â¦vi aÂ¦ Â¦re ver seÂ¦ - Â¦trans c ri pt aseÂ¦ Â¦pol y mer aseÂ¦ Â¦ch ainÂ¦ Â¦rea ctionÂ¦ â–( ğŠ£Â¦r tÂ¦ - Â¦p crÂ¦ğŠ¼ )â– Â¦wasÂ¦ Â¦usedÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦maj orÂ¦ Â¦c ri teri aÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦di a g no sisÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡Â¦e mer g ingÂ¦ Â¦in fe ct iousÂ¦ Â¦diseaseÂ¦ â– â€“ â– ğ‹‡ Â¦in fe ct iousÂ¦ Â¦diseaseÂ¦ Â¦ofÂ¦ Â¦e mer g ingÂ¦ Â¦p at ho g enÂ¦ ,â– Â¦o f tenÂ¦ Â¦no ve lÂ¦ Â¦inÂ¦ Â¦itsÂ¦ Â¦outbreakÂ¦ Â¦r an geÂ¦ Â¦orÂ¦ Â¦transmissionÂ¦ Â¦mo deÂ¦
ğ‹‡ Â¦ki mb er lyÂ¦ - ğ‹‡ Â¦cl ar kÂ¦ ,â– Â¦whichÂ¦ Â¦ma k esÂ¦ ğ‹‡Â¦k l ee ne xÂ¦ ğ‹‡ Â¦to il etÂ¦ ğ‹‡Â¦t is s ueÂ¦ ,â– Â¦andÂ¦ ğ‹‡Â¦s ol ari sÂ¦ ğ‹‡Â¦p ap erÂ¦ Â¦whichÂ¦ Â¦ma k esÂ¦ ğ‹‡Â¦s or b entÂ¦ ,â– Â¦emp ha si zedÂ¦ Â¦theyÂ¦ Â¦wereÂ¦ Â¦workingÂ¦ Â¦24Â¦ / Â¦7Â¦ Â¦toÂ¦ Â¦m ai nt ainÂ¦ Â¦theÂ¦ Â¦supplyÂ¦ ,â– Â¦accordingÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡Â¦ne wsÂ¦ . Â¦c omÂ¦ . Â¦a uÂ¦ Â¦reportÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦au st ri anÂ¦ Â¦governmentÂ¦ Â¦ma nd atedÂ¦ Â¦thatÂ¦ Â¦everyoneÂ¦ Â¦ent eringÂ¦ Â¦aÂ¦ Â¦gr oc er yÂ¦ Â¦st oreÂ¦ Â¦m ustÂ¦ Â¦we arÂ¦ Â¦aÂ¦ Â¦faceÂ¦ Â¦maskÂ¦ .
ğ‹‡ Â¦basedÂ¦ Â¦onÂ¦ Â¦theseÂ¦ ,â– ğ‹‡ Â¦gi le adÂ¦ Â¦hasÂ¦ Â¦prov idedÂ¦ Â¦theÂ¦ Â¦comp oun dÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦toÂ¦ Â¦conduc tÂ¦ Â¦aÂ¦ Â¦pa irÂ¦ Â¦ofÂ¦ Â¦trialsÂ¦ Â¦onÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ - Â¦infectedÂ¦ Â¦in di v id u alsÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ Â¦resul tsÂ¦ Â¦areÂ¦ Â¦high lyÂ¦ Â¦an ti cip atedÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦2 2Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦amongÂ¦ Â¦9Â¦ , Â¦3 3 6Â¦ Â¦follow ersÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦ch ur chÂ¦ ,â– Â¦1Â¦ , Â¦2 6 1Â¦ Â¦orÂ¦ Â¦aboutÂ¦ Â¦1 3Â¦ %â– Â¦reportedÂ¦ Â¦symptomsÂ¦ . ğ‹‡Â¦s outhÂ¦ ğ‹‡Â¦k o re aÂ¦ Â¦dec l aredÂ¦ Â¦theÂ¦ Â¦high estÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦al er tÂ¦ Â¦onÂ¦ Â¦2 3Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ .
ğ‹‡ Â¦glob a li z ationÂ¦ Â¦andÂ¦ Â¦diseaseÂ¦ â– â€“ â– ğ‹‡Â¦ ov erv iewÂ¦ Â¦ofÂ¦ Â¦glob a li z ationÂ¦ Â¦andÂ¦ Â¦diseaseÂ¦ Â¦transmissionÂ¦
ğ‹‡Â¦atÂ¦ Â¦leastÂ¦ Â¦12Â¦ Â¦si ttingÂ¦ Â¦orÂ¦ Â¦for m erÂ¦ ğ‹‡Â¦i ra ni anÂ¦ Â¦po li ti ci ansÂ¦ Â¦andÂ¦ Â¦governmentÂ¦ Â¦offi ci alsÂ¦ Â¦hadÂ¦ Â¦diedÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦byÂ¦ Â¦1 7Â¦ ğ‹‡Â¦marchÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦the ref oreÂ¦ Â¦imp os sib leÂ¦ Â¦toÂ¦ Â¦s ac ri f iceÂ¦ Â¦allÂ¦ Â¦c am elsÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦controlÂ¦ Â¦ofÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ ,â– Â¦asÂ¦ Â¦whatÂ¦ Â¦wasÂ¦ Â¦doneÂ¦ Â¦inÂ¦ Â¦wi ldÂ¦ Â¦ani malÂ¦ Â¦marke tsÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦theÂ¦ Â¦sprea dingÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦becauseÂ¦ Â¦out s ideÂ¦ Â¦theÂ¦ Â¦humanÂ¦ Â¦bodyÂ¦ ,â– Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦ki lledÂ¦ Â¦byÂ¦ Â¦h ou se ho ldÂ¦ Â¦soapÂ¦ ,â– Â¦whichÂ¦ Â¦b ur s tsÂ¦ Â¦itsÂ¦ Â¦prot ec tiveÂ¦ Â¦b ub b leÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦c d cÂ¦ğŠ¼ Â¦recomme ndsÂ¦ Â¦thatÂ¦ Â¦peopleÂ¦ Â¦was hÂ¦ Â¦handsÂ¦ Â¦o f tenÂ¦ Â¦withÂ¦ Â¦soapÂ¦ Â¦andÂ¦ Â¦waterÂ¦ Â¦forÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦tw en tyÂ¦ Â¦se co ndsÂ¦ ,â– Â¦ esp eci allyÂ¦ Â¦afterÂ¦ Â¦goingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦to il etÂ¦ Â¦orÂ¦ Â¦whenÂ¦ Â¦handsÂ¦ Â¦areÂ¦ Â¦vi sib lyÂ¦ Â¦d ir tyÂ¦ ;â– Â¦beforeÂ¦ Â¦ea tingÂ¦ ;â– Â¦andÂ¦ Â¦afterÂ¦ Â¦b l owingÂ¦ Â¦oneÂ¦ ' Â¦sÂ¦ Â¦n oseÂ¦ ,â– Â¦c ou g hingÂ¦ ,â– Â¦orÂ¦ Â¦s n ee z ingÂ¦ .
ğ‹‡ Â¦rapidlyÂ¦ Â¦increasingÂ¦ Â¦c um u la tiveÂ¦ Â¦in ci denceÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦diseaseÂ¦ â–( ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ )â– Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦e ur op e anÂ¦ ğ‹‡Â¦unionÂ¦ / ğ‹‡Â¦e ur op e anÂ¦ ğ‹‡ Â¦econom icÂ¦ ğ‹‡ Â¦areaÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡ Â¦ki ng d omÂ¦ ,â– Â¦1Â¦ ğ‹‡Â¦januaryÂ¦ Â¦toÂ¦ Â¦15Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦
ğ‹‡Â¦theÂ¦ Â¦highÂ¦ - Â¦th r ou gh p utÂ¦ Â¦a ut om atedÂ¦ Â¦sy s te msÂ¦ Â¦inÂ¦ Â¦manyÂ¦ Â¦clinicalÂ¦ Â¦labor at oriesÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦ ableÂ¦ Â¦toÂ¦ Â¦per for mÂ¦ Â¦theseÂ¦ Â¦ass a ysÂ¦ Â¦butÂ¦ Â¦theirÂ¦ Â¦ av a il ab ilityÂ¦ Â¦willÂ¦ Â¦dep endÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦rateÂ¦ Â¦ofÂ¦ Â¦productionÂ¦ Â¦forÂ¦ Â¦eachÂ¦ Â¦systemÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦a ve ra geÂ¦ Â¦timeÂ¦ Â¦fromÂ¦ Â¦o ns etÂ¦ Â¦toÂ¦ Â¦deathÂ¦ Â¦wasÂ¦ Â¦9Â¦ . Â¦5Â¦ â–( Â¦4Â¦ . Â¦8Â¦ - Â¦1 3Â¦ )â– Â¦daysÂ¦ .
ğ‹‡Â¦peopleÂ¦ Â¦haveÂ¦ Â¦testedÂ¦ Â¦positiveÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦threeÂ¦ Â¦daysÂ¦ Â¦beforeÂ¦ Â¦o ns etÂ¦ Â¦ofÂ¦ Â¦symptomsÂ¦ Â¦su gg es tingÂ¦ Â¦transmissionÂ¦ Â¦isÂ¦ Â¦possibleÂ¦ Â¦beforeÂ¦ Â¦develop ingÂ¦ Â¦si gni fic antÂ¦ Â¦symptomsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦virusÂ¦ Â¦canÂ¦ Â¦spreadÂ¦ Â¦toÂ¦ Â¦differentÂ¦ Â¦or g ansÂ¦ Â¦th r ou g ho utÂ¦ Â¦theÂ¦ Â¦ch ic k enÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦a u th or itiesÂ¦ Â¦alsoÂ¦ Â¦announcedÂ¦ Â¦theÂ¦ Â¦con stru ctionÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦te m por aryÂ¦ Â¦hospitalÂ¦ ,â– ğ‹‡Â¦h u os he ns hanÂ¦ ğ‹‡Â¦hospitalÂ¦ ,â– Â¦whichÂ¦ Â¦wasÂ¦ Â¦comple tedÂ¦ Â¦inÂ¦ Â¦10Â¦ Â¦daysÂ¦ .
ğ‹‡ Â¦int ri g u i ng lyÂ¦ ,â– Â¦ser aÂ¦ Â¦ofÂ¦ Â¦con v al es c entÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦patientsÂ¦ Â¦wereÂ¦ Â¦cap ableÂ¦ Â¦ofÂ¦ Â¦ne ut ra li z ingÂ¦ ğŠ£ Â¦wi v ğŠ¼ 1Â¦ .
ğ‹‡ Â¦toÂ¦ Â¦furtherÂ¦ Â¦al le vi ateÂ¦ Â¦theÂ¦ Â¦shortageÂ¦ ,â– ğ‹‡Â¦co lesÂ¦ Â¦or d eredÂ¦ Â¦bi gg erÂ¦ Â¦p ack a gesÂ¦ Â¦fromÂ¦ Â¦supp li ersÂ¦ Â¦andÂ¦ Â¦increasedÂ¦ Â¦de li veryÂ¦ Â¦fre que nc yÂ¦ ,â– ğ‹‡Â¦w o ol w or th sÂ¦ Â¦or d eredÂ¦ Â¦ex tr aÂ¦ Â¦st oc kÂ¦ ,â– Â¦whileÂ¦ ğŠ£ Â¦al di Â¦ğŠ¼ Â¦madeÂ¦ Â¦st oc ksÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦plan nedÂ¦ ğ‹‡Â¦w ed n es dayÂ¦ Â¦speci alÂ¦ Â¦availableÂ¦ Â¦earlyÂ¦ .
ğ‹‡Â¦thereÂ¦ Â¦areÂ¦ Â¦twoÂ¦ Â¦typ esÂ¦ Â¦ofÂ¦ Â¦can ineÂ¦ Â¦coronavirusÂ¦ â–( ğŠ£Â¦c cğŠ¼ o ğ‹‡ vÂ¦ ),â– Â¦oneÂ¦ Â¦thatÂ¦ Â¦cau sesÂ¦ Â¦mi ldÂ¦ Â¦ga st ro i nt est in alÂ¦ Â¦diseaseÂ¦ Â¦andÂ¦ Â¦oneÂ¦ Â¦thatÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦causeÂ¦ Â¦respiratoryÂ¦ Â¦diseaseÂ¦ .
ğ‹‡ Â¦whileÂ¦ Â¦int actÂ¦ ğŠ£ Â¦or f ğŠ¼ 4Â¦ Â¦couldÂ¦ Â¦beÂ¦ Â¦ob s er vedÂ¦ Â¦inÂ¦ Â¦b atÂ¦ Â¦andÂ¦ Â¦ca me lÂ¦ Â¦vi rusesÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - Â¦2 2 9 ğ‹‡ eÂ¦ ,â– Â¦theÂ¦ Â¦al p ac aÂ¦ Â¦al p haÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦dis p la ysÂ¦ Â¦aÂ¦ Â¦sing leÂ¦ Â¦n uc le o t ideÂ¦ Â¦ins er tionÂ¦ ,â– Â¦resul tingÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦f r am es hi f tÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦countriesÂ¦ Â¦inÂ¦ ğ‹‡Â¦a f r ic aÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦seenÂ¦ Â¦aÂ¦ Â¦r iseÂ¦ Â¦inÂ¦ Â¦a nt iÂ¦ - ğ‹‡Â¦chineseÂ¦ Â¦s enti mentÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦c am elsÂ¦ Â¦ser veÂ¦ Â¦asÂ¦ Â¦anÂ¦ Â¦importantÂ¦ Â¦to olÂ¦ Â¦forÂ¦ Â¦trans por t ationÂ¦ Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦m ainÂ¦ Â¦so ur ceÂ¦ Â¦ofÂ¦ Â¦me atÂ¦ ,â– Â¦m il kÂ¦ ,â– Â¦lea therÂ¦ Â¦andÂ¦ Â¦w o olÂ¦ Â¦produc tsÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦localÂ¦ Â¦peopleÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦theirÂ¦ Â¦workÂ¦ Â¦alsoÂ¦ Â¦nee dsÂ¦ Â¦up d ateÂ¦ Â¦accordingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦l at estÂ¦ ğ‹‡Â¦di a g no sisÂ¦ Â¦andÂ¦ ğ‹‡ Â¦treatmentÂ¦ ğ‹‡ Â¦guid el inesÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ â–( ğ‹‡ Â¦tri alÂ¦ Â¦se v en thÂ¦ Â¦ vers ionÂ¦ )â– Â¦andÂ¦ Â¦re ce ntlyÂ¦ Â¦stud iesÂ¦ .
ğ‹‡Â¦co ro na vi rusesÂ¦ Â¦canÂ¦ Â¦causeÂ¦ Â¦c ol dsÂ¦ Â¦withÂ¦ Â¦maj orÂ¦ Â¦symptomsÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦feverÂ¦ ,â– Â¦andÂ¦ Â¦aÂ¦ Â¦s oreÂ¦ Â¦th ro atÂ¦ Â¦fromÂ¦ Â¦sw olle nÂ¦ Â¦a de no i dsÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦studyÂ¦ Â¦p ub lish edÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğŠ£Â¦us Â¦ğŠ¼ ğ‹‡Â¦centerÂ¦ Â¦forÂ¦ ğ‹‡ Â¦diseaseÂ¦ ğ‹‡ Â¦controlÂ¦ Â¦andÂ¦ ğ‹‡ Â¦prev entionÂ¦ Â¦hasÂ¦ Â¦conc lu dedÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦5Â¦ . Â¦7Â¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦moreÂ¦ Â¦p at ho g en icÂ¦ Â¦thanÂ¦ Â¦comm unityÂ¦ - Â¦ac qu ir edÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ Â¦andÂ¦ Â¦lessÂ¦ Â¦p at ho g en icÂ¦ Â¦thanÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦orÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡Â¦atÂ¦ Â¦leastÂ¦ Â¦5 2Â¦ Â¦thousandÂ¦ Â¦deathsÂ¦ Â¦wereÂ¦ Â¦l in kedÂ¦ Â¦toÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦theÂ¦ Â¦diseaseÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ .
ğ‹‡ Â¦fourÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦coron a vi rusesÂ¦ Â¦cont in u allyÂ¦ Â¦c ir c ul ateÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦humanÂ¦ Â¦populationÂ¦ Â¦andÂ¦ Â¦produc eÂ¦ Â¦theÂ¦ Â¦gen er allyÂ¦ Â¦mi ldÂ¦ Â¦symptomsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦comm onÂ¦ Â¦co ldÂ¦ Â¦inÂ¦ Â¦ad ul tsÂ¦ Â¦andÂ¦ Â¦childrenÂ¦ Â¦wor l d w ideÂ¦ :â– - ğŠ£Â¦ oc 4 3Â¦ ,â– - Â¦h k u 1Â¦ ,â– Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - Â¦2 2 9 ğ‹‡ eÂ¦ ,â– - ğŠ£ Â¦n l ğŠ¼ 6 3Â¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦aprilÂ¦ Â¦7Â¦ ,â– Â¦2020Â¦ ,â– Â¦onlyÂ¦ Â¦aÂ¦ Â¦sing leÂ¦ Â¦testÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦approvedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğŠ£ Â¦f d a Â¦ğŠ¼ Â¦underÂ¦ Â¦anÂ¦ Â¦emergencyÂ¦ Â¦useÂ¦ Â¦a ut ho ri z ationÂ¦ . ğ‹‡Â¦inÂ¦ Â¦l ateÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– ğ‹‡Â¦e u ro i m m u nÂ¦ ğ‹‡ Â¦medicalÂ¦ ğ‹‡ Â¦labor atoryÂ¦ ğ‹‡Â¦di a g no st icsÂ¦ Â¦andÂ¦ ğ‹‡Â¦e p it op eÂ¦ ğ‹‡Â¦di a g no st icsÂ¦ Â¦recei vedÂ¦ ğ‹‡Â¦e ur op e anÂ¦ Â¦appro v alsÂ¦ Â¦forÂ¦ Â¦theirÂ¦ Â¦testÂ¦ Â¦ki tsÂ¦ ,â– Â¦whichÂ¦ Â¦canÂ¦ Â¦det ectÂ¦ ğ‹‡Â¦i g ğ‹‡ gÂ¦ Â¦andÂ¦ ğ‹‡Â¦i g ğ‹‡ aÂ¦ Â¦antib odiesÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦inÂ¦ Â¦bloodÂ¦ Â¦samplesÂ¦ .
ğ‹‡Â¦z o o no ticÂ¦ Â¦o ri g insÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ Â¦coron a vi rusesÂ¦
ğ‹‡ Â¦an y oneÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦familyÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦heartÂ¦ Â¦proble mÂ¦ Â¦heartÂ¦ Â¦diseaseÂ¦ Â¦heartÂ¦ Â¦att ackÂ¦ Â¦highÂ¦ Â¦ch ol est er olÂ¦ Â¦highÂ¦ Â¦bloodÂ¦ Â¦pr ess ureÂ¦
ğ‹‡ Â¦sho wÂ¦ Â¦ meÂ¦ Â¦onÂ¦ Â¦thisÂ¦ Â¦i ma geÂ¦ Â¦whereÂ¦ Â¦youÂ¦ Â¦f ee lÂ¦ Â¦theÂ¦ Â¦p ainÂ¦
ğ‹‡Â¦allÂ¦ Â¦ofÂ¦ Â¦themÂ¦ Â¦hadÂ¦ Â¦li veÂ¦ Â¦b ir thÂ¦ Â¦pre g na nc iesÂ¦ Â¦andÂ¦ Â¦noÂ¦ Â¦severeÂ¦ Â¦ne o na talÂ¦ Â¦as p h y xi aÂ¦ Â¦wasÂ¦ Â¦ob s er vedÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦cont ra stÂ¦ ,â– Â¦high lyÂ¦ Â¦p at ho g en icÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦haveÂ¦ Â¦notÂ¦ Â¦ad ap tedÂ¦ Â¦toÂ¦ Â¦hum ansÂ¦ Â¦wellÂ¦ Â¦andÂ¦ Â¦theirÂ¦ Â¦transmissionÂ¦ Â¦withinÂ¦ Â¦hum ansÂ¦ Â¦can no tÂ¦ Â¦beÂ¦ Â¦s us ta inedÂ¦ .
ğ‹‡Â¦b Â¦ ' ğ‹‡Â¦co ro na vi rusesÂ¦ Â¦areÂ¦ Â¦aÂ¦ Â¦groupÂ¦ Â¦ofÂ¦ Â¦relatedÂ¦ Â¦vi rusesÂ¦ Â¦thatÂ¦ Â¦causeÂ¦ Â¦dis easesÂ¦ Â¦inÂ¦ Â¦m am m alsÂ¦ Â¦andÂ¦ Â¦b ir dsÂ¦ .
ğ‹‡ Â¦threeÂ¦ Â¦fe etÂ¦ Â¦isÂ¦ Â¦consid eredÂ¦ Â¦anÂ¦ Â¦appro p ri ateÂ¦ Â¦distanceÂ¦ Â¦forÂ¦ Â¦peopleÂ¦ Â¦toÂ¦ Â¦st ayÂ¦ Â¦a wayÂ¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦patientÂ¦ .
ğ‹‡ Â¦fromÂ¦ Â¦anotherÂ¦ Â¦pers p ec tiveÂ¦ ,â– Â¦itÂ¦ Â¦mi ghtÂ¦ Â¦alsoÂ¦ Â¦beÂ¦ Â¦tr ueÂ¦ Â¦thatÂ¦ Â¦hum ansÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦wellÂ¦ Â¦ad ap tedÂ¦ Â¦toÂ¦ Â¦theseÂ¦ Â¦fourÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦th ur s dayÂ¦ ,â– ğ‹‡ Â¦associ atedÂ¦ ğ‹‡Â¦pr essÂ¦ Â¦reportedÂ¦ Â¦thereÂ¦ Â¦wereÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦1 2 6Â¦ , Â¦000Â¦ Â¦casesÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦wor l d w ideÂ¦ ,â– Â¦resul tingÂ¦ Â¦inÂ¦ Â¦overÂ¦ Â¦4Â¦ , Â¦6 00Â¦ Â¦deathsÂ¦ .
ğ‹‡Â¦chinaÂ¦ Â¦hasÂ¦ Â¦alsoÂ¦ Â¦calledÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğŠ£Â¦us Â¦ğŠ¼ Â¦toÂ¦ Â¦li f tÂ¦ Â¦itsÂ¦ Â¦sa nc tionsÂ¦ Â¦o ffÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦sy ri aÂ¦ ,â– ğ‹‡ Â¦ve ne z u el aÂ¦ Â¦andÂ¦ ğ‹‡Â¦ ir anÂ¦ ,â– Â¦whileÂ¦ Â¦re por t ed lyÂ¦ Â¦s en dingÂ¦ Â¦a idÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦la tterÂ¦ Â¦twoÂ¦ Â¦countriesÂ¦ .
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦cau sesÂ¦ Â¦severeÂ¦ Â¦respiratoryÂ¦ Â¦infectionÂ¦ Â¦likeÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦p res entedÂ¦ Â¦asÂ¦ Â¦feverÂ¦ ,â– Â¦c oughÂ¦ Â¦andÂ¦ Â¦d y s p ne aÂ¦ .
ğ‹‡Â¦me an w hi leÂ¦ ,â– Â¦theÂ¦ Â¦epi demicÂ¦ Â¦rapidlyÂ¦ Â¦spreadÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦ne i gh b or ingÂ¦ Â¦c itiesÂ¦ ,â– Â¦prov in cesÂ¦ ,â– Â¦andÂ¦ Â¦countriesÂ¦ .
ğ‹‡Â¦s por tsÂ¦ Â¦e ve ntsÂ¦ Â¦andÂ¦ Â¦se as onsÂ¦ Â¦wereÂ¦ Â¦can ce lledÂ¦ . ğ‹‡Â¦onÂ¦ Â¦11Â¦ ğ‹‡Â¦marchÂ¦ ,â– ğ‹‡ Â¦tr um pÂ¦ Â¦announcedÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ Â¦forÂ¦ Â¦mostÂ¦ Â¦ofÂ¦ ğ‹‡Â¦e ur op eÂ¦ ,â– Â¦ex c lu dingÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡ Â¦ki ng d omÂ¦ ,â– Â¦forÂ¦ Â¦30Â¦ Â¦daysÂ¦ ,â– Â¦effectiveÂ¦ Â¦1 3Â¦ ğ‹‡Â¦marchÂ¦ .
ğ‹‡ Â¦byÂ¦ Â¦1 3Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦moreÂ¦ Â¦thanÂ¦ Â¦for tyÂ¦ Â¦countriesÂ¦ Â¦andÂ¦ Â¦ter rit oriesÂ¦ Â¦hadÂ¦ Â¦reportedÂ¦ Â¦deathsÂ¦ ,â– Â¦onÂ¦ Â¦everyÂ¦ Â¦cont in entÂ¦ Â¦ex cep tÂ¦ ğ‹‡Â¦a nt ar ct ic aÂ¦ . ğ‹‡ Â¦severalÂ¦ Â¦measuresÂ¦ Â¦areÂ¦ Â¦comm on lyÂ¦ Â¦usedÂ¦ Â¦toÂ¦ Â¦qu an ti f yÂ¦ Â¦mor t alityÂ¦ .
ğ‹‡Â¦ ir aÂ¦ ğ‹‡ Â¦lo ng in iÂ¦ ,â– Â¦ etÂ¦ Â¦ alÂ¦ . ,â– Â¦ est ab lish edÂ¦ Â¦aÂ¦ Â¦mo de lÂ¦ Â¦toÂ¦ Â¦pr ed ic tÂ¦ Â¦theÂ¦ Â¦out c omeÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epi demicÂ¦ Â¦andÂ¦ Â¦su gg es tedÂ¦ Â¦thatÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦couldÂ¦ Â¦inf ectÂ¦ Â¦twoÂ¦ - Â¦th ir dsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦g lobalÂ¦ Â¦populationÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦3 1Â¦ ğ‹‡Â¦de ce mberÂ¦ Â¦2019Â¦ ,â– Â¦theÂ¦ Â¦outbreakÂ¦ Â¦wasÂ¦ Â¦tr ac edÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦no ve lÂ¦ Â¦str ainÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ ,â– Â¦whichÂ¦ Â¦wasÂ¦ Â¦givenÂ¦ Â¦theÂ¦ Â¦in teri mÂ¦ Â¦na meÂ¦ Â¦2019Â¦ - Â¦n ğ‹‡ co ğ‹‡ vÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡Â¦organizationÂ¦ â–( ğŠ£Â¦whoÂ¦ğŠ¼ ),â– Â¦la terÂ¦ Â¦re na medÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡ Â¦intern ationalÂ¦ ğ‹‡Â¦comm it te eÂ¦ Â¦onÂ¦ ğ‹‡ Â¦ta x on om yÂ¦ Â¦ofÂ¦ ğ‹‡Â¦vi rusesÂ¦ .
ğ‹‡Â¦f ol lowÂ¦ - Â¦upÂ¦ Â¦i ma gesÂ¦ Â¦afterÂ¦ Â¦de li veryÂ¦ Â¦sh ow edÂ¦ Â¦noÂ¦ Â¦pro gr ess ionÂ¦ Â¦ofÂ¦ Â¦p ne um o niaÂ¦ . ğ‹‡ Â¦mediaÂ¦ Â¦re por tsÂ¦ Â¦ind ic ateÂ¦ Â¦thatÂ¦ Â¦overÂ¦ Â¦100Â¦ Â¦womenÂ¦ Â¦withÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦mi ghtÂ¦ Â¦haveÂ¦ Â¦de li v eredÂ¦ ,â– Â¦andÂ¦ Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– Â¦noÂ¦ Â¦m at er n alÂ¦ Â¦deathsÂ¦ Â¦wereÂ¦ Â¦reportedÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ma in l andÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦maj orÂ¦ Â¦econom yÂ¦ Â¦andÂ¦ Â¦manufactur ingÂ¦ Â¦h ub Â¦ ,â– Â¦theÂ¦ Â¦v iralÂ¦ Â¦outbreakÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦seenÂ¦ Â¦toÂ¦ Â¦p oseÂ¦ Â¦aÂ¦ Â¦maj orÂ¦ Â¦d es ta bi li z ingÂ¦ Â¦th reatÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦g lobalÂ¦ Â¦econom yÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦es ti ma tesÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦deathÂ¦ - Â¦toÂ¦ - Â¦caseÂ¦ Â¦r ati oÂ¦ Â¦dec rea sedÂ¦ Â¦fromÂ¦ Â¦1 7Â¦ . Â¦3Â¦ % â–( Â¦forÂ¦ Â¦thoseÂ¦ Â¦withÂ¦ Â¦sy m pt omÂ¦ Â¦o ns etÂ¦ Â¦1Â¦ â€“ Â¦10Â¦ ğ‹‡Â¦januaryÂ¦ Â¦2020Â¦ )â– Â¦toÂ¦ Â¦ 0Â¦ . Â¦7Â¦ % â–( Â¦forÂ¦ Â¦thoseÂ¦ Â¦withÂ¦ Â¦sy m pt omÂ¦ Â¦o ns etÂ¦ Â¦afterÂ¦ Â¦1Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ ). ğ‹‡ Â¦otherÂ¦ Â¦measuresÂ¦ Â¦includeÂ¦ Â¦theÂ¦ Â¦caseÂ¦ Â¦f at alityÂ¦ Â¦rateÂ¦ â–( ğŠ£Â¦c f rÂ¦ğŠ¼ ),â– Â¦whichÂ¦ Â¦ ref l ectsÂ¦ Â¦theÂ¦ Â¦percentÂ¦ Â¦ofÂ¦ Â¦di a gn osedÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦di eÂ¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦diseaseÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ Â¦infectionÂ¦ Â¦f at alityÂ¦ Â¦rateÂ¦ â–( ğŠ£Â¦i f rÂ¦ğŠ¼ ),â– Â¦whichÂ¦ Â¦ ref l ectsÂ¦ Â¦theÂ¦ Â¦percentÂ¦ Â¦ofÂ¦ Â¦infectedÂ¦ â–( Â¦di a gn osedÂ¦ Â¦andÂ¦ Â¦un di a gn osedÂ¦ )â– Â¦whoÂ¦ Â¦di eÂ¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦diseaseÂ¦ .
ğ‹‡ Â¦currentlyÂ¦ ,â– Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦l ackÂ¦ Â¦ofÂ¦ Â¦effectiveÂ¦ Â¦andÂ¦ Â¦speci ficÂ¦ Â¦the rap yÂ¦ Â¦forÂ¦ ğŠ£ Â¦covidÂ¦ - Â¦19Â¦ ,â– Â¦t c m Â¦ğŠ¼ Â¦hasÂ¦ Â¦becomeÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦maj orÂ¦ Â¦al t er na tiveÂ¦ Â¦tre at mentsÂ¦ Â¦forÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ Â¦li ghtÂ¦ Â¦toÂ¦ Â¦m od er ateÂ¦ Â¦symptomsÂ¦ Â¦orÂ¦ Â¦forÂ¦ Â¦thoseÂ¦ Â¦whoÂ¦ Â¦haveÂ¦ Â¦rec ov eredÂ¦ Â¦fromÂ¦ Â¦severeÂ¦ Â¦sta gesÂ¦ .
ğ‹‡Â¦t ha il andÂ¦ Â¦isÂ¦ Â¦usingÂ¦ Â¦anÂ¦ Â¦appÂ¦ Â¦andÂ¦ ğŠ£ Â¦si m Â¦ğŠ¼ Â¦car dsÂ¦ Â¦forÂ¦ Â¦allÂ¦ Â¦tr av el ersÂ¦ Â¦toÂ¦ Â¦en for ceÂ¦ Â¦theirÂ¦ Â¦quarantineÂ¦ .
ğ‹‡ Â¦moreÂ¦ Â¦thanÂ¦ Â¦30Â¦ %â– Â¦ofÂ¦ Â¦patientsÂ¦ Â¦presentÂ¦ Â¦withÂ¦ Â¦ga st ro i nt est in alÂ¦ Â¦symptomsÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦di ar r he aÂ¦ Â¦andÂ¦ Â¦v o mi tingÂ¦ .
ğ‹‡Â¦m is in for m ationÂ¦ Â¦aboutÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦hasÂ¦ Â¦spreadÂ¦ Â¦on lineÂ¦ ,â– Â¦andÂ¦ Â¦thereÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦in ci de ntsÂ¦ Â¦ofÂ¦ Â¦ x en op ho bi aÂ¦ Â¦andÂ¦ Â¦dis c ri m inationÂ¦ Â¦againstÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦peopleÂ¦ ,â– Â¦otherÂ¦ Â¦peopleÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦ea stÂ¦ Â¦andÂ¦ ğ‹‡Â¦s ou th ea stÂ¦ ğ‹‡Â¦a si anÂ¦ Â¦d es c entÂ¦ Â¦andÂ¦ Â¦appe ara nceÂ¦ ,â– Â¦andÂ¦ Â¦o thersÂ¦ Â¦fromÂ¦ Â¦areasÂ¦ Â¦withÂ¦ Â¦si gni fic antÂ¦ Â¦virusÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦ad ap tiveÂ¦ Â¦de si g nsÂ¦ Â¦withinÂ¦ Â¦o ng o ingÂ¦ ğ‹‡ Â¦phaseÂ¦ ğŠ£Â¦i iÂ¦ - Â¦i i i Â¦ğŠ¼ Â¦clinicalÂ¦ Â¦trialsÂ¦ Â¦onÂ¦ Â¦ca nd id ateÂ¦ Â¦the rap e ut icsÂ¦ Â¦mayÂ¦ Â¦sh or tenÂ¦ Â¦tri alÂ¦ Â¦d ur ationsÂ¦ Â¦andÂ¦ Â¦useÂ¦ Â¦fe w erÂ¦ Â¦sub j ectsÂ¦ ,â– Â¦pos sib lyÂ¦ Â¦exp e di tingÂ¦ Â¦d eci sionsÂ¦ Â¦forÂ¦ Â¦earlyÂ¦ Â¦t erm inationÂ¦ Â¦orÂ¦ Â¦s uc c essÂ¦ ,â– Â¦andÂ¦ Â¦co or di na tingÂ¦ Â¦de si g nÂ¦ Â¦chan gesÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦speci ficÂ¦ Â¦tri alÂ¦ Â¦acrossÂ¦ Â¦itsÂ¦ Â¦intern ationalÂ¦ Â¦loc ationsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦u pp erÂ¦ Â¦es tim ateÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦r an geÂ¦ Â¦isÂ¦ Â¦con si st entÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦resul tsÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦ra nd omÂ¦ Â¦testingÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦inÂ¦ ğ‹‡Â¦g erm an yÂ¦ ,â– Â¦andÂ¦ Â¦aÂ¦ Â¦st ati st icalÂ¦ Â¦studyÂ¦ Â¦an al y s ingÂ¦ Â¦theÂ¦ Â¦imp actÂ¦ Â¦ofÂ¦ Â¦testingÂ¦ Â¦onÂ¦ ğŠ£Â¦c f rÂ¦ğŠ¼ Â¦es ti ma tesÂ¦ .
ğ‹‡ Â¦otherÂ¦ Â¦countriesÂ¦ Â¦alsoÂ¦ Â¦ad op tedÂ¦ Â¦aÂ¦ Â¦v ar ie tyÂ¦ Â¦ofÂ¦ Â¦measuresÂ¦ Â¦ ai medÂ¦ Â¦atÂ¦ Â¦li mi tingÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦sc ie nt istsÂ¦ Â¦ch oseÂ¦ Â¦toÂ¦ Â¦sh areÂ¦ Â¦theirÂ¦ Â¦resul tsÂ¦ Â¦qu ic k lyÂ¦ Â¦onÂ¦ Â¦pre p r in tÂ¦ Â¦s erv ersÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦b io ğ‹‡ r xi vÂ¦ .
ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦casesÂ¦ Â¦inÂ¦ ğŠ£ Â¦e uÂ¦ / Â¦e ea Â¦ğŠ¼ Â¦countriesÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦ukÂ¦ğŠ¼
ğ‹‡ Â¦bothÂ¦ Â¦d ru gsÂ¦ Â¦haveÂ¦ Â¦ext en siveÂ¦ Â¦inter ac tionsÂ¦ Â¦withÂ¦ Â¦p res c ri p tionÂ¦ Â¦d ru gsÂ¦ ,â– Â¦a ff ec tingÂ¦ Â¦theÂ¦ Â¦the rap e u ticÂ¦ Â¦doseÂ¦ Â¦andÂ¦ Â¦diseaseÂ¦ Â¦mi tig ationÂ¦ .
ğ‹‡Â¦al thoughÂ¦ Â¦ba tsÂ¦ Â¦haveÂ¦ Â¦manyÂ¦ Â¦fe at uresÂ¦ Â¦thatÂ¦ Â¦f av o ur sÂ¦ Â¦theÂ¦ Â¦sprea dingÂ¦ Â¦ofÂ¦ Â¦vi rusesÂ¦ ,â– Â¦theÂ¦ Â¦cha nceÂ¦ Â¦forÂ¦ Â¦hum ansÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦inÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦ba tsÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦w il d li feÂ¦ Â¦speci esÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦mi ni mi zedÂ¦ Â¦ifÂ¦ Â¦peopleÂ¦ Â¦areÂ¦ Â¦ ed uc atedÂ¦ Â¦toÂ¦ Â¦st ayÂ¦ Â¦a wayÂ¦ Â¦fromÂ¦ Â¦themÂ¦ .
ğ‹‡ Â¦fin allyÂ¦ ,â– Â¦al p ac aÂ¦ Â¦al p haÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦hasÂ¦ Â¦notÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦f er alÂ¦ Â¦ani m alsÂ¦ .
ğ‹‡Â¦manyÂ¦ Â¦d io ce sesÂ¦ Â¦haveÂ¦ Â¦recomme ndedÂ¦ Â¦ ol derÂ¦ ğ‹‡Â¦ch r is ti ansÂ¦ Â¦toÂ¦ Â¦st ayÂ¦ Â¦atÂ¦ Â¦homeÂ¦ Â¦ra therÂ¦ Â¦thanÂ¦ Â¦att en dingÂ¦ ğ‹‡Â¦m as sÂ¦ Â¦onÂ¦ ğ‹‡ Â¦su nd a ysÂ¦ ;â– Â¦someÂ¦ Â¦ch ur ch esÂ¦ Â¦haveÂ¦ Â¦madeÂ¦ Â¦ch ur chÂ¦ Â¦servicesÂ¦ Â¦availableÂ¦ Â¦vi aÂ¦ Â¦ra di oÂ¦ ,â– Â¦on lineÂ¦ Â¦li veÂ¦ Â¦st re am ingÂ¦ Â¦orÂ¦ Â¦te le v is ionÂ¦ Â¦whileÂ¦ Â¦o thersÂ¦ Â¦areÂ¦ Â¦off eringÂ¦ Â¦d ri veÂ¦ - Â¦inÂ¦ Â¦wor s hi pÂ¦ .
ğ‹‡Â¦ tenÂ¦ Â¦yearsÂ¦ Â¦la terÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦m id d leÂ¦ ğ‹‡ Â¦ea stÂ¦ Â¦respiratoryÂ¦ Â¦sy nd r omeÂ¦ â–( ğŠ£Â¦m ersÂ¦ ğŠ¼ )â– Â¦outbreakÂ¦ Â¦resul tedÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦per si st entÂ¦ Â¦epi demicÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦ ara bi anÂ¦ ğ‹‡Â¦p e ni ns ul aÂ¦ Â¦withÂ¦ Â¦s po ra d icÂ¦ Â¦sprea dingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦r estÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦worldÂ¦ .
ğ‹‡ Â¦onlyÂ¦ Â¦fewÂ¦ Â¦re por tsÂ¦ Â¦ofÂ¦ Â¦labor atoryÂ¦ - Â¦confirmedÂ¦ Â¦as y m pt o ma ticÂ¦ Â¦casesÂ¦ Â¦e xi stÂ¦ ,â– Â¦butÂ¦ Â¦as y m pt o ma ticÂ¦ Â¦transmissionÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦ id enti fiedÂ¦ Â¦byÂ¦ Â¦someÂ¦ Â¦countriesÂ¦ Â¦duringÂ¦ Â¦contactÂ¦ Â¦tr ac ingÂ¦ Â¦inv es tig ationsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦h ostÂ¦ Â¦ rib os omeÂ¦ Â¦trans la tesÂ¦ Â¦theÂ¦ Â¦initi alÂ¦ Â¦over la pp ingÂ¦ Â¦openÂ¦ Â¦rea dingÂ¦ Â¦f ra meÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦gen omeÂ¦ Â¦andÂ¦ Â¦for msÂ¦ Â¦aÂ¦ Â¦longÂ¦ Â¦pol y p ro te inÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦2 9Â¦ ğ‹‡Â¦marchÂ¦ Â¦itÂ¦ Â¦wasÂ¦ Â¦reportedÂ¦ Â¦thatÂ¦ Â¦beg in ningÂ¦ Â¦1Â¦ ğ‹‡Â¦aprilÂ¦ Â¦allÂ¦ Â¦newÂ¦ Â¦over se asÂ¦ Â¦ar ri v alsÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦qu ara nt inedÂ¦ Â¦forÂ¦ Â¦twoÂ¦ Â¦weeksÂ¦ .
ğ‹‡ Â¦mostÂ¦ Â¦no ve lÂ¦ Â¦drugÂ¦ Â¦ca nd id a tesÂ¦ â–( ğŠ£ Â¦n ce ğŠ¼ sÂ¦ )â– Â¦f ai lÂ¦ Â¦duringÂ¦ Â¦drugÂ¦ Â¦developmentÂ¦ ,â– Â¦e i therÂ¦ Â¦becauseÂ¦ Â¦theyÂ¦ Â¦haveÂ¦ Â¦un ac ce pt ableÂ¦ Â¦to x ic ityÂ¦ Â¦orÂ¦ Â¦becauseÂ¦ Â¦theyÂ¦ Â¦si mp lyÂ¦ Â¦doÂ¦ Â¦notÂ¦ Â¦pro veÂ¦ Â¦e ffic ac yÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦t ar ge tedÂ¦ Â¦diseaseÂ¦ ,â– Â¦asÂ¦ Â¦sh ownÂ¦ Â¦inÂ¦ ğ‹‡ Â¦phaseÂ¦ ğŠ£Â¦i iÂ¦ - Â¦i i i Â¦ğŠ¼ Â¦clinicalÂ¦ Â¦trialsÂ¦ .
ğŠ£ Â¦e uÂ¦ğŠ¼ Â¦fo re i g nÂ¦ Â¦po lic yÂ¦ Â¦ch ie fÂ¦ ğ‹‡ Â¦jo se pÂ¦ ğ‹‡Â¦b or r ellÂ¦ Â¦w ar nedÂ¦ Â¦thatÂ¦ Â¦thereÂ¦ Â¦isÂ¦ â–" Â¦aÂ¦ Â¦ge oÂ¦ - Â¦pol iticalÂ¦ Â¦comp on entÂ¦ Â¦includingÂ¦ Â¦aÂ¦ Â¦ stru gg leÂ¦ Â¦forÂ¦ Â¦inf lu e nceÂ¦ Â¦throughÂ¦ Â¦sp in ningÂ¦ Â¦andÂ¦ Â¦theÂ¦ â–' Â¦pol it icsÂ¦ Â¦ofÂ¦ Â¦gen er os ityÂ¦ ' " .
ğ‹‡Â¦al thoughÂ¦ Â¦severalÂ¦ Â¦countriesÂ¦ Â¦useÂ¦ Â¦ch lo ro qu ineÂ¦ Â¦orÂ¦ Â¦hy d ro x y ch lo ro qu ineÂ¦ Â¦forÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ Â¦pers onsÂ¦ Â¦hos pi ta li zedÂ¦ Â¦withÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ Â¦theÂ¦ Â¦drugÂ¦ Â¦hasÂ¦ Â¦notÂ¦ Â¦beenÂ¦ Â¦for m allyÂ¦ Â¦approvedÂ¦ Â¦throughÂ¦ Â¦clinicalÂ¦ Â¦trialsÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ .
ğ‹‡Â¦ne ver th el essÂ¦ ,â– Â¦respiratoryÂ¦ Â¦d y s f un ctionÂ¦ Â¦andÂ¦ Â¦fa il ureÂ¦ Â¦areÂ¦ Â¦theÂ¦ Â¦maj orÂ¦ Â¦th reatÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦patientsÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦maj orÂ¦ Â¦causeÂ¦ Â¦ofÂ¦ Â¦deathÂ¦ .
ğ‹‡ Â¦firstÂ¦ ,â– Â¦hum ansÂ¦ Â¦butÂ¦ Â¦notÂ¦ Â¦al p ac asÂ¦ Â¦mi ghtÂ¦ Â¦haveÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦ba tsÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦sh aredÂ¦ Â¦e co log icalÂ¦ Â¦ ni ch eÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦thatÂ¦ Â¦aÂ¦ Â¦b atÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ Â¦ter medÂ¦ ğŠ£ Â¦ar cğŠ¼ o ğ‹‡ vÂ¦ . Â¦2Â¦ â–( ğ‹‡ Â¦app al ac hi anÂ¦ ğ‹‡Â¦r id geÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ )â– Â¦det ectedÂ¦ Â¦inÂ¦ ğ‹‡Â¦n or thÂ¦ ğ‹‡Â¦a mer ic anÂ¦ Â¦ tric ol or edÂ¦ Â¦b atÂ¦ Â¦dis p la y edÂ¦ Â¦cl oseÂ¦ Â¦rel at io ns hi pÂ¦ Â¦withÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£ Â¦n l ğŠ¼ 6 3Â¦ .
ğ‹‡Â¦vi ro log icalÂ¦ Â¦surveillanceÂ¦ Â¦isÂ¦ Â¦doneÂ¦ Â¦byÂ¦ Â¦usingÂ¦ Â¦m ol ec ul arÂ¦ Â¦testsÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡Â¦thereÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦supp ortÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ ,â– Â¦bothÂ¦ Â¦onÂ¦ Â¦andÂ¦ Â¦off lineÂ¦ ,â– Â¦andÂ¦ Â¦t ow ar dsÂ¦ Â¦thoseÂ¦ Â¦inÂ¦ Â¦virusÂ¦ - Â¦s tric k enÂ¦ Â¦areasÂ¦ .
ğ‹‡Â¦vi rusesÂ¦ Â¦canÂ¦ Â¦alsoÂ¦ Â¦inf ectÂ¦ Â¦anÂ¦ Â¦in di v id u alÂ¦ Â¦throughÂ¦ Â¦theÂ¦ Â¦e y esÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦20Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦beg anÂ¦ Â¦toÂ¦ Â¦par ti allyÂ¦ Â¦with d ra w alÂ¦ Â¦itsÂ¦ Â¦t ro o psÂ¦ Â¦fromÂ¦ ğ‹‡Â¦i ra q Â¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦aÂ¦ Â¦resultÂ¦ ,â– Â¦theÂ¦ Â¦governmentÂ¦ Â¦recei vedÂ¦ Â¦c rit ic is mÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦per ce i vedÂ¦ Â¦l ackÂ¦ Â¦ofÂ¦ Â¦p aceÂ¦ Â¦andÂ¦ Â¦in te ns ityÂ¦ Â¦inÂ¦ Â¦itsÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦conc er nsÂ¦ Â¦f ac edÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦publicÂ¦ . ğ‹‡Â¦onÂ¦ Â¦1 6Â¦ ğ‹‡Â¦marchÂ¦ ,â– ğ‹‡Â¦primeÂ¦ ğ‹‡Â¦ministerÂ¦ ğ‹‡ Â¦bo ri sÂ¦ ğ‹‡ Â¦jo h ns onÂ¦ Â¦madeÂ¦ Â¦anÂ¦ Â¦an n oun ce mentÂ¦ Â¦ad v is ingÂ¦ Â¦againstÂ¦ Â¦allÂ¦ Â¦n onÂ¦ - Â¦essentialÂ¦ Â¦travelÂ¦ Â¦andÂ¦ Â¦socialÂ¦ Â¦contactÂ¦ ,â– Â¦su gg es tingÂ¦ Â¦peopleÂ¦ Â¦workÂ¦ Â¦fromÂ¦ Â¦homeÂ¦ Â¦whereÂ¦ Â¦possibleÂ¦ Â¦andÂ¦ Â¦avo idÂ¦ Â¦v en u esÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦p ub sÂ¦ ,â– Â¦res ta u ra ntsÂ¦ ,â– Â¦andÂ¦ Â¦th ea tr esÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦11Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– ğŠ£Â¦whoÂ¦ğŠ¼ Â¦c har ac teri zedÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦asÂ¦ Â¦aÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦exa mpleÂ¦ ,â– ğ‹‡ Â¦be i j ingÂ¦ Â¦hasÂ¦ Â¦imposedÂ¦ Â¦aÂ¦ Â¦14Â¦ - Â¦dayÂ¦ Â¦ma nd atoryÂ¦ Â¦quarantineÂ¦ Â¦forÂ¦ Â¦allÂ¦ Â¦intern ationalÂ¦ Â¦tra ve ll ersÂ¦ Â¦ent eringÂ¦ Â¦theÂ¦ Â¦cityÂ¦ . ğ‹‡Â¦onÂ¦ Â¦2 3Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦ma in l andÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦onlyÂ¦ Â¦oneÂ¦ Â¦caseÂ¦ Â¦hadÂ¦ Â¦trans m it tedÂ¦ Â¦d om est icallyÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦fiveÂ¦ Â¦daysÂ¦ Â¦pri orÂ¦ ,â– Â¦inÂ¦ Â¦thisÂ¦ Â¦ins ta nceÂ¦ Â¦vi aÂ¦ Â¦aÂ¦ Â¦tra ve ll erÂ¦ Â¦re tur ningÂ¦ Â¦toÂ¦ ğ‹‡Â¦g u a ng z ho uÂ¦ Â¦fromÂ¦ ğ‹‡Â¦i st an b ulÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦pa stÂ¦ Â¦dec a d esÂ¦ ,â– Â¦se v enÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦ id enti fiedÂ¦ .
ğ‹‡Â¦b atÂ¦ Â¦al p haÂ¦ - ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦clos e lyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - Â¦2 2 9 ğ‹‡ eÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦onÂ¦ Â¦12Â¦ ğ‹‡Â¦mayÂ¦ Â¦201 3Â¦ ,â– Â¦aÂ¦ Â¦caseÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦inÂ¦ ğ‹‡Â¦f ra nceÂ¦ Â¦wasÂ¦ Â¦confirmedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦f r en chÂ¦ ğ‹‡Â¦ministryÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦socialÂ¦ ğ‹‡Â¦a ff a ir sÂ¦ Â¦andÂ¦ ğ‹‡Â¦healthÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦ita li anÂ¦ ğ‹‡Â¦ra d io log icalÂ¦ ğ‹‡Â¦s oc ie tyÂ¦ Â¦isÂ¦ Â¦comp il ingÂ¦ Â¦anÂ¦ Â¦intern ationalÂ¦ Â¦on lineÂ¦ Â¦d at ab aseÂ¦ Â¦ofÂ¦ Â¦i ma g ingÂ¦ Â¦fin di ngsÂ¦ Â¦forÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦2 8Â¦ ğ‹‡Â¦februaryÂ¦ ,â– ğ‹‡ Â¦sc op eÂ¦ ğ‹‡Â¦r ati ngsÂ¦ ğ‹‡Â¦g mb ğ‹‡ hÂ¦ Â¦a ff ir medÂ¦ ğ‹‡Â¦chinaÂ¦ ' Â¦sÂ¦ Â¦so ve re i g nÂ¦ Â¦cr ed itÂ¦ Â¦ra tingÂ¦ ,â– Â¦butÂ¦ Â¦ma in ta inedÂ¦ Â¦aÂ¦ ğ‹‡Â¦ne ga tiveÂ¦ ğ‹‡ Â¦out lo okÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦epi demicÂ¦ Â¦co i nc idedÂ¦ Â¦withÂ¦ Â¦theÂ¦ ğ‹‡Â¦ch un y u nÂ¦ ,â– Â¦aÂ¦ Â¦maj orÂ¦ Â¦travelÂ¦ Â¦se as onÂ¦ Â¦associ atedÂ¦ Â¦withÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ ğ‹‡ Â¦newÂ¦ ğ‹‡ Â¦yearÂ¦ Â¦ho li dayÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦m il est oneÂ¦ Â¦ca meÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ ğ‹‡Â¦ma la w iÂ¦ Â¦confirmedÂ¦ Â¦itsÂ¦ Â¦firstÂ¦ Â¦coronavirusÂ¦ Â¦infectionsÂ¦ Â¦andÂ¦ ğ‹‡Â¦z am bi aÂ¦ Â¦hadÂ¦ Â¦itsÂ¦ Â¦firstÂ¦ Â¦coronavirusÂ¦ - Â¦relatedÂ¦ Â¦deathÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦virusÂ¦ Â¦thatÂ¦ Â¦causedÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦isÂ¦ Â¦knownÂ¦ Â¦asÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ,â– Â¦aÂ¦ Â¦ne w lyÂ¦ Â¦dis c ov eredÂ¦ Â¦virusÂ¦ Â¦clos e lyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦b atÂ¦ Â¦coron a vi rusesÂ¦ ,â– Â¦pa ng ol inÂ¦ Â¦coron a vi rusesÂ¦ ,â– Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ . ğ‹‡Â¦theÂ¦ Â¦e ar li estÂ¦ Â¦knownÂ¦ Â¦personÂ¦ Â¦withÂ¦ Â¦symptomsÂ¦ Â¦wasÂ¦ Â¦la terÂ¦ Â¦dis c ov eredÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦fa ll enÂ¦ Â¦ illÂ¦ Â¦onÂ¦ Â¦1Â¦ ğ‹‡Â¦de ce mberÂ¦ Â¦2019Â¦ ,â– Â¦andÂ¦ Â¦thatÂ¦ Â¦personÂ¦ Â¦didÂ¦ Â¦notÂ¦ Â¦haveÂ¦ Â¦vi sib leÂ¦ Â¦con n ectionsÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦la terÂ¦ Â¦w etÂ¦ Â¦marke tÂ¦ Â¦cl us terÂ¦ .
ğ‹‡Â¦th usÂ¦ ,â– Â¦theyÂ¦ Â¦areÂ¦ Â¦tra di ti onalÂ¦ Â¦marke r sÂ¦ Â¦forÂ¦ Â¦heartÂ¦ Â¦orÂ¦ Â¦li verÂ¦ Â¦d y s f u nc tionsÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦j ap anÂ¦ ,â– Â¦theÂ¦ Â¦h as h ta gÂ¦ â– # ğ‹‡Â¦c hi ne se ğ‹‡ d o nt ğ‹‡ co me ğ‹‡ t o ğ‹‡ j ap anÂ¦ Â¦tre ndedÂ¦ Â¦onÂ¦ ğ‹‡ Â¦tw i tterÂ¦ .
ğ‹‡Â¦b es id esÂ¦ ,â– Â¦thereÂ¦ Â¦areÂ¦ Â¦moreÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦e vi denceÂ¦ Â¦thatÂ¦ Â¦rem in dÂ¦ Â¦ usÂ¦ Â¦toÂ¦ Â¦cau tionÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ at y p icalÂ¦ Â¦sy m pt o ma ticÂ¦ Â¦andÂ¦ Â¦as y m pt o ma ticÂ¦ Â¦patientsÂ¦ .
ğ‹‡ Â¦sub se qu entÂ¦ Â¦ser op re v a le nceÂ¦ Â¦inv es tig ationsÂ¦ Â¦ind ic atedÂ¦ Â¦thatÂ¦ Â¦ani malÂ¦ Â¦tra dersÂ¦ Â¦hadÂ¦ Â¦aÂ¦ Â¦higherÂ¦ Â¦prev a le nceÂ¦ Â¦ofÂ¦ Â¦a nt iÂ¦ - ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ğ‹‡Â¦i g ğ‹‡ gÂ¦ Â¦comp aredÂ¦ Â¦withÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦generalÂ¦ Â¦populationÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦3 1Â¦ ğ‹‡Â¦de ce mberÂ¦ Â¦2019Â¦ ,â– Â¦aÂ¦ Â¦cl us terÂ¦ Â¦ofÂ¦ Â¦p ne um o niaÂ¦ Â¦casesÂ¦ Â¦ofÂ¦ Â¦un k n ownÂ¦ Â¦a e t io logyÂ¦ Â¦wasÂ¦ Â¦reportedÂ¦ Â¦inÂ¦ ğ‹‡Â¦w uhanÂ¦ ,â– ğ‹‡Â¦h ub e iÂ¦ ğ‹‡ Â¦pro vi nceÂ¦ ,â– ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦no tedÂ¦ Â¦theÂ¦ Â¦cont ra stÂ¦ Â¦betweenÂ¦ Â¦theÂ¦ Â¦20 0 2Â¦ â€“ Â¦20 0 4Â¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦outbreakÂ¦ ,â– Â¦whereÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦a u th or itiesÂ¦ Â¦wereÂ¦ Â¦acc u sedÂ¦ Â¦ofÂ¦ Â¦s ecre c yÂ¦ Â¦thatÂ¦ Â¦imp e dedÂ¦ Â¦prev entionÂ¦ Â¦andÂ¦ Â¦conta in mentÂ¦ Â¦e f for tsÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ Â¦currentÂ¦ Â¦crisisÂ¦ Â¦whereÂ¦ Â¦theÂ¦ Â¦centralÂ¦ Â¦governmentÂ¦ â–" Â¦hasÂ¦ Â¦prov idedÂ¦ Â¦regul arÂ¦ Â¦up d a tesÂ¦ Â¦toÂ¦ Â¦avo idÂ¦ Â¦p an icÂ¦ Â¦a he adÂ¦ Â¦ofÂ¦ ğ‹‡Â¦l un arÂ¦ ğ‹‡ Â¦newÂ¦ ğ‹‡ Â¦yearÂ¦ Â¦h ol id a ysÂ¦ " .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦thereÂ¦ Â¦areÂ¦ Â¦someÂ¦ Â¦rem ar k ableÂ¦ Â¦di ff er en cesÂ¦ Â¦betweenÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ ,â– Â¦whichÂ¦ Â¦areÂ¦ Â¦essentialÂ¦ Â¦forÂ¦ Â¦cont ainingÂ¦ Â¦theÂ¦ Â¦epi demicÂ¦ Â¦andÂ¦ Â¦t rea tingÂ¦ Â¦theÂ¦ Â¦patientsÂ¦ .
ğ‹‡ Â¦patientsÂ¦ Â¦o f tenÂ¦ Â¦develop Â¦ Â¦anÂ¦ Â¦ at y p icalÂ¦ Â¦p ne um o niaÂ¦ ,â– Â¦ac uteÂ¦ Â¦l un gÂ¦ Â¦inj ur yÂ¦ ,â– Â¦andÂ¦ Â¦ac uteÂ¦ Â¦respiratoryÂ¦ Â¦dis tr essÂ¦ Â¦sy nd r omeÂ¦ â–( ğŠ£ Â¦ar dsÂ¦ ğŠ¼ ).
ğ‹‡ Â¦ph y lo ge nt icallyÂ¦ ,â– Â¦mo useÂ¦ Â¦he p ati ti sÂ¦ Â¦virusÂ¦ â–( ğ‹‡Â¦m ur ineÂ¦ Â¦coronavirusÂ¦ ),â– Â¦whichÂ¦ Â¦inf ectsÂ¦ Â¦theÂ¦ Â¦mo useÂ¦ ' Â¦sÂ¦ Â¦li verÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦centralÂ¦ Â¦n erv o usÂ¦ Â¦systemÂ¦ ,â– Â¦isÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦humanÂ¦ Â¦coronavirusÂ¦ ğŠ£ Â¦o cğŠ¼ 4 3Â¦ Â¦andÂ¦ Â¦b ov ineÂ¦ Â¦coronavirusÂ¦ .
ğ‹‡ Â¦on lineÂ¦ ,â– Â¦n u me ro usÂ¦ Â¦coronavirusÂ¦ - Â¦the medÂ¦ ğ‹‡ Â¦intern etÂ¦ Â¦me m esÂ¦ Â¦haveÂ¦ Â¦spreadÂ¦ Â¦asÂ¦ Â¦manyÂ¦ Â¦ tur nÂ¦ Â¦toÂ¦ Â¦hum o urÂ¦ Â¦andÂ¦ Â¦di stra ctionÂ¦ Â¦ am idÂ¦ Â¦u nc er ta in tyÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦ofÂ¦ Â¦thoseÂ¦ Â¦infectedÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦as y m pt o ma ticÂ¦ ,â– Â¦withÂ¦ Â¦noÂ¦ Â¦clinicalÂ¦ Â¦symptomsÂ¦ Â¦butÂ¦ Â¦withÂ¦ Â¦testÂ¦ Â¦resul tsÂ¦ Â¦thatÂ¦ Â¦confir mÂ¦ Â¦infectionÂ¦ ,â– Â¦soÂ¦ Â¦re se ar ch ersÂ¦ Â¦haveÂ¦ Â¦issuedÂ¦ Â¦ad v iceÂ¦ Â¦thatÂ¦ Â¦thoseÂ¦ Â¦withÂ¦ Â¦cl oseÂ¦ Â¦contactÂ¦ Â¦toÂ¦ Â¦confirmedÂ¦ Â¦infectedÂ¦ Â¦peopleÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦clos e lyÂ¦ Â¦monit or edÂ¦ Â¦andÂ¦ Â¦exam inedÂ¦ Â¦toÂ¦ Â¦ ru leÂ¦ Â¦outÂ¦ Â¦infectionÂ¦ .
ğ‹‡ Â¦andÂ¦ Â¦al ongÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦feverÂ¦
ğ‹‡Â¦l edÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦b illÂ¦ Â¦andÂ¦ ğ‹‡Â¦me li nd aÂ¦ ğ‹‡ Â¦ga tesÂ¦ ğ‹‡Â¦f ou nd ationÂ¦ Â¦withÂ¦ Â¦part n ersÂ¦ Â¦inv es tingÂ¦ ğŠ£Â¦us Â¦ğŠ¼ $ Â¦1 2 5Â¦ Â¦millionÂ¦ Â¦andÂ¦ Â¦co or di na tingÂ¦ Â¦withÂ¦ Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡Â¦organizationÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ğ‹‡ Â¦the rap e ut icsÂ¦ ğ‹‡ Â¦acc el er atorÂ¦ Â¦beg anÂ¦ Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦facil i ta tingÂ¦ Â¦drugÂ¦ Â¦developmentÂ¦ Â¦re se ar ch ersÂ¦ Â¦toÂ¦ Â¦rapidlyÂ¦ Â¦ id enti f yÂ¦ ,â– Â¦ass essÂ¦ ,â– Â¦develop Â¦ ,â– Â¦andÂ¦ Â¦sc a leÂ¦ Â¦upÂ¦ Â¦po t enti alÂ¦ Â¦tre at mentsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦tr ueÂ¦ Â¦f at al itiesÂ¦ Â¦fromÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦muchÂ¦ Â¦higherÂ¦ ,â– Â¦asÂ¦ Â¦itÂ¦ Â¦mayÂ¦ Â¦notÂ¦ Â¦includeÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦di eÂ¦ Â¦withoutÂ¦ Â¦testingÂ¦ â–-â– Â¦ eÂ¦ . Â¦ gÂ¦ .â– Â¦atÂ¦ Â¦homeÂ¦ ,â– Â¦inÂ¦ Â¦n ur s ingÂ¦ Â¦h om esÂ¦ ,â– Â¦e t c Â¦ .
ğ‹‡Â¦c er ta in lyÂ¦ ,â– Â¦thisÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦aÂ¦ Â¦go odÂ¦ Â¦sig nÂ¦ Â¦ofÂ¦ ğ‹‡Â¦e ur op e anÂ¦ Â¦s ol id ar ityÂ¦ ."
ğ‹‡Â¦aÂ¦ Â¦ medi anÂ¦ Â¦c ostÂ¦ Â¦es tim ateÂ¦ Â¦ofÂ¦ Â¦201 5Â¦ - Â¦1 6Â¦ Â¦trialsÂ¦ Â¦forÂ¦ Â¦developmentÂ¦ Â¦ofÂ¦ Â¦10Â¦ Â¦a nt iÂ¦ - Â¦ca nc erÂ¦ Â¦d ru gsÂ¦ Â¦wasÂ¦ â– $ Â¦6 4 8Â¦ Â¦millionÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ ,â– Â¦givenÂ¦ Â¦theÂ¦ Â¦the rap e u ticÂ¦ Â¦effec tsÂ¦ ,â– Â¦someÂ¦ Â¦dis a d v an ta gesÂ¦ Â¦associ atedÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦pl as maÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦consid eredÂ¦ Â¦ca ref ul lyÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦campaignÂ¦ Â¦forÂ¦ ğ‹‡Â¦n uc le arÂ¦ ğ‹‡ Â¦dis ar ma mentÂ¦ ' Â¦sÂ¦ Â¦generalÂ¦ Â¦s ecre t aryÂ¦ ğ‹‡Â¦k ateÂ¦ ğ‹‡Â¦h u d s onÂ¦ Â¦c ri ti ci zedÂ¦ Â¦theÂ¦ ğ‹‡Â¦de f en derÂ¦ Â¦2020Â¦ Â¦ex er c iseÂ¦ : â–" ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦currentÂ¦ Â¦publicÂ¦ - Â¦healthÂ¦ Â¦crisisÂ¦ ,â– Â¦itÂ¦ Â¦j e o par di z esÂ¦ Â¦theÂ¦ Â¦li vesÂ¦ Â¦notÂ¦ Â¦onlyÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦t ro o psÂ¦ Â¦fromÂ¦ Â¦theÂ¦ ğŠ£Â¦us Â¦ğŠ¼ Â¦andÂ¦ Â¦theÂ¦ Â¦manyÂ¦ ğ‹‡Â¦e ur op e anÂ¦ Â¦countriesÂ¦ Â¦par ti cip a tingÂ¦ Â¦butÂ¦ Â¦theÂ¦ Â¦in ha bi ta ntsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦countriesÂ¦ Â¦inÂ¦ Â¦whichÂ¦ Â¦theyÂ¦ Â¦areÂ¦ Â¦op e ra tingÂ¦ ." ğ‹‡Â¦theÂ¦ ğ‹‡Â¦i ra ni anÂ¦ Â¦governmentÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦h ea vi lyÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦virusÂ¦ ,â– Â¦withÂ¦ Â¦aroundÂ¦ Â¦twoÂ¦ Â¦do z enÂ¦ Â¦par li a mentÂ¦ Â¦me mb ersÂ¦ Â¦infectedÂ¦ Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦fi f te enÂ¦ Â¦otherÂ¦ Â¦currentÂ¦ Â¦orÂ¦ Â¦for m erÂ¦ Â¦pol iticalÂ¦ Â¦fi g uresÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦aÂ¦ Â¦comm onÂ¦ Â¦p ra ct iceÂ¦ ,â– Â¦in di v id u alsÂ¦ Â¦exp osedÂ¦ Â¦toÂ¦ ,â– Â¦orÂ¦ Â¦infectedÂ¦ Â¦byÂ¦ ,â– Â¦theÂ¦ Â¦virusÂ¦ Â¦areÂ¦ Â¦us u allyÂ¦ Â¦requir edÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦qu ara nt inedÂ¦ Â¦forÂ¦ Â¦14Â¦ Â¦daysÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦vi ru le nceÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦co me b ackÂ¦ Â¦wouldÂ¦ Â¦dep endÂ¦ Â¦onÂ¦ Â¦h er dÂ¦ Â¦imm unityÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦ext entÂ¦ Â¦ofÂ¦ Â¦mut ationÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦theyÂ¦ Â¦areÂ¦ Â¦e qu allyÂ¦ Â¦clos e lyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ ğ‹‡Â¦ra ğŠ£ t g ğŠ¼ 1 3Â¦ Â¦withÂ¦ Â¦aboutÂ¦ Â¦9 0Â¦ %â– Â¦i de nt ityÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦n uc le o t ideÂ¦ Â¦se que nceÂ¦ .
ğ‹‡Â¦someÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦studentsÂ¦ Â¦atÂ¦ ğ‹‡Â¦a mer ic anÂ¦ Â¦u ni vers itiesÂ¦ Â¦jo inedÂ¦ Â¦to ge therÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦s endÂ¦ Â¦a idÂ¦ Â¦toÂ¦ Â¦virusÂ¦ - Â¦s tric k enÂ¦ Â¦par tsÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦withÂ¦ Â¦aÂ¦ Â¦jo in tÂ¦ Â¦groupÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦g rea terÂ¦ ğ‹‡Â¦ch ic a g oÂ¦ Â¦areaÂ¦ Â¦re por t ed lyÂ¦ Â¦ma na g ingÂ¦ Â¦toÂ¦ Â¦s endÂ¦ Â¦50Â¦ , Â¦000Â¦ ğ‹‡Â¦n 9 5Â¦ Â¦masksÂ¦ Â¦toÂ¦ Â¦hospitalsÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦h ub e iÂ¦ Â¦pro vi nceÂ¦ Â¦onÂ¦ Â¦30Â¦ ğ‹‡Â¦januaryÂ¦ . ğ‹‡Â¦theÂ¦ Â¦hum an it ari anÂ¦ Â¦a idÂ¦ Â¦or ga ni z ationÂ¦ ğ‹‡Â¦d ir ectÂ¦ ğ‹‡ Â¦rel ie fÂ¦ ,â– Â¦inÂ¦ Â¦co or d inationÂ¦ Â¦withÂ¦ ğ‹‡Â¦f ed ğ‹‡ e xÂ¦ ,â– Â¦sentÂ¦ Â¦2 00Â¦ , Â¦000Â¦ Â¦faceÂ¦ Â¦masksÂ¦ Â¦al ongÂ¦ Â¦withÂ¦ Â¦otherÂ¦ Â¦pers onalÂ¦ Â¦prot ec tiveÂ¦ Â¦e qu i p mentÂ¦ ,â– Â¦includingÂ¦ Â¦g lo vesÂ¦ Â¦andÂ¦ Â¦g ow nsÂ¦ ,â– Â¦byÂ¦ Â¦emergencyÂ¦ Â¦a ir li f tÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡Â¦w uhanÂ¦ ğ‹‡Â¦unionÂ¦ ğ‹‡Â¦hospitalÂ¦ Â¦byÂ¦ Â¦30Â¦ ğ‹‡Â¦januaryÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦hum ansÂ¦ ,â– Â¦coron a vi rusesÂ¦ Â¦causeÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦infectionsÂ¦ Â¦thatÂ¦ Â¦canÂ¦ Â¦r an geÂ¦ Â¦fromÂ¦ Â¦mi ldÂ¦ Â¦toÂ¦ Â¦le th alÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦e mer ge nceÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦inÂ¦ Â¦centralÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦ endÂ¦ Â¦ofÂ¦ Â¦2019Â¦ Â¦hasÂ¦ Â¦th r us tedÂ¦ ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦intoÂ¦ Â¦theÂ¦ Â¦s po t li ghtÂ¦ Â¦againÂ¦ Â¦andÂ¦ Â¦sur p ri sedÂ¦ Â¦ usÂ¦ Â¦withÂ¦ Â¦itsÂ¦ Â¦highÂ¦ Â¦trans m is sib ilityÂ¦ Â¦butÂ¦ Â¦reduc edÂ¦ Â¦p at ho g en ic ityÂ¦ Â¦comp aredÂ¦ Â¦toÂ¦ Â¦itsÂ¦ Â¦s is terÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡Â¦forÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ ,â– Â¦basedÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦ dem o g rap h icÂ¦ Â¦studyÂ¦ Â¦inÂ¦ ğ‹‡Â¦j uneÂ¦ Â¦201 2Â¦ ,â– Â¦theÂ¦ Â¦mor t alityÂ¦ Â¦wasÂ¦ Â¦3 7Â¦ %â– Â¦ofÂ¦ Â¦2Â¦ , Â¦4 9 4Â¦ Â¦confirmedÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦re se ar ch ersÂ¦ Â¦haveÂ¦ Â¦su gg es tedÂ¦ Â¦theÂ¦ ğ‹‡Â¦h u an anÂ¦ ğ‹‡Â¦s ea f o odÂ¦ ğ‹‡Â¦w h ol es a leÂ¦ ğ‹‡ Â¦marke tÂ¦ Â¦mayÂ¦ Â¦notÂ¦ Â¦beÂ¦ Â¦theÂ¦ Â¦o ri g in alÂ¦ Â¦so ur ceÂ¦ Â¦ofÂ¦ Â¦v iralÂ¦ Â¦transmissionÂ¦ Â¦toÂ¦ Â¦hum ansÂ¦ . ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦1 7Â¦ ğ‹‡Â¦aprilÂ¦ Â¦2020Â¦ ,â– Â¦thereÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦1 5 3Â¦ , Â¦8 2 2Â¦ Â¦confirmedÂ¦ Â¦deathsÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦2Â¦ , Â¦2 4 0Â¦ , Â¦1 9 1Â¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦p ne um o niaÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦i m por ta ntlyÂ¦ ,â– Â¦weÂ¦ Â¦comp areÂ¦ Â¦andÂ¦ Â¦cont ra stÂ¦ Â¦theÂ¦ Â¦differentÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦pers p ec tiveÂ¦ Â¦ofÂ¦ Â¦virusÂ¦ Â¦e v o lu tionÂ¦ Â¦andÂ¦ Â¦gen omeÂ¦ Â¦reco mb inationÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦di vers ityÂ¦ Â¦ofÂ¦ Â¦b atÂ¦ ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦prov id esÂ¦ Â¦a mpleÂ¦ Â¦op por t un itiesÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦e mer ge nceÂ¦ Â¦ofÂ¦ Â¦no ve lÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ .
ğ‹‡ Â¦secondÂ¦ ,â– Â¦pa ng ol insÂ¦ Â¦couldÂ¦ Â¦beÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦inter medi ateÂ¦ Â¦a mp li f yingÂ¦ Â¦h ostÂ¦ Â¦toÂ¦ Â¦whichÂ¦ Â¦aÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ - Â¦relatedÂ¦ Â¦virusÂ¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦ne w lyÂ¦ Â¦in tr od uc edÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦manyÂ¦ Â¦yearsÂ¦ ,â– Â¦theÂ¦ Â¦fourÂ¦ Â¦comm unityÂ¦ - Â¦ac qu ir edÂ¦ ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦c ir c ul ateÂ¦ Â¦inÂ¦ Â¦humanÂ¦ Â¦p op ul ationsÂ¦ ,â– Â¦tri gg eringÂ¦ Â¦comm onÂ¦ Â¦co ldÂ¦ Â¦inÂ¦ Â¦imm u no co mp e t entÂ¦ Â¦sub j ectsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦clinicalÂ¦ Â¦fe at uresÂ¦ Â¦ofÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£ Â¦o cğŠ¼ 4 3Â¦ Â¦infectionÂ¦ Â¦appe arÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦simil arÂ¦ Â¦toÂ¦ Â¦thoseÂ¦ Â¦causedÂ¦ Â¦byÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - Â¦2 2 9 ğ‹‡ eÂ¦ ,â– Â¦whichÂ¦ Â¦areÂ¦ Â¦sy m pt om at icallyÂ¦ Â¦ind is ti ng u ish ableÂ¦ Â¦fromÂ¦ Â¦infectionÂ¦ Â¦withÂ¦ Â¦otherÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦p at ho ge nsÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦inf lu en z aÂ¦ ğ‹‡Â¦aÂ¦ Â¦vi rusesÂ¦ Â¦andÂ¦ Â¦r hi no vi rusesÂ¦ .
ğ‹‡Â¦inÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦patientsÂ¦ ,â– Â¦itÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦ dem on stra tedÂ¦ Â¦thatÂ¦ Â¦feverÂ¦ â–( Â¦9 9Â¦ % - Â¦100Â¦ % ),â– Â¦dr yÂ¦ Â¦c oughÂ¦ â–( Â¦2 9Â¦ % - Â¦7 5Â¦ % ),â– Â¦d y s p ne aÂ¦ â–( Â¦4 0Â¦ % - Â¦4 2Â¦ % ),â– Â¦di ar r he aÂ¦ â–( Â¦20Â¦ - Â¦2 5Â¦ % ),â– Â¦andÂ¦ Â¦s oreÂ¦ Â¦th ro atÂ¦ â–( Â¦1 3Â¦ - Â¦2 5Â¦ % )â– Â¦wereÂ¦ Â¦theÂ¦ Â¦maj orÂ¦ Â¦symptomsÂ¦ Â¦andÂ¦ Â¦ventil ationÂ¦ Â¦supp ortÂ¦ Â¦wasÂ¦ Â¦requir edÂ¦ Â¦forÂ¦ Â¦appro xi ma telyÂ¦ Â¦14Â¦ % - Â¦20Â¦ %â– Â¦ofÂ¦ Â¦theÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦v iralÂ¦ ğŠ£Â¦r na Â¦ğŠ¼ Â¦gen omeÂ¦ Â¦isÂ¦ Â¦rel ea sedÂ¦ Â¦intoÂ¦ Â¦theÂ¦ Â¦cy t op l as mÂ¦ ;â– Â¦afterÂ¦ Â¦rep lic ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦v iralÂ¦ Â¦gen omeÂ¦ ,â– Â¦ge no micÂ¦ ğŠ£Â¦r na Â¦ğŠ¼ Â¦ac co mp a ni edÂ¦ Â¦byÂ¦ Â¦en v el op eÂ¦ Â¦g l yc op ro te insÂ¦ Â¦andÂ¦ Â¦n uc le oc ap s idÂ¦ Â¦prote insÂ¦ Â¦for msÂ¦ Â¦v ir ionÂ¦ - Â¦cont ainingÂ¦ Â¦v es ic lesÂ¦ ,â– Â¦whichÂ¦ Â¦thenÂ¦ Â¦f useÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦pl as maÂ¦ Â¦me mb r aneÂ¦ Â¦toÂ¦ Â¦re le aseÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ 'â– ğ‹‡Â¦n ationalÂ¦ ğ‹‡Â¦instituteÂ¦ Â¦ofÂ¦ ğ‹‡Â¦a ll er g yÂ¦ Â¦andÂ¦ ğ‹‡ Â¦in fe ct iousÂ¦ ğ‹‡ Â¦diseaseÂ¦ ' Â¦sÂ¦ Â¦dire ctorÂ¦ ,â– ğ‹‡Â¦drÂ¦ .â– ğ‹‡ Â¦an th on yÂ¦ ğ‹‡Â¦fa uc iÂ¦ ,â– Â¦saidÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ ,â–" Â¦bo t t omÂ¦ Â¦ lineÂ¦ ,â– Â¦itÂ¦ ' Â¦sÂ¦ Â¦goingÂ¦ Â¦toÂ¦ Â¦getÂ¦ Â¦wor seÂ¦ ."
ğ‹‡ Â¦anÂ¦ Â¦ani malÂ¦ Â¦ser vesÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦e v o lu ti on aryÂ¦ Â¦h ostÂ¦ Â¦ofÂ¦ Â¦anÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ Â¦ifÂ¦ Â¦itÂ¦ Â¦ har b o ur sÂ¦ Â¦aÂ¦ Â¦clos e lyÂ¦ Â¦relatedÂ¦ Â¦a nc est orÂ¦ Â¦s har ingÂ¦ Â¦highÂ¦ Â¦h om o logyÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦n uc le o t ideÂ¦ Â¦se que nceÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦n ationÂ¦ ' Â¦sÂ¦ Â¦healthÂ¦ Â¦a ge nc yÂ¦ Â¦reportedÂ¦ Â¦aÂ¦ Â¦si gni fic antÂ¦ Â¦increaseÂ¦ Â¦inÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦onÂ¦ Â¦20Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦l ar ge lyÂ¦ Â¦att rib u tedÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦ga th eringÂ¦ Â¦inÂ¦ ğ‹‡Â¦d a e g uÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦re li g iousÂ¦ Â¦mo ve mentÂ¦ Â¦knownÂ¦ Â¦asÂ¦ Â¦theÂ¦ ğ‹‡Â¦s hi nc he on j iÂ¦ ğ‹‡Â¦ch ur chÂ¦ Â¦ofÂ¦ ğ‹‡Â¦j es usÂ¦ .
ğ‹‡Â¦e mer ge nceÂ¦ Â¦ofÂ¦ Â¦no ve lÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ :â– Â¦b ackÂ¦ Â¦toÂ¦ Â¦gr oun dÂ¦ Â¦ z er oÂ¦
ğ‹‡ Â¦tr ac ingÂ¦ Â¦theÂ¦ Â¦ z o o no ticÂ¦ Â¦o ri g insÂ¦ Â¦ofÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ Â¦prov id esÂ¦ Â¦aÂ¦ Â¦f ra me w or kÂ¦ Â¦toÂ¦ Â¦under st andÂ¦ Â¦theÂ¦ Â¦n atur alÂ¦ Â¦hi st oryÂ¦ ,â– Â¦d ri vingÂ¦ Â¦forceÂ¦ Â¦andÂ¦ Â¦res tric tionÂ¦ Â¦fa ct orsÂ¦ Â¦ofÂ¦ Â¦speci esÂ¦ Â¦j u mp ingÂ¦ .
ğ‹‡Â¦thereÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦ mÂ¦ Â¦prote insÂ¦ Â¦d ir ectÂ¦ Â¦mostÂ¦ Â¦prote inÂ¦ - Â¦prote inÂ¦ Â¦inter ac tionsÂ¦ Â¦requir edÂ¦ Â¦forÂ¦ Â¦as se mb lyÂ¦ Â¦ofÂ¦ Â¦vi rusesÂ¦ Â¦follow ingÂ¦ Â¦itsÂ¦ Â¦b in dingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦n uc le oc ap s idÂ¦ .
ğ‹‡ Â¦sinceÂ¦ Â¦thenÂ¦ ,â– Â¦moreÂ¦ Â¦kno w l ed geÂ¦ Â¦wasÂ¦ Â¦acc um ul atedÂ¦ Â¦throughÂ¦ Â¦ext en siveÂ¦ Â¦stud iesÂ¦ Â¦onÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - Â¦2 2 9 ğ‹‡ eÂ¦ Â¦andÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£ Â¦o cğŠ¼ 4 3Â¦ ,â– Â¦bothÂ¦ Â¦ofÂ¦ Â¦whichÂ¦ Â¦causeÂ¦ Â¦s elfÂ¦ - Â¦li mi tingÂ¦ Â¦symptomsÂ¦ .
ğ‹‡Â¦d esp iteÂ¦ Â¦thisÂ¦ ,â– Â¦itÂ¦ Â¦appe ar sÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦hadÂ¦ Â¦t ro ub leÂ¦ Â¦sprea dingÂ¦ Â¦fromÂ¦ Â¦humanÂ¦ Â¦toÂ¦ Â¦humanÂ¦ ,â– Â¦asÂ¦ Â¦mostÂ¦ Â¦in di v id u alsÂ¦ Â¦whoÂ¦ Â¦areÂ¦ Â¦infectedÂ¦ Â¦doÂ¦ Â¦notÂ¦ Â¦trans m itÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦pr ess ureÂ¦ Â¦likeÂ¦ Â¦ch estÂ¦ Â¦p ainÂ¦
ğ‹‡ Â¦hum ansÂ¦ Â¦contr actÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦throughÂ¦ Â¦b ut ch eringÂ¦ Â¦andÂ¦ Â¦cons u mp tionÂ¦ Â¦ofÂ¦ Â¦ga meÂ¦ Â¦me atÂ¦ .
ğ‹‡ Â¦whileÂ¦ Â¦thereÂ¦ Â¦areÂ¦ Â¦conc er nsÂ¦ Â¦itÂ¦ Â¦mayÂ¦ Â¦spreadÂ¦ Â¦byÂ¦ Â¦fa e cesÂ¦ ,â– Â¦thisÂ¦ Â¦riskÂ¦ Â¦isÂ¦ Â¦b el ie vedÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦lowÂ¦ .
ğ‹‡Â¦thereforeÂ¦ ,â– Â¦bu il dingÂ¦ Â¦aÂ¦ Â¦pro g no sisÂ¦ Â¦mo de lÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦isÂ¦ Â¦essentialÂ¦ Â¦forÂ¦ Â¦healthÂ¦ - Â¦careÂ¦ Â¦a ge nc iesÂ¦ Â¦toÂ¦ Â¦pr io ri ti z eÂ¦ Â¦theirÂ¦ Â¦servicesÂ¦ ,â– Â¦ esp eci allyÂ¦ Â¦inÂ¦ Â¦res o ur ceÂ¦ - Â¦con stra inedÂ¦ Â¦areasÂ¦ .
ğ‹‡ Â¦doesÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦alsoÂ¦ Â¦b in dÂ¦ ğŠ£ Â¦a ce ğŠ¼ 2Â¦ - Â¦exp r ess ingÂ¦ Â¦ce llsÂ¦ Â¦inÂ¦ Â¦otherÂ¦ Â¦or g ansÂ¦ ?
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦doctorÂ¦ Â¦ por terÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦emergencyÂ¦ Â¦ro omÂ¦ Â¦tri a geÂ¦ Â¦centerÂ¦
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦ uÂ¦ . ğ‹‡Â¦sÂ¦ . ,â– Â¦theÂ¦ ğŠ£Â¦c d cÂ¦ğŠ¼ Â¦recomme ndsÂ¦ Â¦we ar ingÂ¦ Â¦n onÂ¦ - Â¦medicalÂ¦ Â¦faceÂ¦ Â¦maskÂ¦ Â¦madeÂ¦ Â¦outÂ¦ Â¦ofÂ¦ Â¦c lo thÂ¦ . ğ‹‡Â¦chinaÂ¦ Â¦hasÂ¦ Â¦speci f icallyÂ¦ Â¦recomme ndedÂ¦ Â¦theÂ¦ Â¦useÂ¦ Â¦ofÂ¦ Â¦dis p os ableÂ¦ Â¦medicalÂ¦ Â¦masksÂ¦ Â¦byÂ¦ Â¦heal t hyÂ¦ Â¦me mb ersÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦publicÂ¦ ,â– Â¦part icul ar lyÂ¦ Â¦whenÂ¦ Â¦com ingÂ¦ Â¦intoÂ¦ Â¦cl oseÂ¦ Â¦contactÂ¦ â–( Â¦1Â¦ Â¦me tr eÂ¦ â–( Â¦3Â¦ Â¦f tÂ¦ )â– Â¦orÂ¦ Â¦lessÂ¦ )â– Â¦withÂ¦ Â¦otherÂ¦ Â¦peopleÂ¦ .
ğ‹‡Â¦l on ge v ityÂ¦ ,â– Â¦d en se lyÂ¦ Â¦p ac kedÂ¦ Â¦c ol on iesÂ¦ ,â– Â¦cl oseÂ¦ Â¦socialÂ¦ Â¦inter a ctionÂ¦ Â¦andÂ¦ Â¦str ongÂ¦ Â¦ab ilityÂ¦ Â¦toÂ¦ Â¦f lyÂ¦ Â¦areÂ¦ Â¦allÂ¦ Â¦f av o ur ableÂ¦ Â¦conditionsÂ¦ Â¦forÂ¦ Â¦ba tsÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦anÂ¦ Â¦i de alÂ¦ â–' Â¦virusÂ¦ Â¦sprea derÂ¦ ' .
ğ‹‡Â¦p ne um o niaÂ¦ Â¦isÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦mostÂ¦ Â¦severeÂ¦ Â¦symptomsÂ¦ Â¦andÂ¦ Â¦canÂ¦ Â¦pro gr essÂ¦ Â¦rapidlyÂ¦ Â¦toÂ¦ Â¦ac uteÂ¦ Â¦respiratoryÂ¦ Â¦dis tr essÂ¦ Â¦sy nd r omeÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦l ateÂ¦ ğ‹‡Â¦januaryÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦governmentÂ¦ Â¦la un ch edÂ¦ Â¦aÂ¦ Â¦ra d icalÂ¦ Â¦campaignÂ¦ Â¦la terÂ¦ Â¦d es c rib edÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ ğ‹‡Â¦comm u ni stÂ¦ ğ‹‡ Â¦par tyÂ¦ Â¦generalÂ¦ Â¦s ecre t aryÂ¦ ğ‹‡Â¦ x iÂ¦ ğ‹‡Â¦j in p ingÂ¦ Â¦asÂ¦ Â¦aÂ¦ â–" Â¦peopleÂ¦ ' Â¦sÂ¦ Â¦ warÂ¦ "â– Â¦toÂ¦ Â¦cont ainÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡ Â¦prot est ersÂ¦ Â¦inÂ¦ ğ‹‡ Â¦u k ra ineÂ¦ Â¦att ac kedÂ¦ Â¦bu sesÂ¦ Â¦car r yingÂ¦ ğ‹‡ Â¦u k r ai ni anÂ¦ Â¦andÂ¦ Â¦fo re i g nÂ¦ Â¦e v ac u e esÂ¦ Â¦fromÂ¦ ğ‹‡Â¦w uhanÂ¦ Â¦toÂ¦ ğ‹‡Â¦n ov iÂ¦ ğ‹‡Â¦s an z h aryÂ¦ .
ğ‹‡Â¦y est er dayÂ¦ ,â– ğ‹‡ Â¦ba ng la d eshÂ¦ Â¦hasÂ¦ Â¦confirmedÂ¦ Â¦fiveÂ¦ Â¦newÂ¦ Â¦deathsÂ¦ Â¦dueÂ¦ Â¦toÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦onÂ¦ Â¦theÂ¦ Â¦dayÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦demandÂ¦ Â¦hasÂ¦ Â¦l edÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦increaseÂ¦ Â¦inÂ¦ Â¦pri cesÂ¦ Â¦ofÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦tw en tyÂ¦ Â¦ timesÂ¦ Â¦theÂ¦ Â¦n or malÂ¦ Â¦pr iceÂ¦ Â¦andÂ¦ Â¦alsoÂ¦ Â¦ind uc edÂ¦ Â¦de la ysÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦supplyÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦i te msÂ¦ Â¦forÂ¦ Â¦fourÂ¦ Â¦toÂ¦ Â¦sixÂ¦ Â¦monthsÂ¦ .
ğ‹‡Â¦whenÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦lo ngerÂ¦ Â¦possibleÂ¦ Â¦toÂ¦ Â¦cont ainÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ ,â– Â¦e f for tsÂ¦ Â¦thenÂ¦ Â¦mo veÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦mi tig ationÂ¦ Â¦sta geÂ¦ :â– Â¦measuresÂ¦ Â¦areÂ¦ Â¦takenÂ¦ Â¦toÂ¦ Â¦s lowÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦andÂ¦ Â¦mi tig ateÂ¦ Â¦itsÂ¦ Â¦effec tsÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦heal th c areÂ¦ Â¦systemÂ¦ Â¦andÂ¦ Â¦s oc ie tyÂ¦ .
ğ‹‡ Â¦beg in ningÂ¦ Â¦onÂ¦ Â¦15Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦manyÂ¦ Â¦b us in es sesÂ¦ Â¦closedÂ¦ Â¦orÂ¦ Â¦reduc edÂ¦ Â¦hoursÂ¦ Â¦th r ou g ho utÂ¦ Â¦theÂ¦ ğ‹‡Â¦ uÂ¦ . ğ‹‡Â¦sÂ¦ .â– Â¦toÂ¦ Â¦ tryÂ¦ Â¦toÂ¦ Â¦reduceÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦numberÂ¦ Â¦v ar iesÂ¦ Â¦byÂ¦ Â¦reg ionÂ¦ .
ğ‹‡ Â¦pro g en yÂ¦ Â¦vi rusesÂ¦ Â¦areÂ¦ Â¦thenÂ¦ Â¦rel ea sedÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦h ostÂ¦ Â¦c ellÂ¦ Â¦byÂ¦ Â¦ex oc y t o sisÂ¦ Â¦throughÂ¦ Â¦s ecre t oryÂ¦ Â¦v es ic lesÂ¦ .
ğ‹‡ Â¦presidentÂ¦ ğ‹‡Â¦h as s anÂ¦ ğ‹‡Â¦r ou h an iÂ¦ Â¦saidÂ¦ Â¦onÂ¦ Â¦2 6Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ Â¦thatÂ¦ Â¦thereÂ¦ Â¦wereÂ¦ Â¦noÂ¦ Â¦pl ansÂ¦ Â¦toÂ¦ Â¦quarantineÂ¦ Â¦areasÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ ,â– Â¦andÂ¦ Â¦onlyÂ¦ Â¦in di v id u alsÂ¦ Â¦wouldÂ¦ Â¦beÂ¦ Â¦qu ara nt inedÂ¦ .
ğ‹‡Â¦thereforeÂ¦ ,â– Â¦infectedÂ¦ Â¦patientsÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦phaseÂ¦ Â¦orÂ¦ Â¦inc ub ationÂ¦ Â¦periodÂ¦ Â¦canÂ¦ Â¦produc eÂ¦ Â¦aÂ¦ Â¦largeÂ¦ Â¦ am oun tÂ¦ Â¦ofÂ¦ Â¦virusÂ¦ Â¦duringÂ¦ Â¦d ai lyÂ¦ Â¦ac tiv itiesÂ¦ ,â– Â¦ca us ingÂ¦ Â¦g reatÂ¦ Â¦difficul tyÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦controlÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epi demicÂ¦ .
ğ‹‡ Â¦ph y lo ge ne ticÂ¦ Â¦e vi denceÂ¦ Â¦ofÂ¦ Â¦n atur alÂ¦ Â¦reco mb inationÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦bothÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£Â¦h k u ğŠ¼ 1Â¦ Â¦andÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£ Â¦o cğŠ¼ 4 3Â¦ ,â– Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦ani malÂ¦ ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦b atÂ¦ ğŠ£ Â¦s l Â¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ Â¦b at ğ‹‡ co ğ‹‡ vÂ¦ - ğŠ£Â¦h k u ğŠ¼ 9Â¦ .
ğ‹‡Â¦theÂ¦ Â¦highÂ¦ Â¦fa il ureÂ¦ Â¦ra tesÂ¦ Â¦associ atedÂ¦ Â¦withÂ¦ Â¦p har ma ce ut icalÂ¦ Â¦developmentÂ¦ Â¦areÂ¦ Â¦ ref er r edÂ¦ Â¦toÂ¦ Â¦asÂ¦ Â¦anÂ¦ â–" Â¦att r itionÂ¦ Â¦rateÂ¦ " ,â– Â¦requir ingÂ¦ Â¦d eci sionsÂ¦ Â¦duringÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦sta gesÂ¦ Â¦ofÂ¦ Â¦drugÂ¦ Â¦developmentÂ¦ Â¦toÂ¦ â–" Â¦k illÂ¦ "â– Â¦pro j ectsÂ¦ Â¦earlyÂ¦ Â¦toÂ¦ Â¦avo idÂ¦ Â¦co st lyÂ¦ Â¦fa il uresÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦es tim atedÂ¦ Â¦me anÂ¦ Â¦inc ub ationÂ¦ Â¦periodÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦isÂ¦ Â¦1Â¦ - Â¦14Â¦ Â¦daysÂ¦ ,â– Â¦mo st lyÂ¦ Â¦3Â¦ - Â¦7Â¦ Â¦daysÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦studyÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦4 2 5Â¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡Â¦w uhanÂ¦ .
ğ‹‡Â¦d ub a iÂ¦ ,â– ğ‹‡ Â¦sy d ne yÂ¦ ,â– Â¦andÂ¦ ğ‹‡Â¦m el b o ur n eÂ¦ Â¦wereÂ¦ Â¦alsoÂ¦ Â¦reportedÂ¦ Â¦asÂ¦ Â¦p op ul arÂ¦ Â¦d est in ationsÂ¦ Â¦forÂ¦ Â¦peopleÂ¦ Â¦tra ve llingÂ¦ Â¦fromÂ¦ ğ‹‡Â¦w uhanÂ¦ .
ğ‹‡ Â¦andÂ¦ Â¦isÂ¦ Â¦thisÂ¦ Â¦theÂ¦ Â¦ri ghtÂ¦ Â¦timeÂ¦ Â¦forÂ¦ Â¦yourÂ¦ Â¦h ayÂ¦ Â¦feverÂ¦
ğ‹‡ Â¦byÂ¦ Â¦1 3Â¦ ğ‹‡Â¦marchÂ¦ ,â– ğ‹‡Â¦theÂ¦ ğ‹‡Â¦ at l an ticÂ¦ Â¦reportedÂ¦ Â¦thatÂ¦ Â¦lessÂ¦ Â¦thanÂ¦ Â¦14Â¦ , Â¦000Â¦ Â¦testsÂ¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦conduc tedÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦j ur yÂ¦ Â¦isÂ¦ Â¦stillÂ¦ Â¦outÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦immedi ateÂ¦ Â¦ z o o no ticÂ¦ Â¦o ri g inÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦e b ol aÂ¦ Â¦wasÂ¦ Â¦o ri g in allyÂ¦ Â¦pr ed ic tedÂ¦ Â¦toÂ¦ Â¦causeÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦millionÂ¦ Â¦casesÂ¦ Â¦withÂ¦ Â¦h alfÂ¦ Â¦aÂ¦ Â¦millionÂ¦ Â¦deathsÂ¦ .
ğ‹‡Â¦c or por ationsÂ¦ Â¦imposedÂ¦ Â¦emp loy e eÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ ,â– Â¦can ce lledÂ¦ Â¦con fere n cesÂ¦ ,â– Â¦andÂ¦ Â¦e nc ou ra gedÂ¦ Â¦emp loy e esÂ¦ Â¦toÂ¦ Â¦workÂ¦ Â¦fromÂ¦ Â¦homeÂ¦ .
ğŠ£Â¦c b s Â¦ğŠ¼ ğ‹‡Â¦ne wsÂ¦ Â¦reportedÂ¦ ,â– Â¦ ci tingÂ¦ ğ‹‡ Â¦jo h nsÂ¦ ğ‹‡Â¦h op k insÂ¦ ğ‹‡Â¦universityÂ¦ Â¦dataÂ¦ ,â– Â¦thereÂ¦ Â¦wereÂ¦ Â¦overÂ¦ Â¦1Â¦ , Â¦000Â¦ ğŠ£Â¦us Â¦ğŠ¼ Â¦deathsÂ¦ Â¦onÂ¦ ğ‹‡Â¦w ed n es dayÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦coronavirusÂ¦ Â¦infectionsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦rem ar ksÂ¦ Â¦wereÂ¦ Â¦la terÂ¦ Â¦con dem nedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦cons ul ateÂ¦ Â¦inÂ¦ ğ‹‡Â¦k ol k at aÂ¦ ,â– Â¦ca llingÂ¦ Â¦itÂ¦ â–" Â¦ er ro ne o usÂ¦ " . ğ‹‡Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦ x en op ho bi aÂ¦ Â¦andÂ¦ Â¦r ac is mÂ¦ Â¦a ga insÂ¦ Â¦n onÂ¦ - ğ‹‡Â¦chineseÂ¦ Â¦re si de ntsÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦inf la medÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ ,â– Â¦withÂ¦ Â¦fo re i gn ersÂ¦ Â¦d es c rib edÂ¦ Â¦asÂ¦ â–" Â¦fo re i g nÂ¦ Â¦g ar b a geÂ¦ "â– Â¦andÂ¦ Â¦t ar ge tedÂ¦ Â¦forÂ¦ â–" Â¦dis p os alÂ¦ " .
ğ‹‡Â¦theÂ¦ Â¦pol y p ro te insÂ¦ Â¦areÂ¦ Â¦furtherÂ¦ Â¦pr oc es sedÂ¦ Â¦toÂ¦ Â¦gen er ateÂ¦ Â¦1 6Â¦ Â¦n onÂ¦ - Â¦str uc tur alÂ¦ Â¦prote insÂ¦ ,â– Â¦de si gn atedÂ¦ Â¦ ns p 1Â¦ ~ Â¦1 6Â¦ .
ğ‹‡ Â¦severalÂ¦ Â¦comp ou ndsÂ¦ Â¦thatÂ¦ Â¦wereÂ¦ Â¦prev io us lyÂ¦ Â¦approvedÂ¦ Â¦forÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ Â¦otherÂ¦ Â¦v iralÂ¦ Â¦dis easesÂ¦ Â¦areÂ¦ Â¦beingÂ¦ Â¦inv es tig atedÂ¦ Â¦forÂ¦ Â¦useÂ¦ Â¦inÂ¦ Â¦t rea tingÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦exp a ndedÂ¦ Â¦inÂ¦ Â¦c lu st ersÂ¦ Â¦ma in lyÂ¦ Â¦inÂ¦ Â¦andÂ¦ Â¦aroundÂ¦ ğ‹‡Â¦h ub e iÂ¦ .
ğ‹‡ Â¦as y m pt o ma ticÂ¦ Â¦orÂ¦ Â¦onlyÂ¦ Â¦mi ldÂ¦ Â¦symptomsÂ¦ Â¦wereÂ¦ Â¦det ectedÂ¦ Â¦whenÂ¦ Â¦ba tsÂ¦ Â¦wereÂ¦ Â¦infectedÂ¦ Â¦withÂ¦ ğ‹‡Â¦c oğ‹‡vsÂ¦ ,â– Â¦ind ic a tingÂ¦ Â¦theÂ¦ Â¦mut u alÂ¦ Â¦ad a pt ationÂ¦ Â¦betweenÂ¦ ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦andÂ¦ Â¦ba tsÂ¦ .
ğ‹‡ Â¦humanÂ¦ Â¦ri gh tsÂ¦ Â¦or ga ni z ationsÂ¦ Â¦haveÂ¦ Â¦c ri ti ci zedÂ¦ Â¦someÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦measuresÂ¦ ,â– Â¦as kingÂ¦ Â¦theÂ¦ Â¦go ver n mentsÂ¦ Â¦notÂ¦ Â¦toÂ¦ Â¦useÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦co verÂ¦ Â¦toÂ¦ Â¦in tr od u ceÂ¦ Â¦inv a siveÂ¦ Â¦di gi talÂ¦ Â¦surveillanceÂ¦ .
ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - Â¦2 2 9 ğ‹‡ eÂ¦ ,â– ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£Â¦ oc 4 3Â¦ ,â– Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£Â¦h k u ğŠ¼ 1Â¦ Â¦andÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£ Â¦n l ğŠ¼ 6 3Â¦ Â¦us u allyÂ¦ Â¦causeÂ¦ Â¦mi ldÂ¦ Â¦symptomsÂ¦ ,â– Â¦likeÂ¦ Â¦comm onÂ¦ Â¦co ldÂ¦ Â¦andÂ¦ / Â¦orÂ¦ Â¦di ar r he aÂ¦ .
ğ‹‡ Â¦epi dem io log icalÂ¦ Â¦hi st oryÂ¦ : â–( Â¦1Â¦ )â– Â¦aÂ¦ Â¦hi st oryÂ¦ Â¦ofÂ¦ Â¦travelÂ¦ Â¦orÂ¦ Â¦re si denceÂ¦ Â¦inÂ¦ ğ‹‡Â¦w uhanÂ¦ Â¦cityÂ¦ Â¦andÂ¦ Â¦sur r oun dingÂ¦ Â¦areasÂ¦ ,â– Â¦orÂ¦ Â¦otherÂ¦ Â¦comm un itiesÂ¦ Â¦whereÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦casesÂ¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦lastÂ¦ Â¦14Â¦ Â¦daysÂ¦ Â¦beforeÂ¦ Â¦sy m pt omÂ¦ Â¦o ns etÂ¦ ; â–( Â¦2Â¦ )â– Â¦aÂ¦ Â¦hi st oryÂ¦ Â¦ofÂ¦ Â¦contactÂ¦ Â¦withÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦in fe ct iousÂ¦ Â¦casesÂ¦ â–( Â¦withÂ¦ Â¦positiveÂ¦ Â¦n uc le icÂ¦ Â¦ac idÂ¦ Â¦testÂ¦ ) ; â–( Â¦3Â¦ )â– Â¦aÂ¦ Â¦hi st oryÂ¦ Â¦ofÂ¦ Â¦cont ac tingÂ¦ Â¦withÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ Â¦feverÂ¦ Â¦orÂ¦ Â¦respiratoryÂ¦ Â¦symptomsÂ¦ Â¦fromÂ¦ ğ‹‡Â¦w uhanÂ¦ Â¦cityÂ¦ Â¦andÂ¦ Â¦sur r oun dingÂ¦ Â¦areasÂ¦ ,â– Â¦orÂ¦ Â¦otherÂ¦ Â¦comm un itiesÂ¦ Â¦whereÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦lastÂ¦ Â¦14Â¦ Â¦daysÂ¦ Â¦beforeÂ¦ Â¦sy m pt omÂ¦ Â¦o ns etÂ¦ ; â–( Â¦4Â¦ )â– Â¦aÂ¦ Â¦hi st oryÂ¦ Â¦ofÂ¦ Â¦cont ac tingÂ¦ Â¦withÂ¦ Â¦cl us terÂ¦ Â¦ofÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ â–( â‰¥ â– Â¦2Â¦ Â¦casesÂ¦ Â¦withÂ¦ Â¦feverÂ¦ Â¦andÂ¦ / Â¦orÂ¦ Â¦respiratoryÂ¦ Â¦symptomsÂ¦ Â¦occ ur r edÂ¦ Â¦withinÂ¦ Â¦2Â¦ Â¦weeksÂ¦ Â¦inÂ¦ Â¦smallÂ¦ Â¦areasÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦homeÂ¦ ,â– Â¦officeÂ¦ ,â– Â¦clas sÂ¦ Â¦ofÂ¦ Â¦schoolÂ¦ ,â– Â¦e t c Â¦ ).
ğ‹‡ Â¦doÂ¦ Â¦youÂ¦ Â¦haveÂ¦ Â¦anyÂ¦ Â¦otherÂ¦ Â¦ch r on icÂ¦ Â¦likeÂ¦ Â¦highÂ¦ Â¦bloodÂ¦ Â¦pr ess ureÂ¦ Â¦orÂ¦ Â¦an y t hingÂ¦ Â¦likeÂ¦ Â¦thatÂ¦ ?
ğ‹‡Â¦b es id esÂ¦ ,â– Â¦theÂ¦ Â¦n atur alÂ¦ Â¦k ill erÂ¦ Â¦c ellÂ¦ Â¦ac tiv ityÂ¦ Â¦inÂ¦ Â¦ba tsÂ¦ Â¦isÂ¦ Â¦supp res sedÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦up re g ul ationÂ¦ Â¦ofÂ¦ Â¦in hi b it oryÂ¦ Â¦n atur alÂ¦ Â¦k ill erÂ¦ Â¦c ellÂ¦ Â¦re ce pt orÂ¦ ğŠ£ Â¦n k g 2Â¦ / Â¦c d ğŠ¼ 9 4Â¦ Â¦andÂ¦ Â¦lowÂ¦ Â¦exp r ess ionÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦maj orÂ¦ Â¦hi st o co mp ati b ilityÂ¦ Â¦comple xÂ¦ Â¦clas sÂ¦ ğ‹‡Â¦iÂ¦ Â¦m ol ec u lesÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦theÂ¦ Â¦otherÂ¦ Â¦handÂ¦ ,â– ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - Â¦2 2 9 ğ‹‡ eÂ¦ Â¦wasÂ¦ Â¦ge ne t icallyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦anotherÂ¦ Â¦b atÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦ter medÂ¦ ğ‹‡ Â¦hi p po si de ro sÂ¦ / ğ‹‡Â¦g ha na ğ‹‡ k wa mÂ¦ / Â¦19Â¦ / Â¦20 0 8Â¦ ,â– Â¦whichÂ¦ Â¦wasÂ¦ Â¦det ectedÂ¦ Â¦inÂ¦ ğ‹‡Â¦ gh an aÂ¦ ,â– Â¦whileÂ¦ Â¦ca me li dsÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦susp ectedÂ¦ Â¦asÂ¦ Â¦itsÂ¦ Â¦inter medi ateÂ¦ Â¦h ostÂ¦ .
ğ‹‡Â¦thereÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦e vi denceÂ¦ Â¦ani m alsÂ¦ Â¦canÂ¦ Â¦pas sÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦onÂ¦ Â¦toÂ¦ Â¦hum ansÂ¦ ,â– Â¦ thoughÂ¦ ğ‹‡Â¦b rit is hÂ¦ Â¦a u th or itiesÂ¦ Â¦ad v iseÂ¦ Â¦washingÂ¦ Â¦oneÂ¦ ' Â¦sÂ¦ Â¦handsÂ¦ Â¦afterÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦ani m alsÂ¦ ,â– Â¦likeÂ¦ Â¦afterÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦otherÂ¦ Â¦sur f a cesÂ¦ Â¦infectedÂ¦ Â¦peopleÂ¦ Â¦couldÂ¦ Â¦haveÂ¦ Â¦t ou ch edÂ¦ .
ğ‹‡Â¦h ongÂ¦ ğ‹‡Â¦k ongÂ¦ Â¦recomme ndsÂ¦ Â¦we ar ingÂ¦ Â¦aÂ¦ Â¦sur g icalÂ¦ Â¦maskÂ¦ Â¦whenÂ¦ Â¦takingÂ¦ Â¦publicÂ¦ Â¦trans portÂ¦ Â¦orÂ¦ Â¦sta yingÂ¦ Â¦inÂ¦ Â¦crow dedÂ¦ Â¦placesÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡Â¦organizationÂ¦ â–( ğŠ£Â¦whoÂ¦ğŠ¼ )â– Â¦dec l aredÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦aÂ¦ Â¦pandemicÂ¦ Â¦onÂ¦ ğ‹‡Â¦marchÂ¦ Â¦11Â¦ .
ğ‹‡Â¦sh eÂ¦ Â¦alsoÂ¦ Â¦saidÂ¦ Â¦twoÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦v ic ti msÂ¦ Â¦wereÂ¦ Â¦fromÂ¦ ğ‹‡Â¦d ha kaÂ¦ .
ğ‹‡ Â¦andÂ¦ Â¦theyÂ¦ ' Â¦r eÂ¦ Â¦ha vingÂ¦ Â¦someÂ¦ Â¦fe v ersÂ¦ Â¦asÂ¦ Â¦wellÂ¦
ğ‹‡Â¦evenÂ¦ Â¦pl as maÂ¦ Â¦fromÂ¦ Â¦rec ov eredÂ¦ Â¦patientsÂ¦ Â¦wasÂ¦ Â¦prop osedÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦usedÂ¦ Â¦forÂ¦ Â¦treatmentÂ¦ .
ğ‹‡ Â¦in de edÂ¦ ,â– Â¦aÂ¦ Â¦cr y oÂ¦ - ğŠ£ Â¦e m Â¦ğŠ¼ Â¦studyÂ¦ Â¦ind ic a tesÂ¦ Â¦aÂ¦ Â¦10Â¦ - â– Â¦toÂ¦ Â¦20Â¦ - Â¦fo ldÂ¦ Â¦higherÂ¦ Â¦a ff in ityÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦b in dingÂ¦ Â¦thanÂ¦ Â¦thatÂ¦ Â¦betweenÂ¦ Â¦humanÂ¦ ğŠ£ Â¦a ce ğŠ¼ 2Â¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ğ‹‡Â¦sÂ¦ Â¦prote inÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦useÂ¦ Â¦ofÂ¦ Â¦s te ro i dsÂ¦ Â¦mayÂ¦ Â¦wor s enÂ¦ Â¦out c om esÂ¦ .
ğ‹‡Â¦thereÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦pre fere nceÂ¦ Â¦t ow ar dsÂ¦ Â¦aÂ¦ Â¦part icul arÂ¦ Â¦se as onÂ¦ Â¦inÂ¦ Â¦tr op icalÂ¦ Â¦c li ma tesÂ¦ .
ğ‹‡ Â¦inv es ti ga tingÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦h ostÂ¦ Â¦inter ac tionsÂ¦ Â¦inÂ¦ Â¦ani m alsÂ¦ Â¦mi ghtÂ¦ Â¦alsoÂ¦ Â¦de ri veÂ¦ Â¦importantÂ¦ Â¦in si ghtÂ¦ Â¦onÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ Â¦p at ho ge ne sisÂ¦ Â¦inÂ¦ Â¦hum ansÂ¦ .
ğ‹‡ Â¦li veÂ¦ - Â¦att en u atedÂ¦ Â¦vaccinesÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦e v a lu atedÂ¦ Â¦inÂ¦ Â¦ani malÂ¦ Â¦m od elsÂ¦ Â¦forÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ .
ğ‹‡ Â¦ar tsÂ¦ Â¦andÂ¦ Â¦c ul t ureÂ¦ Â¦se ctorÂ¦ Â¦or ga ni z ationsÂ¦ Â¦att e mp tedÂ¦ Â¦toÂ¦ Â¦up ho ldÂ¦ Â¦theirÂ¦ â–( Â¦o f tenÂ¦ Â¦p ub lic lyÂ¦ Â¦f u ndedÂ¦ )â– Â¦ missionÂ¦ Â¦toÂ¦ Â¦provideÂ¦ Â¦acc essÂ¦ Â¦toÂ¦ Â¦c ul tur alÂ¦ Â¦he ri ta geÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦comm unityÂ¦ ,â– Â¦m ai nt ainÂ¦ Â¦theÂ¦ Â¦sa fetyÂ¦ Â¦ofÂ¦ Â¦theirÂ¦ Â¦emp loy e esÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦publicÂ¦ ,â– Â¦andÂ¦ Â¦supp ortÂ¦ Â¦ art istsÂ¦ Â¦whereÂ¦ Â¦possibleÂ¦ .
ğ‹‡ Â¦currentlyÂ¦ ,â– Â¦noÂ¦ Â¦de ta il edÂ¦ Â¦studyÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦reg ar dingÂ¦ Â¦theÂ¦ Â¦imm u no log icalÂ¦ Â¦responseÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦onÂ¦ Â¦oneÂ¦ Â¦handÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦infectionÂ¦ Â¦ex hi bi tsÂ¦ Â¦fe at uresÂ¦ Â¦thatÂ¦ Â¦areÂ¦ Â¦moreÂ¦ Â¦comm on lyÂ¦ Â¦seenÂ¦ Â¦duringÂ¦ Â¦infectionÂ¦ Â¦withÂ¦ Â¦comm unityÂ¦ - Â¦ac qu ir edÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ ,â– Â¦includingÂ¦ Â¦theÂ¦ Â¦pre se nt ationÂ¦ Â¦ofÂ¦ Â¦n onÂ¦ - Â¦speci ficÂ¦ ,â– Â¦mi ldÂ¦ Â¦orÂ¦ Â¦evenÂ¦ Â¦noÂ¦ Â¦symptomsÂ¦ .
ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦re tur nedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦li me li ghtÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦rec entÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦w h iteÂ¦ ğ‹‡ Â¦ho useÂ¦ ğ‹‡ Â¦coronavirusÂ¦ ğ‹‡Â¦t as kÂ¦ ğ‹‡ Â¦forceÂ¦ Â¦wasÂ¦ Â¦ est ab lish edÂ¦ Â¦onÂ¦ Â¦2 9Â¦ ğ‹‡Â¦januaryÂ¦ .
ğ‹‡ Â¦andÂ¦ Â¦withÂ¦ Â¦yourÂ¦ Â¦hi st oryÂ¦ Â¦ofÂ¦ Â¦di ab e tesÂ¦
ğ‹‡Â¦onÂ¦ Â¦theÂ¦ Â¦otherÂ¦ Â¦handÂ¦ ,â– ğ‹‡Â¦chineseÂ¦ Â¦a idÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦wellÂ¦ - Â¦recei vedÂ¦ Â¦inÂ¦ Â¦par tsÂ¦ Â¦ofÂ¦ ğ‹‡Â¦l at inÂ¦ ğ‹‡Â¦a mer ic aÂ¦ Â¦andÂ¦ ğ‹‡Â¦a f r ic aÂ¦ . ğ‹‡Â¦onÂ¦ Â¦2Â¦ ğ‹‡Â¦aprilÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦b an kÂ¦ Â¦la un ch edÂ¦ Â¦emergencyÂ¦ Â¦supp ortÂ¦ Â¦op er ationsÂ¦ Â¦forÂ¦ Â¦develop ingÂ¦ Â¦countriesÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦follow edÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦trans c ri p tionÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦ne ga tiveÂ¦ - Â¦s en seÂ¦ Â¦sub ge no micÂ¦ ğŠ£Â¦r na Â¦ğŠ¼ Â¦m ol ec u lesÂ¦ Â¦toÂ¦ Â¦theirÂ¦ Â¦c or r esp on dingÂ¦ Â¦positiveÂ¦ - Â¦s en seÂ¦ Â¦m ğŠ£ r na ğŠ¼ sÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦g lobalÂ¦ ğ‹‡Â¦s ol id ar ityÂ¦ Â¦andÂ¦ ğ‹‡Â¦e ur op e anÂ¦ ğ‹‡ Â¦dis co veryÂ¦ Â¦trialsÂ¦ Â¦ofÂ¦ Â¦hos pi ta li zedÂ¦ Â¦peopleÂ¦ Â¦withÂ¦ Â¦severeÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦infectionÂ¦ Â¦app lyÂ¦ Â¦ad ap tiveÂ¦ Â¦de si g nÂ¦ Â¦toÂ¦ Â¦rapidlyÂ¦ Â¦al terÂ¦ Â¦tri alÂ¦ Â¦p ara me t ersÂ¦ Â¦asÂ¦ Â¦resul tsÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦fourÂ¦ Â¦exp e ri m en talÂ¦ Â¦the rap e u ticÂ¦ Â¦stra te g iesÂ¦ Â¦e mer geÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦st ati st icsÂ¦ Â¦areÂ¦ Â¦notÂ¦ Â¦ ti me b oun dÂ¦ Â¦andÂ¦ Â¦follow Â¦ Â¦aÂ¦ Â¦speci ficÂ¦ Â¦populationÂ¦ Â¦fromÂ¦ Â¦infectionÂ¦ Â¦throughÂ¦ Â¦caseÂ¦ Â¦res o lu tionÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦phaseÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦outbreakÂ¦ ,â– Â¦aÂ¦ Â¦r an geÂ¦ Â¦ofÂ¦ Â¦p s yc hi a tr icÂ¦ Â¦mor b id itiesÂ¦ Â¦includingÂ¦ Â¦per si st entÂ¦ Â¦dep r ess ionÂ¦ ,â– Â¦an x ie tyÂ¦ ,â– Â¦p an icÂ¦ Â¦att ac ksÂ¦ ,â– Â¦p s y ch om o t orÂ¦ Â¦ex ci te mentÂ¦ ,â– Â¦p s yc ho ticÂ¦ Â¦symptomsÂ¦ ,â– Â¦de li ri umÂ¦ ,â– Â¦andÂ¦ Â¦evenÂ¦ Â¦su ic id alityÂ¦ Â¦wereÂ¦ Â¦reportedÂ¦ .
ğ‹‡Â¦w he ne verÂ¦ Â¦possibleÂ¦ ,â– Â¦weÂ¦ Â¦willÂ¦ Â¦ tryÂ¦ Â¦toÂ¦ Â¦comp areÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦withÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦andÂ¦ Â¦anotherÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦causedÂ¦ Â¦diseaseÂ¦ ,â– ğ‹‡Â¦m id d leÂ¦ ğ‹‡ Â¦ea stÂ¦ Â¦respiratoryÂ¦ Â¦sy nd r omeÂ¦ â–( ğŠ£Â¦m ersÂ¦ ğŠ¼ ,â– Â¦anÂ¦ Â¦outbreakÂ¦ Â¦inÂ¦ Â¦201 2Â¦ ).
ğ‹‡Â¦itÂ¦ Â¦hasÂ¦ Â¦att r actedÂ¦ Â¦aÂ¦ Â¦g reatÂ¦ Â¦att entionÂ¦ Â¦sinceÂ¦ Â¦p ub lish edÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦en z y meÂ¦ Â¦isÂ¦ Â¦essentialÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦h ostÂ¦ Â¦c ellÂ¦ Â¦toÂ¦ Â¦rep r od u ceÂ¦ Â¦theÂ¦ Â¦ rib on uc le icÂ¦ Â¦ac idÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦a ff ectsÂ¦ Â¦moreÂ¦ Â¦el d er lyÂ¦ Â¦in di v id u alsÂ¦ Â¦thanÂ¦ Â¦y outhÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦m enÂ¦ Â¦thanÂ¦ Â¦womenÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ Â¦se ver ityÂ¦ Â¦andÂ¦ Â¦deathÂ¦ Â¦rateÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦higherÂ¦ Â¦inÂ¦ Â¦el d er lyÂ¦ Â¦in di v id u alÂ¦ Â¦thanÂ¦ Â¦inÂ¦ Â¦y outhÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦theÂ¦ Â¦transmissionÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦wasÂ¦ Â¦consid eredÂ¦ Â¦toÂ¦ Â¦occ urÂ¦ Â¦whenÂ¦ Â¦theÂ¦ Â¦patientsÂ¦ Â¦areÂ¦ Â¦se ve re lyÂ¦ Â¦ illÂ¦ ,â– Â¦whileÂ¦ Â¦mostÂ¦ Â¦transmissionÂ¦ Â¦didÂ¦ Â¦notÂ¦ Â¦happ enÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦phaseÂ¦ .
ğ‹‡ Â¦rep ur p osedÂ¦ Â¦an tiv iralÂ¦ Â¦d ru gsÂ¦ Â¦makeÂ¦ Â¦upÂ¦ Â¦mostÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦researchÂ¦ ,â– Â¦withÂ¦ Â¦9Â¦ ğ‹‡ Â¦phaseÂ¦ ğŠ£Â¦i i i Â¦ğŠ¼ Â¦trialsÂ¦ Â¦onÂ¦ Â¦rem desivirÂ¦ Â¦acrossÂ¦ Â¦severalÂ¦ Â¦countriesÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦reportÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦ endÂ¦ Â¦ofÂ¦ ğ‹‡Â¦aprilÂ¦ .
ğ‹‡Â¦j ap anÂ¦ Â¦d on atedÂ¦ Â¦oneÂ¦ Â¦millionÂ¦ Â¦faceÂ¦ Â¦masksÂ¦ Â¦toÂ¦ ğ‹‡Â¦w uhanÂ¦ ,â– ğ‹‡Â¦ tur ke yÂ¦ Â¦dis p at ch edÂ¦ Â¦medicalÂ¦ Â¦e qu i p mentÂ¦ ,â– ğ‹‡Â¦r us si aÂ¦ Â¦sentÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦1 3Â¦ Â¦t on n esÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦supp l iesÂ¦ Â¦toÂ¦ ğ‹‡Â¦w uhanÂ¦ ,â– ğ‹‡Â¦ma la y si aÂ¦ Â¦announcedÂ¦ Â¦aÂ¦ Â¦d on ationÂ¦ Â¦ofÂ¦ Â¦18Â¦ Â¦millionÂ¦ Â¦medicalÂ¦ Â¦g lo vesÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– ğ‹‡Â¦g erm an yÂ¦ Â¦de li v eredÂ¦ Â¦variousÂ¦ Â¦medicalÂ¦ Â¦supp l iesÂ¦ Â¦includingÂ¦ Â¦10Â¦ , Â¦000Â¦ ğ‹‡ Â¦ha z m atÂ¦ Â¦su i tsÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦d on atedÂ¦ Â¦1 7Â¦ . Â¦8Â¦ Â¦t onsÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦supp l iesÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦andÂ¦ Â¦pro mi sedÂ¦ Â¦anÂ¦ Â¦ad di ti onalÂ¦ â– $ Â¦100Â¦ Â¦millionÂ¦ Â¦inÂ¦ Â¦fin an cialÂ¦ Â¦supp ortÂ¦ Â¦toÂ¦ Â¦affectedÂ¦ Â¦countriesÂ¦ . ğ‹‡Â¦afterÂ¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦see medÂ¦ Â¦toÂ¦ Â¦sta bi li z eÂ¦ ,â– Â¦theÂ¦ Â¦countryÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦s en dingÂ¦ Â¦a idÂ¦ Â¦toÂ¦ Â¦variousÂ¦ Â¦n ationsÂ¦ Â¦h itÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦2 2Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦associ atedÂ¦ ğ‹‡Â¦pr essÂ¦ Â¦reportedÂ¦ : â–" ğ‹‡Â¦manyÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦haveÂ¦ Â¦symptomsÂ¦ Â¦andÂ¦ Â¦aÂ¦ Â¦doctorÂ¦ ' Â¦sÂ¦ Â¦orderÂ¦ Â¦haveÂ¦ Â¦w ai tedÂ¦ Â¦hoursÂ¦ Â¦orÂ¦ Â¦daysÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦testÂ¦ ." ğ‹‡Â¦afterÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦deathÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦wasÂ¦ Â¦reportedÂ¦ Â¦inÂ¦ ğ‹‡ Â¦was hi ng t onÂ¦ Â¦stateÂ¦ Â¦onÂ¦ Â¦2 9Â¦ ğ‹‡Â¦februaryÂ¦ ,â– ğ‹‡ Â¦go ver n orÂ¦ ğ‹‡Â¦j ayÂ¦ ğ‹‡ Â¦ins le eÂ¦ Â¦dec l aredÂ¦ Â¦aÂ¦ Â¦stateÂ¦ Â¦ofÂ¦ Â¦emergencyÂ¦ ,â– Â¦anÂ¦ Â¦a ctionÂ¦ Â¦thatÂ¦ Â¦wasÂ¦ Â¦so onÂ¦ Â¦follow edÂ¦ Â¦byÂ¦ Â¦otherÂ¦ Â¦statesÂ¦ .
ğ‹‡ Â¦patientsÂ¦ Â¦infectedÂ¦ Â¦withÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - Â¦2 2 9 ğ‹‡ eÂ¦ Â¦p res entedÂ¦ Â¦withÂ¦ Â¦comm onÂ¦ Â¦co ldÂ¦ Â¦symptomsÂ¦ ,â– Â¦includingÂ¦ Â¦h ea d ach eÂ¦ ,â– Â¦s n ee z ingÂ¦ ,â– Â¦ma la iseÂ¦ Â¦andÂ¦ Â¦s oreÂ¦ - Â¦th ro atÂ¦ ,â– Â¦withÂ¦ Â¦feverÂ¦ Â¦andÂ¦ Â¦c oughÂ¦ Â¦seenÂ¦ Â¦inÂ¦ Â¦10Â¦ ~ Â¦20Â¦ %â– Â¦casesÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦th ur s dayÂ¦ Â¦ ed itionÂ¦ Â¦ofÂ¦ ğŠ£Â¦ nt Â¦ğŠ¼ ğ‹‡Â¦ne wsÂ¦ ,â– Â¦aÂ¦ Â¦d ai lyÂ¦ Â¦pr in tedÂ¦ Â¦inÂ¦ ğ‹‡Â¦d ar w inÂ¦ ,â– Â¦inc lu dedÂ¦ Â¦anÂ¦ Â¦e i ghtÂ¦ - Â¦pa geÂ¦ Â¦ins er tÂ¦ Â¦me antÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦c utÂ¦ Â¦upÂ¦ Â¦andÂ¦ Â¦usedÂ¦ Â¦asÂ¦ Â¦to il etÂ¦ Â¦p ap erÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦me ansÂ¦ Â¦thatÂ¦ Â¦countriesÂ¦ Â¦mayÂ¦ Â¦haveÂ¦ Â¦moreÂ¦ Â¦orÂ¦ Â¦lessÂ¦ Â¦res o ur cesÂ¦ Â¦thanÂ¦ ğ‹‡Â¦ita lyÂ¦ â–( Â¦12Â¦ . Â¦5Â¦ Â¦int en siveÂ¦ Â¦careÂ¦ Â¦andÂ¦ Â¦inter medi ateÂ¦ Â¦careÂ¦ Â¦bedsÂ¦ Â¦perÂ¦ Â¦100Â¦ , Â¦000Â¦ Â¦populationÂ¦ Â¦inÂ¦ Â¦201 0Â¦ â€“ Â¦11Â¦ ).
ğ‹‡ Â¦sinceÂ¦ Â¦part ic lesÂ¦ Â¦canÂ¦ Â¦p e ne tr ateÂ¦ Â¦evenÂ¦ Â¦fiveÂ¦ Â¦sur g icalÂ¦ Â¦masksÂ¦ Â¦st ac kedÂ¦ Â¦to ge therÂ¦ ,â– Â¦healthÂ¦ - Â¦careÂ¦ Â¦pro vi dersÂ¦ Â¦inÂ¦ Â¦d ir ectÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦patientsÂ¦ Â¦m ustÂ¦ Â¦we arÂ¦ ğ‹‡Â¦n 9 5Â¦ â–( Â¦ser iesÂ¦ â– # â– Â¦1 8 6 0 sÂ¦ )â– Â¦masksÂ¦ Â¦butÂ¦ Â¦notÂ¦ Â¦sur g icalÂ¦ Â¦masksÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦inÂ¦ Â¦m yÂ¦ Â¦ch estÂ¦
ğ‹‡ Â¦controlÂ¦ Â¦ofÂ¦ Â¦publicÂ¦ Â¦mo ve mentÂ¦ Â¦wasÂ¦ Â¦app li edÂ¦ Â¦inÂ¦ Â¦manyÂ¦ Â¦c itiesÂ¦ ,â– Â¦andÂ¦ Â¦itÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦es tim atedÂ¦ Â¦thatÂ¦ Â¦aboutÂ¦ Â¦7 6 0Â¦ Â¦millionÂ¦ Â¦peopleÂ¦ â–( Â¦moreÂ¦ Â¦thanÂ¦ Â¦h alfÂ¦ Â¦theÂ¦ Â¦populationÂ¦ )â– Â¦f ac edÂ¦ Â¦someÂ¦ Â¦for mÂ¦ Â¦ofÂ¦ Â¦out d o orÂ¦ Â¦res tric tionÂ¦ . ğ‹‡Â¦afterÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦ent eredÂ¦ Â¦itsÂ¦ Â¦g lobalÂ¦ Â¦phaseÂ¦ Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ ,â– ğ‹‡Â¦chineseÂ¦ Â¦a u th or itiesÂ¦ Â¦to okÂ¦ Â¦s tric tÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦fromÂ¦ â–" Â¦imp or tingÂ¦ "â– Â¦fromÂ¦ Â¦otherÂ¦ Â¦countriesÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦diseaseÂ¦ Â¦2019Â¦ â–( ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ )â– Â¦isÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦diseaseÂ¦ ,â– Â¦ourÂ¦ Â¦a wa re nessÂ¦ Â¦andÂ¦ Â¦kno w l ed geÂ¦ Â¦areÂ¦ Â¦g ra d u allyÂ¦ Â¦increasingÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦o ng o ingÂ¦ Â¦researchÂ¦ Â¦fin di ngsÂ¦ Â¦andÂ¦ Â¦clinicalÂ¦ Â¦p ra ct iceÂ¦ Â¦experie nceÂ¦ ;â– Â¦he nceÂ¦ ,â– Â¦theÂ¦ Â¦stra te g iesÂ¦ Â¦ofÂ¦ Â¦di a g no sisÂ¦ Â¦andÂ¦ Â¦treatmentÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦cont in u allyÂ¦ Â¦up d atedÂ¦ .
ğ‹‡ Â¦rem o teÂ¦ Â¦workingÂ¦ Â¦measuresÂ¦ Â¦wereÂ¦ Â¦in st itu tedÂ¦ Â¦inÂ¦ Â¦severalÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦regi onsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦experie nceÂ¦ Â¦fromÂ¦ ğ‹‡Â¦ita lyÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦currentÂ¦ Â¦tre ndsÂ¦ Â¦inÂ¦ Â¦otherÂ¦ Â¦countriesÂ¦ Â¦sho wÂ¦ Â¦thatÂ¦ Â¦theÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦pandemicÂ¦ Â¦isÂ¦ Â¦pro gr ess ingÂ¦ Â¦rapidlyÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğŠ£ Â¦e uÂ¦ / Â¦e ea Â¦ğŠ¼ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦ukÂ¦ğŠ¼ .
ğ‹‡ Â¦withÂ¦ Â¦theÂ¦ Â¦or de alsÂ¦ Â¦ofÂ¦ ğŠ£ Â¦s ar sÂ¦ ,â– Â¦m ersÂ¦ ğŠ¼ Â¦andÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦aÂ¦ Â¦be tterÂ¦ Â¦pre par ed nessÂ¦ Â¦andÂ¦ Â¦responseÂ¦ Â¦pl anÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦inÂ¦ Â¦placeÂ¦ .
ğ‹‡Â¦manyÂ¦ Â¦re si de ntsÂ¦ Â¦ofÂ¦ ğ‹‡Â¦w uhanÂ¦ Â¦andÂ¦ ğ‹‡Â¦h ub e iÂ¦ Â¦haveÂ¦ Â¦reportedÂ¦ Â¦dis c ri m inationÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theirÂ¦ Â¦regi onalÂ¦ Â¦o ri g inÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦st ati st icalÂ¦ Â¦an al y sisÂ¦ Â¦p ub lish edÂ¦ Â¦30Â¦ ğ‹‡Â¦marchÂ¦ Â¦es tim atedÂ¦ Â¦thatÂ¦ Â¦n umb ersÂ¦ Â¦ofÂ¦ Â¦infectionsÂ¦ Â¦inÂ¦ ğ‹‡Â¦ita lyÂ¦ Â¦wereÂ¦ Â¦consid er ab lyÂ¦ Â¦g rea terÂ¦ Â¦thanÂ¦ Â¦theÂ¦ Â¦reportedÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦2 2Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦afterÂ¦ Â¦aÂ¦ Â¦ph oneÂ¦ Â¦c allÂ¦ Â¦withÂ¦ ğ‹‡Â¦ita li anÂ¦ ğ‹‡Â¦primeÂ¦ ğ‹‡Â¦ministerÂ¦ ğ‹‡ Â¦gi u se pp eÂ¦ ğ‹‡ Â¦con teÂ¦ ,â– ğ‹‡Â¦r us si anÂ¦ Â¦presidentÂ¦ ğ‹‡Â¦v la di m irÂ¦ ğ‹‡Â¦p ut inÂ¦ Â¦ar r an gedÂ¦ Â¦theÂ¦ ğ‹‡Â¦r us si anÂ¦ Â¦ar m yÂ¦ Â¦toÂ¦ Â¦s endÂ¦ Â¦m il it aryÂ¦ Â¦medic sÂ¦ ,â– Â¦speci alÂ¦ Â¦dis in fe ctionÂ¦ Â¦ve h ic lesÂ¦ ,â– Â¦andÂ¦ Â¦otherÂ¦ Â¦medicalÂ¦ Â¦e qu i p mentÂ¦ Â¦toÂ¦ ğ‹‡Â¦ita lyÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦governmentÂ¦ Â¦e nc ou ra gedÂ¦ Â¦b us in es sesÂ¦ Â¦andÂ¦ Â¦fa ct oriesÂ¦ Â¦toÂ¦ Â¦r eÂ¦ - Â¦openÂ¦ Â¦onÂ¦ Â¦30Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦andÂ¦ Â¦prov idedÂ¦ Â¦mo ne t aryÂ¦ Â¦s tim ul usÂ¦ Â¦p ack a gesÂ¦ Â¦forÂ¦ Â¦f ir msÂ¦ . ğ‹‡Â¦theÂ¦ ğ‹‡Â¦stateÂ¦ ğ‹‡Â¦c oun ci lÂ¦ Â¦dec l aredÂ¦ Â¦aÂ¦ Â¦dayÂ¦ Â¦ofÂ¦ Â¦mo ur ningÂ¦ Â¦toÂ¦ Â¦beg inÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦n ationalÂ¦ Â¦threeÂ¦ - Â¦min uteÂ¦ Â¦mo mentÂ¦ Â¦ofÂ¦ Â¦si le nceÂ¦ Â¦onÂ¦ Â¦10Â¦ : Â¦ 00Â¦ Â¦4Â¦ ğ‹‡Â¦aprilÂ¦ ,â– Â¦co in ci dingÂ¦ Â¦withÂ¦ ğ‹‡Â¦ q i ng m ingÂ¦ ğ‹‡Â¦f es tiv alÂ¦ ,â– Â¦al thoughÂ¦ Â¦theÂ¦ Â¦centralÂ¦ Â¦governmentÂ¦ Â¦askedÂ¦ Â¦f am il iesÂ¦ Â¦toÂ¦ Â¦p ayÂ¦ Â¦theirÂ¦ Â¦r esp ectsÂ¦ Â¦on lineÂ¦ Â¦inÂ¦ Â¦ob s erv a nceÂ¦ Â¦ofÂ¦ Â¦ph y s icalÂ¦ Â¦dis ta ncingÂ¦ Â¦asÂ¦ Â¦toÂ¦ Â¦avo idÂ¦ Â¦aÂ¦ Â¦re ne w edÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦outbreakÂ¦ .
ğ‹‡ Â¦privateÂ¦ Â¦ve h ic leÂ¦ Â¦useÂ¦ Â¦wasÂ¦ Â¦b an nedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦cityÂ¦ .
ğ‹‡ Â¦aroundÂ¦ Â¦2 00Â¦ Â¦countriesÂ¦ Â¦andÂ¦ Â¦ter rit oriesÂ¦ Â¦haveÂ¦ Â¦hadÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦oneÂ¦ Â¦caseÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦e ur op e anÂ¦ ğ‹‡Â¦c en tr eÂ¦ Â¦forÂ¦ ğ‹‡ Â¦diseaseÂ¦ ğ‹‡ Â¦prev entionÂ¦ Â¦andÂ¦ ğ‹‡ Â¦controlÂ¦ â–( ğŠ£Â¦ ec d cÂ¦ğŠ¼ )â– Â¦statesÂ¦ Â¦thatÂ¦ Â¦whileÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦ enti re lyÂ¦ Â¦cle arÂ¦ Â¦howÂ¦ Â¦ea si lyÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦sprea dsÂ¦ ,â– Â¦oneÂ¦ Â¦personÂ¦ Â¦gen er allyÂ¦ Â¦inf ectsÂ¦ Â¦twoÂ¦ Â¦toÂ¦ Â¦threeÂ¦ Â¦o thersÂ¦ . ğ‹‡Â¦theÂ¦ Â¦virusÂ¦ Â¦sur vi vesÂ¦ Â¦forÂ¦ Â¦hoursÂ¦ Â¦toÂ¦ Â¦daysÂ¦ Â¦onÂ¦ Â¦sur f a cesÂ¦ .
ğ‹‡Â¦ ap artÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦su p erÂ¦ - Â¦sprea dersÂ¦ ,â– Â¦itÂ¦ Â¦wasÂ¦ Â¦es tim atedÂ¦ Â¦thatÂ¦ Â¦eachÂ¦ Â¦caseÂ¦ Â¦couldÂ¦ Â¦gi veÂ¦ Â¦r iseÂ¦ Â¦toÂ¦ Â¦appro xi ma telyÂ¦ Â¦twoÂ¦ Â¦se co nd aryÂ¦ Â¦casesÂ¦ ,â– Â¦withÂ¦ Â¦anÂ¦ Â¦inc ub ationÂ¦ Â¦periodÂ¦ Â¦ofÂ¦ Â¦4Â¦ Â¦toÂ¦ Â¦7Â¦ Â¦daysÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦p ea kÂ¦ Â¦ofÂ¦ Â¦v iralÂ¦ Â¦lo adÂ¦ Â¦appe ar ingÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦1 0 thÂ¦ Â¦dayÂ¦ Â¦ofÂ¦ Â¦ ill nessÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦thisÂ¦ Â¦toÂ¦ Â¦happ enÂ¦ ,â– ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦toÂ¦ Â¦rep lic ateÂ¦ Â¦inÂ¦ Â¦hum ansÂ¦ Â¦toÂ¦ Â¦su ffic i entÂ¦ Â¦ext entÂ¦ Â¦toÂ¦ Â¦al lowÂ¦ Â¦theÂ¦ Â¦acc um ul ationÂ¦ Â¦ofÂ¦ Â¦ad ap tiveÂ¦ Â¦mut ationsÂ¦ Â¦thatÂ¦ Â¦c ou nt er actÂ¦ Â¦h ostÂ¦ Â¦res tric tionÂ¦ Â¦fa ct orsÂ¦ .
ğ‹‡Â¦s te ro i dsÂ¦ ,â– Â¦asÂ¦ Â¦imm un os u pp r ess a ntsÂ¦ ,â– Â¦wereÂ¦ Â¦wi de lyÂ¦ Â¦usedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦toÂ¦ Â¦reduceÂ¦ Â¦theÂ¦ Â¦se ver ityÂ¦ Â¦ofÂ¦ Â¦inf l am m atoryÂ¦ Â¦d a ma geÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦high li gh tsÂ¦ Â¦thatÂ¦ ,â– Â¦asÂ¦ Â¦atÂ¦ Â¦15Â¦ ğ‹‡Â¦marchÂ¦ Â¦8Â¦ : Â¦ 00Â¦ Â¦aÂ¦ . Â¦ mÂ¦ . ,â– Â¦15Â¦ Â¦otherÂ¦ ğŠ£ Â¦e uÂ¦ / Â¦e ea Â¦ğŠ¼ Â¦countriesÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦ukÂ¦ğŠ¼ Â¦hadÂ¦ Â¦al rea dyÂ¦ Â¦reportedÂ¦ Â¦aÂ¦ Â¦totalÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦casesÂ¦ Â¦com par ableÂ¦ Â¦toÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ ğ‹‡Â¦ita lyÂ¦ Â¦j ustÂ¦ Â¦3Â¦ Â¦weeksÂ¦ Â¦pri orÂ¦ Â¦orÂ¦ Â¦lessÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦outbreakÂ¦ Â¦dis ru p tedÂ¦ Â¦pl ansÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦2020Â¦ ğ‹‡Â¦s um m erÂ¦ ğ‹‡Â¦ ol y mp icsÂ¦ ,â– Â¦whichÂ¦ Â¦wereÂ¦ Â¦o ri g in allyÂ¦ Â¦s ch ed ul edÂ¦ Â¦toÂ¦ Â¦startÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦ endÂ¦ Â¦ofÂ¦ ğ‹‡Â¦j u lyÂ¦ ;â– Â¦theÂ¦ ğ‹‡ Â¦intern ationalÂ¦ ğ‹‡Â¦ ol y mp icÂ¦ ğ‹‡Â¦comm it te eÂ¦ Â¦announcedÂ¦ Â¦onÂ¦ Â¦24Â¦ ğ‹‡Â¦marchÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦e v entÂ¦ Â¦willÂ¦ Â¦beÂ¦ â–" Â¦res ch ed ul edÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦d ateÂ¦ Â¦be y on dÂ¦ Â¦2020Â¦ Â¦butÂ¦ Â¦notÂ¦ Â¦la terÂ¦ Â¦thanÂ¦ Â¦s um m erÂ¦ Â¦20 2 1Â¦ " . ğ‹‡Â¦ca si no sÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦g am ingÂ¦ Â¦v en u esÂ¦ Â¦wor l d w ideÂ¦ Â¦haveÂ¦ Â¦closedÂ¦ Â¦andÂ¦ Â¦li veÂ¦ Â¦po k erÂ¦ Â¦to ur na mentsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦e i therÂ¦ Â¦po st po nedÂ¦ Â¦orÂ¦ Â¦can ce lledÂ¦ .
ğ‹‡ Â¦areÂ¦ Â¦youÂ¦ Â¦ha vingÂ¦ Â¦anyÂ¦ Â¦sh or t nessÂ¦ Â¦ofÂ¦ Â¦brea thÂ¦ ?
ğ‹‡Â¦di ar r he aÂ¦ â–( Â¦2 6Â¦ % )â– Â¦andÂ¦ Â¦s oreÂ¦ Â¦th ro atÂ¦ â–( Â¦2 1Â¦ % )â– Â¦wereÂ¦ Â¦alsoÂ¦ Â¦ob s er vedÂ¦ Â¦withÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ Â¦patientsÂ¦ .
ğ‹‡Â¦healthÂ¦ Â¦or ga ni z ationsÂ¦ Â¦recomme ndedÂ¦ Â¦thatÂ¦ Â¦peopleÂ¦ Â¦co verÂ¦ Â¦theirÂ¦ Â¦m outhÂ¦ Â¦andÂ¦ Â¦n oseÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦b entÂ¦ Â¦el b o wÂ¦ Â¦orÂ¦ Â¦aÂ¦ Â¦t is s ueÂ¦ Â¦whenÂ¦ Â¦c ou g hingÂ¦ Â¦orÂ¦ Â¦s n ee z ingÂ¦ ,â– Â¦andÂ¦ Â¦dis p os ingÂ¦ Â¦ofÂ¦ Â¦anyÂ¦ Â¦t is s ueÂ¦ Â¦immedi a telyÂ¦ .
ğ‹‡ Â¦aboutÂ¦ Â¦3 6 4Â¦ , Â¦000Â¦ Â¦peopleÂ¦ Â¦haveÂ¦ Â¦rec ov eredÂ¦ .
ğ‹‡Â¦co ro na vi rusesÂ¦ Â¦canÂ¦ Â¦causeÂ¦ Â¦p ne um o niaÂ¦ â–( Â¦e i therÂ¦ Â¦d ir ectÂ¦ Â¦v iralÂ¦ Â¦p ne um o niaÂ¦ Â¦orÂ¦ Â¦se co nd aryÂ¦ Â¦b ac teri alÂ¦ Â¦p ne um o niaÂ¦ )â– Â¦andÂ¦ Â¦b ro nc hi ti sÂ¦ â–( Â¦e i therÂ¦ Â¦d ir ectÂ¦ Â¦v iralÂ¦ Â¦b ro nc hi ti sÂ¦ Â¦orÂ¦ Â¦se co nd aryÂ¦ Â¦b ac teri alÂ¦ Â¦b ro nc hi ti sÂ¦ ).
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦1 9 5 0 sÂ¦ ,â– Â¦theÂ¦ Â¦humanÂ¦ Â¦coronavirusÂ¦ ğŠ£ Â¦o cğŠ¼ 4 3Â¦ Â¦beg anÂ¦ Â¦toÂ¦ Â¦di ver geÂ¦ Â¦intoÂ¦ Â¦itsÂ¦ Â¦presentÂ¦ Â¦ge no t y p esÂ¦ .
ğ‹‡ Â¦beforeÂ¦ Â¦discus s ingÂ¦ Â¦theÂ¦ Â¦ani malÂ¦ Â¦o ri g insÂ¦ Â¦ofÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ ,â– Â¦itÂ¦ Â¦willÂ¦ Â¦ser veÂ¦ Â¦ usÂ¦ Â¦wellÂ¦ Â¦toÂ¦ Â¦discus sÂ¦ Â¦theÂ¦ Â¦de fi ni tionsÂ¦ Â¦andÂ¦ Â¦c har ac teri st icsÂ¦ Â¦ofÂ¦ Â¦e v o lu ti on aryÂ¦ ,â– Â¦n atur alÂ¦ ,â– Â¦res erv o irÂ¦ ,â– Â¦inter medi ateÂ¦ Â¦andÂ¦ Â¦a mp li f yingÂ¦ Â¦hos tsÂ¦ Â¦ofÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦hasÂ¦ Â¦issuedÂ¦ Â¦ins tr uc tionsÂ¦ Â¦onÂ¦ Â¦whenÂ¦ Â¦andÂ¦ Â¦howÂ¦ Â¦toÂ¦ Â¦useÂ¦ Â¦masksÂ¦ .
ğ‹‡ Â¦anotherÂ¦ Â¦hospitalÂ¦ Â¦wasÂ¦ Â¦bu il tÂ¦ Â¦a f t er w ar dsÂ¦ ,â– ğ‹‡ Â¦le is he ns hanÂ¦ ğ‹‡Â¦hospitalÂ¦ ,â– Â¦toÂ¦ Â¦ha nd leÂ¦ Â¦ad di ti onalÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦6Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ ,â– Â¦ourÂ¦ Â¦t ea mÂ¦ Â¦hadÂ¦ Â¦p ub lish edÂ¦ Â¦aÂ¦ Â¦rap idÂ¦ Â¦ad v iceÂ¦ Â¦guid e lineÂ¦ Â¦forÂ¦ Â¦di a g no sisÂ¦ Â¦andÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ Â¦2019Â¦ Â¦no ve lÂ¦ Â¦coronavirusÂ¦ â–( Â¦2019Â¦ - Â¦n ğ‹‡ co ğ‹‡ vÂ¦ )â– Â¦infectionÂ¦ ,â– Â¦andÂ¦ Â¦thisÂ¦ Â¦guid e lineÂ¦ Â¦prov idedÂ¦ Â¦ourÂ¦ Â¦experie nceÂ¦ Â¦andÂ¦ Â¦makeÂ¦ Â¦wellÂ¦ Â¦re fere nceÂ¦ Â¦forÂ¦ Â¦fi gh tingÂ¦ Â¦againstÂ¦ Â¦thisÂ¦ Â¦pandemicÂ¦ Â¦wor l d w ideÂ¦ .
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦hasÂ¦ Â¦fe at uresÂ¦ Â¦thatÂ¦ Â¦areÂ¦ Â¦simil arÂ¦ Â¦toÂ¦ Â¦bothÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ / ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦fourÂ¦ Â¦comm unityÂ¦ - Â¦ac qu ir edÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ .
ğ‹‡ Â¦theirÂ¦ Â¦guid el inesÂ¦ Â¦th usÂ¦ Â¦ad v iseÂ¦ Â¦thatÂ¦ Â¦anyÂ¦ Â¦pre gn antÂ¦ Â¦personÂ¦ Â¦admittedÂ¦ Â¦toÂ¦ Â¦hospitalÂ¦ Â¦withÂ¦ Â¦aÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦infectionÂ¦ Â¦shouldÂ¦ Â¦recei veÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦10Â¦ Â¦daysÂ¦ Â¦ofÂ¦ Â¦prop h y l ac ticÂ¦ Â¦lowÂ¦ - Â¦m ol ec ul arÂ¦ - Â¦we i ghtÂ¦ Â¦he par inÂ¦ Â¦afterÂ¦ Â¦beingÂ¦ Â¦dis c har gedÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦hospitalÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦o ri g inÂ¦ Â¦andÂ¦ Â¦inter medi ateÂ¦ Â¦h ostÂ¦
ğ‹‡Â¦forÂ¦ Â¦thoseÂ¦ Â¦whoÂ¦ Â¦doÂ¦ Â¦notÂ¦ ,â– Â¦theÂ¦ Â¦timeÂ¦ Â¦fromÂ¦ Â¦developmentÂ¦ Â¦ofÂ¦ Â¦symptomsÂ¦ Â¦toÂ¦ Â¦deathÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦betweenÂ¦ Â¦6Â¦ Â¦andÂ¦ Â¦4 1Â¦ Â¦daysÂ¦ ,â– Â¦withÂ¦ Â¦theÂ¦ Â¦mostÂ¦ Â¦comm onÂ¦ Â¦beingÂ¦ Â¦14Â¦ Â¦daysÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦smallÂ¦ Â¦studyÂ¦ Â¦inv ol vingÂ¦ Â¦6Â¦ Â¦confirmedÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦mo thersÂ¦ Â¦sh ow edÂ¦ Â¦noÂ¦ Â¦ind ic ationÂ¦ Â¦ofÂ¦ ğŠ£ Â¦s ar sÂ¦ - Â¦cov Â¦ğŠ¼ - Â¦19Â¦ Â¦inÂ¦ Â¦theirÂ¦ Â¦ne w b or nsÂ¦ 'â– Â¦th ro a tsÂ¦ Â¦orÂ¦ Â¦ser umÂ¦ Â¦butÂ¦ Â¦antib odiesÂ¦ Â¦wereÂ¦ Â¦presentÂ¦ Â¦inÂ¦ Â¦ne o na talÂ¦ Â¦bloodÂ¦ Â¦ser aÂ¦ Â¦samplesÂ¦ ,â– Â¦includingÂ¦ ğ‹‡Â¦i g ğ‹‡ mÂ¦ Â¦inÂ¦ Â¦twoÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦inf a ntsÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ Â¦severeÂ¦ Â¦casesÂ¦ ,â– Â¦theÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ ğ‹‡Â¦ dÂ¦ - Â¦di m erÂ¦ ,â– Â¦aÂ¦ Â¦fi b r inÂ¦ Â¦de g ra d ationÂ¦ Â¦produc tÂ¦ Â¦presentÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦bloodÂ¦ ,â– Â¦wasÂ¦ Â¦e le v atedÂ¦ ,â– Â¦andÂ¦ Â¦l y mp h oc y teÂ¦ Â¦c oun tÂ¦ Â¦wasÂ¦ Â¦pro g res si ve lyÂ¦ Â¦reduc edÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦2 3Â¦ ğ‹‡Â¦januaryÂ¦ ,â– Â¦inÂ¦ Â¦rea ctionÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦centralÂ¦ Â¦a u th or itiesÂ¦ 'â– Â¦decisionÂ¦ Â¦toÂ¦ Â¦imple mentÂ¦ Â¦aÂ¦ Â¦trans por t ationÂ¦ Â¦b anÂ¦ Â¦inÂ¦ ğ‹‡Â¦w uhanÂ¦ ,â– ğŠ£Â¦whoÂ¦ğŠ¼ Â¦rep res en ta tiveÂ¦ ğ‹‡ Â¦ga u d enÂ¦ ğ‹‡ Â¦ga le aÂ¦ Â¦rem ar kedÂ¦ Â¦thatÂ¦ Â¦whileÂ¦ Â¦itÂ¦ Â¦wasÂ¦ â–" Â¦c er ta in lyÂ¦ Â¦notÂ¦ Â¦aÂ¦ Â¦recomme nd ationÂ¦ Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦hasÂ¦ Â¦madeÂ¦ " ,â– Â¦itÂ¦ Â¦wasÂ¦ Â¦alsoÂ¦ â–" Â¦aÂ¦ Â¦veryÂ¦ Â¦importantÂ¦ Â¦ind ic ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦comm it mentÂ¦ Â¦toÂ¦ Â¦cont ainÂ¦ Â¦theÂ¦ Â¦epi demicÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦placeÂ¦ Â¦whereÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦mostÂ¦ Â¦conc en tr atedÂ¦ "â– Â¦andÂ¦ Â¦calledÂ¦ Â¦itÂ¦ â–" Â¦un p r ec ed entedÂ¦ Â¦inÂ¦ Â¦publicÂ¦ Â¦healthÂ¦ Â¦hi st oryÂ¦ " . ğ‹‡Â¦onÂ¦ Â¦30Â¦ ğ‹‡Â¦januaryÂ¦ ,â– Â¦follow ingÂ¦ Â¦confir m ationÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦out s ideÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦increaseÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦casesÂ¦ Â¦inÂ¦ Â¦otherÂ¦ Â¦countriesÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦dec l aredÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦aÂ¦ ğ‹‡ Â¦publicÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡ Â¦emergencyÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦intern ationalÂ¦ ğ‹‡ Â¦conc ernÂ¦ â–( ğŠ£Â¦p he i cÂ¦ğŠ¼ ),â– Â¦theÂ¦ Â¦si x thÂ¦ ğŠ£Â¦p he i cÂ¦ğŠ¼ Â¦sinceÂ¦ Â¦theÂ¦ Â¦me as ureÂ¦ Â¦wasÂ¦ Â¦firstÂ¦ Â¦inv o kedÂ¦ Â¦duringÂ¦ Â¦theÂ¦ Â¦20 0 9Â¦ Â¦sw ineÂ¦ Â¦fl uÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦the rap iesÂ¦ Â¦includeÂ¦ Â¦currentÂ¦ Â¦andÂ¦ Â¦po t enti alÂ¦ Â¦tre at mentsÂ¦ Â¦withÂ¦ Â¦an tiv iralÂ¦ Â¦d ru gsÂ¦ ,â– Â¦imm un os u pp r ess a ntsÂ¦ ,â– Â¦s te ro i dsÂ¦ ,â– Â¦pl as maÂ¦ Â¦fromÂ¦ Â¦rec ov eredÂ¦ Â¦patientsÂ¦ ,â– ğ‹‡Â¦chineseÂ¦ Â¦medic ineÂ¦ ,â– Â¦andÂ¦ Â¦p s yc ho log icalÂ¦ Â¦supp ortÂ¦ .
ğ‹‡ Â¦severalÂ¦ Â¦rec entÂ¦ Â¦stud iesÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦me ta ge no micÂ¦ Â¦se que ncingÂ¦ Â¦haveÂ¦ Â¦su gg es tedÂ¦ Â¦thatÂ¦ Â¦aÂ¦ Â¦groupÂ¦ Â¦ofÂ¦ Â¦e nd a ng eredÂ¦ Â¦smallÂ¦ Â¦m am m alsÂ¦ Â¦knownÂ¦ Â¦asÂ¦ Â¦pa ng ol insÂ¦ â–( ğ‹‡Â¦ma ni sÂ¦ Â¦j av an ic aÂ¦ )â– Â¦couldÂ¦ Â¦alsoÂ¦ Â¦ har b o urÂ¦ Â¦an ce stra lÂ¦ Â¦be t aÂ¦ - ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦theyÂ¦ Â¦areÂ¦ Â¦wi de lyÂ¦ Â¦dist rib u tedÂ¦ Â¦acrossÂ¦ Â¦theÂ¦ ğ‹‡Â¦m id d leÂ¦ ğ‹‡ Â¦ea stÂ¦ Â¦andÂ¦ ğ‹‡Â¦a f r ic aÂ¦ .
ğ‹‡Â¦ifÂ¦ Â¦youÂ¦ Â¦continueÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦highÂ¦ Â¦fe v ersÂ¦
ğ‹‡Â¦primeÂ¦ ğ‹‡Â¦ministerÂ¦ ğ‹‡ Â¦gi u se pp eÂ¦ ğ‹‡ Â¦con teÂ¦ Â¦saidÂ¦ ,â–" ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦areasÂ¦ ,â– Â¦en tryÂ¦ Â¦andÂ¦ Â¦ex itÂ¦ Â¦willÂ¦ Â¦notÂ¦ Â¦beÂ¦ Â¦prov idedÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦so ur ceÂ¦ Â¦acc u sedÂ¦ ğ‹‡Â¦r us si aÂ¦ Â¦ofÂ¦ Â¦e mb ar kingÂ¦ Â¦onÂ¦ Â¦aÂ¦ â–" Â¦ge op ol iticalÂ¦ Â¦andÂ¦ Â¦di p lo ma ticÂ¦ "â– Â¦c har mÂ¦ Â¦off en siveÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ ,â– Â¦theÂ¦ Â¦requir e mentsÂ¦ Â¦forÂ¦ Â¦s uc c ess f ulÂ¦ Â¦h ostÂ¦ Â¦sw it ch esÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦imp lic ationsÂ¦ Â¦ofÂ¦ Â¦virusÂ¦ Â¦e v o lu tionÂ¦ Â¦onÂ¦ Â¦diseaseÂ¦ Â¦se ver ityÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦high li gh tedÂ¦ .
ğ‹‡Â¦sa lesÂ¦ Â¦w entÂ¦ Â¦upÂ¦ Â¦inÂ¦ Â¦aÂ¦ â–" Â¦s har pÂ¦ Â¦increaseÂ¦ "â– Â¦lastÂ¦ Â¦weekÂ¦ ,â– Â¦accordingÂ¦ Â¦toÂ¦ Â¦aÂ¦ ğ‹‡Â¦w o ol w or th sÂ¦ Â¦s po k esp er s onÂ¦ .
ğ‹‡ Â¦throughÂ¦ Â¦differentÂ¦ Â¦pa th wa ysÂ¦ ,â– Â¦theÂ¦ Â¦virusÂ¦ Â¦ind u cesÂ¦ Â¦theÂ¦ Â¦exp r ess ionÂ¦ Â¦ofÂ¦ Â¦inf l am m atoryÂ¦ Â¦fa ct orsÂ¦ ,â– Â¦m atur ationÂ¦ Â¦ofÂ¦ Â¦de nd ri ticÂ¦ Â¦ce llsÂ¦ ,â– Â¦andÂ¦ Â¦sy nt he sisÂ¦ Â¦ofÂ¦ Â¦typ eÂ¦ ğ‹‡Â¦iÂ¦ Â¦inter f er onsÂ¦ â–( ğŠ£Â¦i f n ğŠ¼ sÂ¦ )â– Â¦whichÂ¦ Â¦li m itÂ¦ Â¦theÂ¦ Â¦sprea dingÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦andÂ¦ Â¦acc el er ateÂ¦ Â¦m ac r op ha geÂ¦ Â¦p ha g oc y t o sisÂ¦ Â¦ofÂ¦ Â¦v iralÂ¦ Â¦an ti ge nsÂ¦ .
ğ‹‡ Â¦amongÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦acc ess oryÂ¦ Â¦prote insÂ¦ ,â– ğŠ£ Â¦or f ğŠ¼ 8Â¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦th oughtÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦importantÂ¦ Â¦inÂ¦ Â¦ad a pt ationÂ¦ Â¦toÂ¦ Â¦hum ansÂ¦ ,â– Â¦asÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦relatedÂ¦ Â¦b atÂ¦ Â¦vi rusesÂ¦ Â¦wereÂ¦ Â¦isol atedÂ¦ Â¦butÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦en co deÂ¦ Â¦di ver g entÂ¦ ğŠ£ Â¦or f ğŠ¼ 8Â¦ Â¦prote insÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦prov in cialÂ¦ - Â¦levelÂ¦ Â¦ad m in is tr atorsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦comm u ni stÂ¦ ğ‹‡ Â¦par tyÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chinaÂ¦ â–( ğŠ£Â¦c p cÂ¦ğŠ¼ )â– Â¦wereÂ¦ Â¦dis m is sedÂ¦ Â¦overÂ¦ Â¦theirÂ¦ Â¦ha nd l ingÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦quarantineÂ¦ Â¦e f for tsÂ¦ Â¦inÂ¦ ğ‹‡ Â¦centralÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦aÂ¦ Â¦sig nÂ¦ Â¦ofÂ¦ Â¦dis co nt entÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦pol iticalÂ¦ Â¦ est ab lish mentÂ¦ ' Â¦sÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦inÂ¦ Â¦thoseÂ¦ Â¦regi onsÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ ğŠ£Â¦us Â¦ğŠ¼ Â¦thereÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦theÂ¦ Â¦recomme nd ationÂ¦ Â¦thatÂ¦ Â¦ne w b or nsÂ¦ Â¦andÂ¦ Â¦mo thersÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦te m por ari lyÂ¦ Â¦se par atedÂ¦ Â¦un ti lÂ¦ Â¦transmissionÂ¦ - Â¦basedÂ¦ Â¦pr ec a u tionsÂ¦ Â¦areÂ¦ Â¦dis co nt in u edÂ¦ ,â– Â¦andÂ¦ Â¦thatÂ¦ Â¦whereÂ¦ Â¦thisÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦possibleÂ¦ Â¦theÂ¦ Â¦ne w b or nÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦ ke p tÂ¦ Â¦2Â¦ Â¦me tr esÂ¦ Â¦a wayÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦mo therÂ¦ .
ğ‹‡Â¦re por tsÂ¦ Â¦fromÂ¦ ğ‹‡Â¦februaryÂ¦ â–( Â¦whenÂ¦ Â¦theÂ¦ Â¦maj or ityÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦casesÂ¦ Â¦hadÂ¦ Â¦stillÂ¦ Â¦beenÂ¦ Â¦con f inedÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ )â– Â¦haveÂ¦ Â¦d oc um entedÂ¦ Â¦ra ci stÂ¦ Â¦s enti mentsÂ¦ Â¦exp res sedÂ¦ Â¦inÂ¦ Â¦variousÂ¦ Â¦gr ou psÂ¦ Â¦wor l d w ideÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦peopleÂ¦ Â¦d es er vingÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦orÂ¦ Â¦recei vingÂ¦ Â¦whatÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦clai medÂ¦ Â¦asÂ¦ Â¦j us ti fiedÂ¦ Â¦re t rib u tionÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦thisÂ¦ Â¦s en seÂ¦ ,â– Â¦theÂ¦ Â¦lo ngerÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦outbreakÂ¦ Â¦pers istsÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦moreÂ¦ Â¦peopleÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦inf ectsÂ¦ ,â– Â¦theÂ¦ Â¦g rea terÂ¦ Â¦cha nceÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦willÂ¦ Â¦f ul lyÂ¦ Â¦ad ap tÂ¦ Â¦toÂ¦ Â¦hum ansÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦v ari ab ilityÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦likelyÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦si gni fic a ntlyÂ¦ Â¦a ff ec tingÂ¦ Â¦reportedÂ¦ Â¦caseÂ¦ Â¦f at alityÂ¦ Â¦ra tesÂ¦ ,â– Â¦whichÂ¦ Â¦areÂ¦ Â¦likelyÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦si gni fic a ntlyÂ¦ Â¦overÂ¦ - Â¦es tim atedÂ¦ Â¦inÂ¦ Â¦someÂ¦ Â¦countriesÂ¦ .
ğ‹‡ Â¦com par ab lyÂ¦ ,â– Â¦theÂ¦ Â¦mor t alityÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦byÂ¦ ğ‹‡ Â¦no ve mberÂ¦ Â¦20 0 2Â¦ Â¦wasÂ¦ Â¦10Â¦ %â– Â¦ofÂ¦ Â¦8Â¦ , Â¦ 0 9 6Â¦ Â¦confirmedÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦manyÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chinaÂ¦ ' Â¦sÂ¦ Â¦ne ar lyÂ¦ Â¦3 00Â¦ Â¦millionÂ¦ Â¦ruralÂ¦ Â¦mi gr antÂ¦ Â¦workersÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦stra ndedÂ¦ Â¦atÂ¦ Â¦homeÂ¦ Â¦inÂ¦ Â¦in l andÂ¦ Â¦prov in cesÂ¦ Â¦orÂ¦ Â¦tra pp edÂ¦ Â¦inÂ¦ ğ‹‡Â¦h ub e iÂ¦ Â¦pro vi nceÂ¦ . ğ‹‡Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– Â¦moreÂ¦ Â¦thanÂ¦ Â¦10Â¦ Â¦millionÂ¦ ğ‹‡Â¦a mer ic ansÂ¦ Â¦l ostÂ¦ Â¦theirÂ¦ Â¦jo b sÂ¦ Â¦andÂ¦ Â¦app li edÂ¦ Â¦forÂ¦ Â¦governmentÂ¦ Â¦a idÂ¦ .
ğ‹‡ Â¦clinicalÂ¦ Â¦ma ni f est ationsÂ¦ Â¦ofÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ Â¦re se mb leÂ¦ Â¦thoseÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ ,â– Â¦c har ac teri zedÂ¦ Â¦byÂ¦ Â¦pro g res siveÂ¦ Â¦ac uteÂ¦ Â¦p ne um o niaÂ¦ .
ğ‹‡ Â¦conta in mentÂ¦ Â¦isÂ¦ Â¦under ta k enÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦sta gesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦andÂ¦ Â¦ ai msÂ¦ Â¦toÂ¦ Â¦tr aceÂ¦ Â¦andÂ¦ Â¦isol ateÂ¦ Â¦thoseÂ¦ Â¦infectedÂ¦ Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦in tr od u ceÂ¦ Â¦otherÂ¦ Â¦measuresÂ¦ Â¦ofÂ¦ Â¦infectionÂ¦ Â¦controlÂ¦ Â¦andÂ¦ Â¦vaccin ationsÂ¦ Â¦toÂ¦ Â¦sto pÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦fromÂ¦ Â¦sprea dingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦r estÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦populationÂ¦ .
ğ‹‡Â¦h ongÂ¦ ğ‹‡Â¦k ongÂ¦ Â¦hasÂ¦ Â¦setÂ¦ Â¦upÂ¦ Â¦aÂ¦ Â¦sc he meÂ¦ Â¦whereÂ¦ Â¦susp ectedÂ¦ Â¦patientsÂ¦ Â¦canÂ¦ Â¦st ayÂ¦ Â¦homeÂ¦ ,â–" Â¦emergencyÂ¦ Â¦departmentÂ¦ Â¦willÂ¦ Â¦gi veÂ¦ Â¦aÂ¦ Â¦speci m enÂ¦ Â¦t ub eÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦patientÂ¦ " ,â– Â¦theyÂ¦ Â¦sp itÂ¦ Â¦intoÂ¦ Â¦itÂ¦ ,â– Â¦s endÂ¦ Â¦itÂ¦ Â¦b ackÂ¦ Â¦andÂ¦ Â¦getÂ¦ Â¦aÂ¦ Â¦testÂ¦ Â¦resultÂ¦ Â¦aÂ¦ Â¦whileÂ¦ Â¦afterÂ¦ . ğ‹‡Â¦theÂ¦ ğ‹‡Â¦b rit is hÂ¦ ğŠ£ Â¦n h s Â¦ğŠ¼ Â¦hasÂ¦ Â¦announcedÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦ pi lo tingÂ¦ Â¦aÂ¦ Â¦sc he meÂ¦ Â¦toÂ¦ Â¦testÂ¦ Â¦susp ectedÂ¦ Â¦casesÂ¦ Â¦atÂ¦ Â¦homeÂ¦ ,â– Â¦whichÂ¦ Â¦rem o vesÂ¦ Â¦theÂ¦ Â¦riskÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦patientÂ¦ Â¦inf ec tingÂ¦ Â¦o thersÂ¦ Â¦ifÂ¦ Â¦theyÂ¦ Â¦comeÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦hospitalÂ¦ Â¦orÂ¦ Â¦ha vingÂ¦ Â¦toÂ¦ Â¦dis in f ectÂ¦ Â¦anÂ¦ Â¦a mb u la nceÂ¦ Â¦ifÂ¦ Â¦oneÂ¦ Â¦isÂ¦ Â¦usedÂ¦ . ğ‹‡Â¦inÂ¦ Â¦d ri veÂ¦ - Â¦throughÂ¦ Â¦testingÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦forÂ¦ Â¦susp ectedÂ¦ Â¦casesÂ¦ ,â– Â¦aÂ¦ Â¦heal th c areÂ¦ Â¦pro f es si onalÂ¦ Â¦ta k esÂ¦ Â¦sa mpleÂ¦ Â¦usingÂ¦ Â¦appro p ri ateÂ¦ Â¦pr ec a u tionsÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦exa mpleÂ¦ ,â– ğ‹‡Â¦sh uÂ¦ ğ‹‡Â¦f en gÂ¦ ğ‹‡Â¦j i eÂ¦ ğ‹‡Â¦d uÂ¦ Â¦cap s u lesÂ¦ Â¦andÂ¦ ğ‹‡ Â¦li anÂ¦ ğ‹‡Â¦h u aÂ¦ ğ‹‡Â¦ q ingÂ¦ ğ‹‡Â¦w enÂ¦ Â¦cap s u lesÂ¦ Â¦wereÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦effectiveÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦treatmentÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦de ce mberÂ¦ Â¦2019Â¦ ,â– Â¦theÂ¦ Â¦2019Â¦ Â¦no ve lÂ¦ Â¦coronavirusÂ¦ â–( Â¦2019Â¦ - Â¦n ğ‹‡ co ğ‹‡ vÂ¦ )â– Â¦hasÂ¦ Â¦causedÂ¦ Â¦anÂ¦ Â¦outbreakÂ¦ ,â– Â¦whichÂ¦ Â¦isÂ¦ Â¦nowÂ¦ Â¦offi ci allyÂ¦ Â¦na medÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦diseaseÂ¦ Â¦2019Â¦ â–( ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ )â– Â¦andÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦na medÂ¦ Â¦severeÂ¦ Â¦ac uteÂ¦ Â¦respiratoryÂ¦ Â¦sy nd r omeÂ¦ Â¦coronavirusÂ¦ Â¦2Â¦ â–( ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ).
ğ‹‡Â¦r us s ellÂ¦ ğ‹‡Â¦z i m m erm anÂ¦ Â¦ad dedÂ¦ Â¦thatÂ¦ Â¦otherÂ¦ Â¦produc tsÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦inÂ¦ Â¦highÂ¦ Â¦demandÂ¦ ,â– Â¦includingÂ¦ Â¦masksÂ¦ ,â– Â¦sa niti s erÂ¦ ,â– Â¦d ri edÂ¦ Â¦go o dsÂ¦ ,â– Â¦ha nd w as hÂ¦ Â¦andÂ¦ Â¦f lo urÂ¦ .
ğ‹‡ Â¦occ a si on allyÂ¦ ğ‹‡Â¦iÂ¦ Â¦haveÂ¦ Â¦someÂ¦ Â¦ch estÂ¦ Â¦p ainÂ¦
ğ‹‡Â¦theyÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦di v idedÂ¦ Â¦intoÂ¦ Â¦fourÂ¦ Â¦gen er aÂ¦ ,â– Â¦ iÂ¦ . Â¦ eÂ¦ . ,â– Â¦al p haÂ¦ ,â– Â¦be t aÂ¦ ,â– Â¦g am maÂ¦ ,â– Â¦andÂ¦ Â¦d el t aÂ¦ ,â– Â¦ofÂ¦ Â¦whichÂ¦ Â¦al p haÂ¦ - â– Â¦andÂ¦ Â¦be t aÂ¦ - ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦areÂ¦ Â¦knownÂ¦ Â¦toÂ¦ Â¦inf ectÂ¦ Â¦hum ansÂ¦ .
ğ‹‡Â¦th usÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦moreÂ¦ Â¦cr iticalÂ¦ Â¦andÂ¦ Â¦p ra ct icalÂ¦ Â¦toÂ¦ Â¦isol ateÂ¦ ğ‹‡Â¦b Â¦ Â¦ce llsÂ¦ Â¦fromÂ¦ Â¦rec ov eredÂ¦ Â¦patientsÂ¦ Â¦andÂ¦ Â¦ id enti f yÂ¦ Â¦theÂ¦ Â¦ge ne ticÂ¦ Â¦c od esÂ¦ Â¦en co dingÂ¦ Â¦effectiveÂ¦ Â¦antib odiesÂ¦ Â¦orÂ¦ Â¦sc re enÂ¦ Â¦forÂ¦ Â¦effectiveÂ¦ Â¦antib odiesÂ¦ Â¦againstÂ¦ Â¦essentialÂ¦ Â¦prote insÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ ğŠ£Â¦us Â¦ğŠ¼ Â¦aÂ¦ Â¦se ro log icalÂ¦ Â¦testÂ¦ Â¦developedÂ¦ Â¦byÂ¦ ğ‹‡Â¦c el le xÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦approvedÂ¦ Â¦forÂ¦ Â¦emergencyÂ¦ Â¦useÂ¦ Â¦byÂ¦ Â¦c er ti fiedÂ¦ Â¦labor at oriesÂ¦ Â¦onlyÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦su gg es tedÂ¦ Â¦thatÂ¦ ğ‹‡Â¦ uÂ¦ . ğ‹‡Â¦sÂ¦ .â– Â¦sa nc tionsÂ¦ Â¦onÂ¦ ğ‹‡Â¦ ir anÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦a ff ec tingÂ¦ Â¦theÂ¦ Â¦countryÂ¦ ' Â¦sÂ¦ Â¦fin an cialÂ¦ Â¦ab ilityÂ¦ Â¦toÂ¦ Â¦respon dÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦v iralÂ¦ Â¦outbreakÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦cont ra stÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦ne w lyÂ¦ - Â¦ id enti fiedÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦areÂ¦ Â¦high lyÂ¦ Â¦p at ho g en icÂ¦ ,â– Â¦ca us ingÂ¦ Â¦severeÂ¦ Â¦l ow erÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦infectionÂ¦ Â¦inÂ¦ Â¦rel ati ve lyÂ¦ Â¦moreÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦higherÂ¦ Â¦cha nceÂ¦ Â¦toÂ¦ Â¦develop Â¦ Â¦ac uteÂ¦ Â¦respiratoryÂ¦ Â¦dis tr essÂ¦ Â¦sy nd r omeÂ¦ â–( ğŠ£ Â¦ar dsÂ¦ ğŠ¼ )â– Â¦andÂ¦ Â¦ext rap ul m on aryÂ¦ Â¦ma ni f est ationsÂ¦ .
ğ‹‡ Â¦upÂ¦ Â¦toÂ¦ Â¦nowÂ¦ ,â– Â¦noÂ¦ Â¦li veÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦wi ldÂ¦ Â¦ba tsÂ¦ .
ğ‹‡Â¦heÂ¦ Â¦saidÂ¦ ,â– Â¦inÂ¦ Â¦rem ar ksÂ¦ Â¦p ub lish edÂ¦ Â¦byÂ¦ ğŠ£Â¦c n n Â¦ğŠ¼ Â¦inÂ¦ ğ‹‡Â¦februaryÂ¦ ,â–" Â¦otherÂ¦ Â¦thanÂ¦ Â¦inf lu en z aÂ¦ ,â– Â¦noÂ¦ Â¦otherÂ¦ Â¦respiratoryÂ¦ Â¦virusÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦tr ac kedÂ¦ Â¦fromÂ¦ Â¦e mer ge nceÂ¦ Â¦toÂ¦ Â¦cont in u o usÂ¦ Â¦g lobalÂ¦ Â¦spreadÂ¦ ."
ğ‹‡Â¦inÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦imple me nt ationsÂ¦ Â¦ofÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ ,â– ğ‹‡Â¦t ed ro sÂ¦ Â¦st atedÂ¦ Â¦thatÂ¦ â–" Â¦thereÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦reas onÂ¦ Â¦forÂ¦ Â¦measuresÂ¦ Â¦thatÂ¦ Â¦un n ecess ari lyÂ¦ Â¦inter f ereÂ¦ Â¦withÂ¦ Â¦intern ationalÂ¦ Â¦travelÂ¦ Â¦andÂ¦ Â¦tra deÂ¦ "â– Â¦andÂ¦ Â¦thatÂ¦ Â¦theÂ¦ â–" ğŠ£Â¦whoÂ¦ğŠ¼ Â¦do es nÂ¦ ' Â¦tÂ¦ Â¦recomme n dÂ¦ Â¦li mi tingÂ¦ Â¦tra deÂ¦ Â¦andÂ¦ Â¦mo ve mentÂ¦ ."
ğ‹‡Â¦thisÂ¦ Â¦de le tionÂ¦ Â¦sp li tsÂ¦ ğŠ£ Â¦or f ğŠ¼ 8Â¦ Â¦intoÂ¦ ğŠ£ Â¦or f ğŠ¼ 8 aÂ¦ Â¦andÂ¦ ğŠ£ Â¦or f ğŠ¼ 8 b Â¦ Â¦andÂ¦ Â¦isÂ¦ Â¦th oughtÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦anÂ¦ Â¦ad ap tiveÂ¦ Â¦mut ationÂ¦ Â¦thatÂ¦ Â¦pr om o tesÂ¦ Â¦theÂ¦ Â¦sw it chÂ¦ Â¦ofÂ¦ Â¦hos tsÂ¦ .
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦s har esÂ¦ Â¦9 6Â¦ . Â¦2Â¦ %â– Â¦n uc le o t ideÂ¦ Â¦h om o logyÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦b atÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ ğ‹‡Â¦ra ğŠ£ t g ğŠ¼ 1 3Â¦ Â¦isol atedÂ¦ Â¦fromÂ¦ ğ‹‡Â¦r h in ol op h usÂ¦ Â¦a f fi ni sÂ¦ Â¦ba tsÂ¦ .
ğ‹‡Â¦aÂ¦ ğŠ£ Â¦un Â¦ğŠ¼ ğ‹‡ Â¦crisisÂ¦ ğ‹‡Â¦ma na ge mentÂ¦ ğ‹‡Â¦t ea mÂ¦ Â¦wasÂ¦ Â¦ac tiv atedÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦resultÂ¦ ,â– Â¦a ll owingÂ¦ Â¦co or d inationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦ent ireÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦n ationsÂ¦ Â¦responseÂ¦ ,â– Â¦whichÂ¦ Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦statesÂ¦ Â¦willÂ¦ Â¦al lowÂ¦ Â¦themÂ¦ Â¦toÂ¦ â–" Â¦f oc usÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦healthÂ¦ Â¦responseÂ¦ Â¦whileÂ¦ Â¦theÂ¦ Â¦otherÂ¦ Â¦a ge nc iesÂ¦ Â¦canÂ¦ Â¦br ingÂ¦ Â¦theirÂ¦ Â¦exp er t iseÂ¦ Â¦toÂ¦ Â¦be arÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦wi derÂ¦ Â¦socialÂ¦ ,â– Â¦econom icÂ¦ Â¦andÂ¦ Â¦develop m en talÂ¦ Â¦imp lic ationsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ " .
ğ‹‡Â¦allÂ¦ Â¦theseÂ¦ Â¦fourÂ¦ Â¦comm unityÂ¦ - Â¦ac qu ir edÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦wellÂ¦ Â¦ad ap tedÂ¦ Â¦toÂ¦ Â¦hum ansÂ¦ Â¦andÂ¦ Â¦areÂ¦ Â¦gen er allyÂ¦ Â¦lessÂ¦ Â¦likelyÂ¦ Â¦toÂ¦ Â¦mut ateÂ¦ Â¦toÂ¦ Â¦causeÂ¦ Â¦high lyÂ¦ Â¦p at ho g en icÂ¦ Â¦dis easesÂ¦ ,â– Â¦ thoughÂ¦ Â¦ac ci de ntsÂ¦ Â¦didÂ¦ Â¦occ urÂ¦ Â¦forÂ¦ Â¦un k n ownÂ¦ Â¦reas onsÂ¦ Â¦asÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦r areÂ¦ Â¦caseÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦moreÂ¦ Â¦v ir ul entÂ¦ Â¦sub t y p eÂ¦ Â¦ofÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£ Â¦n l ğŠ¼ 6 3Â¦ ,â– Â¦whichÂ¦ Â¦hasÂ¦ Â¦re ce ntlyÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦toÂ¦ Â¦causeÂ¦ Â¦severeÂ¦ Â¦l ow erÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦infectionÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦anÂ¦ Â¦on lineÂ¦ Â¦ne wsÂ¦ Â¦br ie f ingÂ¦ ,â– Â¦theÂ¦ Â¦dire ctorÂ¦ Â¦ofÂ¦ ğŠ£Â¦i ed crÂ¦ğŠ¼ ,â– ğ‹‡Â¦drÂ¦ ğ‹‡Â¦me er j a dyÂ¦ ğ‹‡Â¦s ab r in aÂ¦ ğ‹‡ Â¦fl or aÂ¦ ,â– Â¦saidÂ¦ Â¦theÂ¦ Â¦f at al itiesÂ¦ Â¦inc lu dedÂ¦ Â¦fourÂ¦ Â¦ma lesÂ¦ Â¦andÂ¦ Â¦oneÂ¦ Â¦fe ma leÂ¦ .
ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ Â¦itsÂ¦ Â¦clos estÂ¦ Â¦re la tiveÂ¦ Â¦b atÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ - ğŠ£Â¦h k u ğŠ¼ 2 5Â¦ Â¦sh areÂ¦ Â¦onlyÂ¦ Â¦8 7Â¦ %â– Â¦n uc le o t ideÂ¦ Â¦se que nceÂ¦ Â¦h om o logyÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦5Â¦ ğ‹‡Â¦marchÂ¦ Â¦issu eÂ¦ Â¦ofÂ¦ ğ‹‡Â¦e ur os ur ve il la nceÂ¦ Â¦2020Â¦ ,â– ğ‹‡Â¦s pi teri Â¦ Â¦ etÂ¦ Â¦ alÂ¦ .â– Â¦reportedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦firstÂ¦ ğ‹‡Â¦e ur op e anÂ¦ Â¦confirmedÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦casesÂ¦ Â¦accordingÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦caseÂ¦ Â¦de f in itionÂ¦ .
ğ‹‡ Â¦gen er allyÂ¦ ,â– Â¦whenÂ¦ Â¦theseÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ Â¦ac qu ireÂ¦ Â¦theÂ¦ Â¦ab il itiesÂ¦ Â¦toÂ¦ Â¦trans m itÂ¦ Â¦e ffic ie ntlyÂ¦ Â¦andÂ¦ Â¦toÂ¦ Â¦m ai nt ainÂ¦ Â¦the m s el vesÂ¦ Â¦cont in u o us lyÂ¦ Â¦withinÂ¦ Â¦hum ansÂ¦ ,â– Â¦theyÂ¦ Â¦alsoÂ¦ Â¦becomeÂ¦ Â¦lessÂ¦ Â¦v ir ul entÂ¦ Â¦orÂ¦ Â¦p at ho g en icÂ¦ .
ğ‹‡ Â¦si al od ac r y o a de niti sÂ¦ Â¦virusÂ¦ â–( ğŠ£ Â¦s d av Â¦ğŠ¼ )â– Â¦isÂ¦ Â¦high lyÂ¦ Â¦in fe ct iousÂ¦ Â¦coronavirusÂ¦ Â¦ofÂ¦ Â¦labor atoryÂ¦ Â¦ra tsÂ¦ ,â– Â¦whichÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦trans m it tedÂ¦ Â¦betweenÂ¦ Â¦in di v id u alsÂ¦ Â¦byÂ¦ Â¦d ir ectÂ¦ Â¦contactÂ¦ Â¦andÂ¦ Â¦in di re ctlyÂ¦ Â¦byÂ¦ Â¦a er os olÂ¦ .
ğ‹‡ Â¦imm un os u pp r ess ionÂ¦ Â¦isÂ¦ Â¦essentialÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ Â¦cy t o k ineÂ¦ Â¦st or msÂ¦ ,â– Â¦ esp eci allyÂ¦ Â¦inÂ¦ Â¦severeÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦largeÂ¦ Â¦studyÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦comp aredÂ¦ Â¦ch estÂ¦ ğŠ£Â¦ ct Â¦ğŠ¼ Â¦resul tsÂ¦ Â¦toÂ¦ ğŠ£Â¦p crÂ¦ğŠ¼ Â¦andÂ¦ Â¦ dem on stra tedÂ¦ Â¦thatÂ¦ Â¦ thoughÂ¦ Â¦i ma g ingÂ¦ Â¦isÂ¦ Â¦lessÂ¦ Â¦speci ficÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦infectionÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦f as terÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦s en si tiveÂ¦ ,â– Â¦su gg es tingÂ¦ Â¦itsÂ¦ Â¦consid er ationÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦sc r ee ningÂ¦ Â¦to olÂ¦ Â¦inÂ¦ Â¦epi demicÂ¦ Â¦areasÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦hasÂ¦ Â¦l ow erÂ¦ Â¦se ver ityÂ¦ Â¦andÂ¦ Â¦mor t alityÂ¦ Â¦thanÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦butÂ¦ Â¦isÂ¦ Â¦muchÂ¦ Â¦moreÂ¦ Â¦trans m is siveÂ¦ Â¦andÂ¦ Â¦a ff ectsÂ¦ Â¦moreÂ¦ Â¦el d er lyÂ¦ Â¦in di v id u alsÂ¦ Â¦thanÂ¦ Â¦y outhÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦m enÂ¦ Â¦thanÂ¦ Â¦womenÂ¦ .
ğ‹‡ Â¦andÂ¦ Â¦thereÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦maskÂ¦ - Â¦relatedÂ¦ Â¦dis p u tesÂ¦ Â¦reportedÂ¦ Â¦betweenÂ¦ Â¦otherÂ¦ Â¦countriesÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ ğ‹‡Â¦g erm an yÂ¦ ,â– ğ‹‡Â¦au st ri aÂ¦ Â¦andÂ¦ ğ‹‡ Â¦sw it z er l andÂ¦ ;â– Â¦andÂ¦ Â¦theÂ¦ ğ‹‡Â¦c z e chÂ¦ ğ‹‡ Â¦rep ub l icÂ¦ Â¦andÂ¦ ğ‹‡Â¦ita lyÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ Â¦toÂ¦ Â¦ce ll ul arÂ¦ Â¦re ce pt orsÂ¦ ,â– Â¦theÂ¦ Â¦out c omeÂ¦ Â¦ofÂ¦ Â¦inter s p ec iesÂ¦ Â¦transmissionÂ¦ Â¦ofÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦go ver nedÂ¦ Â¦byÂ¦ Â¦otherÂ¦ Â¦h ostÂ¦ Â¦dep en de nc yÂ¦ Â¦andÂ¦ Â¦res tric tionÂ¦ Â¦fa ct orsÂ¦ .
ğ‹‡ Â¦schoolsÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦se at t leÂ¦ Â¦areaÂ¦ Â¦can ce lledÂ¦ Â¦clas sesÂ¦ Â¦onÂ¦ Â¦3Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦andÂ¦ Â¦byÂ¦ Â¦m idÂ¦ - ğ‹‡Â¦marchÂ¦ ,â– Â¦schoolsÂ¦ Â¦acrossÂ¦ Â¦theÂ¦ Â¦countryÂ¦ Â¦wereÂ¦ Â¦sh u ttingÂ¦ Â¦downÂ¦ . ğ‹‡Â¦onÂ¦ Â¦6Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦wasÂ¦ Â¦ad vi sedÂ¦ Â¦ofÂ¦ Â¦pro j ectionsÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦imp actÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦newÂ¦ Â¦coronavirusÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦countryÂ¦ Â¦byÂ¦ Â¦aÂ¦ Â¦groupÂ¦ Â¦ofÂ¦ Â¦epi dem io log istsÂ¦ Â¦atÂ¦ ğ‹‡ Â¦imp e ri alÂ¦ ğ‹‡Â¦c olle geÂ¦ ğ‹‡ Â¦lo nd onÂ¦ .
ğ‹‡Â¦manyÂ¦ Â¦s ci enti ficÂ¦ Â¦p ub lish ersÂ¦ Â¦madeÂ¦ Â¦s ci enti ficÂ¦ Â¦p ap ersÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦availableÂ¦ Â¦withÂ¦ Â¦openÂ¦ Â¦acc essÂ¦ .
ğ‹‡Â¦manyÂ¦ ğ‹‡Â¦l un arÂ¦ ğ‹‡ Â¦newÂ¦ ğ‹‡ Â¦yearÂ¦ Â¦e ve ntsÂ¦ Â¦andÂ¦ Â¦t ou ri stÂ¦ Â¦att r ac tionsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦closedÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦m as sÂ¦ Â¦g at he ri ngsÂ¦ ,â– Â¦includingÂ¦ Â¦theÂ¦ ğ‹‡ Â¦for b id d enÂ¦ ğ‹‡ Â¦cityÂ¦ Â¦inÂ¦ ğ‹‡ Â¦be i j ingÂ¦ Â¦andÂ¦ Â¦tra di ti onalÂ¦ Â¦te mpleÂ¦ Â¦fa ir sÂ¦ .
ğ‹‡Â¦thereÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦dataÂ¦ Â¦yetÂ¦ Â¦onÂ¦ Â¦earlyÂ¦ Â¦pre g na nc yÂ¦ .
ğ‹‡Â¦al thoughÂ¦ Â¦theÂ¦ Â¦wor dÂ¦ â–" Â¦pandemicÂ¦ "â– Â¦onlyÂ¦ Â¦ ref ersÂ¦ Â¦toÂ¦ Â¦howÂ¦ Â¦wi de lyÂ¦ Â¦aÂ¦ Â¦diseaseÂ¦ Â¦hasÂ¦ Â¦spreadÂ¦ ,â– Â¦notÂ¦ Â¦howÂ¦ Â¦d an ge ro usÂ¦ Â¦speci ficÂ¦ Â¦casesÂ¦ Â¦areÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦no tedÂ¦ Â¦theÂ¦ Â¦needÂ¦ Â¦toÂ¦ Â¦d ri veÂ¦ Â¦go ver n mentsÂ¦ Â¦toÂ¦ Â¦a ctionÂ¦ :
ğ‹‡Â¦p erv a siveÂ¦ Â¦e vi denceÂ¦ Â¦hasÂ¦ Â¦sh ownÂ¦ Â¦thatÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦b atÂ¦ Â¦o ri g inÂ¦ Â¦andÂ¦ Â¦areÂ¦ Â¦trans m it tedÂ¦ Â¦toÂ¦ Â¦hum ansÂ¦ Â¦vi aÂ¦ Â¦inter medi ateÂ¦ Â¦hos tsÂ¦ .
ğ‹‡ Â¦areÂ¦ Â¦youÂ¦ Â¦ha vingÂ¦ Â¦anyÂ¦ Â¦otherÂ¦ Â¦symptomsÂ¦ ?
ğ‹‡Â¦aÂ¦ Â¦g lobalÂ¦ Â¦sa fetyÂ¦ Â¦monit or ingÂ¦ Â¦bo ardÂ¦ Â¦ofÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦ph y si ci ansÂ¦ Â¦exam ineÂ¦ Â¦in teri mÂ¦ Â¦resul tsÂ¦ Â¦toÂ¦ Â¦as si stÂ¦ Â¦d eci sionsÂ¦ Â¦onÂ¦ Â¦sa fetyÂ¦ Â¦andÂ¦ Â¦effec ti ve nessÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦tri alÂ¦ Â¦d ru gsÂ¦ ,â– Â¦andÂ¦ Â¦al terÂ¦ Â¦theÂ¦ Â¦tri alÂ¦ Â¦de si g nÂ¦ Â¦orÂ¦ Â¦recomme n dÂ¦ Â¦anÂ¦ Â¦effectiveÂ¦ Â¦the rap yÂ¦ .
ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£ Â¦n l ğŠ¼ 6 3Â¦ Â¦isÂ¦ Â¦associ atedÂ¦ Â¦withÂ¦ Â¦ob stru c tiveÂ¦ Â¦l ar y n gi ti sÂ¦ ,â– Â¦alsoÂ¦ Â¦knownÂ¦ Â¦asÂ¦ Â¦cr ou pÂ¦ .
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦isÂ¦ Â¦app a re ntlyÂ¦ Â¦lessÂ¦ Â¦p at ho g en icÂ¦ Â¦butÂ¦ Â¦moreÂ¦ Â¦trans m is sib leÂ¦ Â¦comp aredÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦initi alÂ¦ Â¦es ti ma tesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦b as icÂ¦ Â¦rep r od u ctionÂ¦ Â¦numberÂ¦ â–( ğ‹‡Â¦r 0Â¦ )â– Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦wereÂ¦ Â¦1Â¦ . Â¦4Â¦ Â¦toÂ¦ Â¦2Â¦ . Â¦4Â¦ .
ğ‹‡Â¦itÂ¦ Â¦st atedÂ¦ Â¦thatÂ¦ Â¦muchÂ¦ Â¦wasÂ¦ Â¦yetÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦dis c ov eredÂ¦ Â¦aboutÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦andÂ¦ Â¦thatÂ¦ ğ‹‡Â¦au stra li aÂ¦ Â¦wouldÂ¦ Â¦emp ha si z eÂ¦ Â¦b or derÂ¦ Â¦controlÂ¦ Â¦andÂ¦ Â¦comm un ic ationÂ¦ Â¦inÂ¦ Â¦itsÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦14Â¦ ,â– Â¦2020Â¦ ,â– Â¦overÂ¦ Â¦2 5 00Â¦ Â¦labor atoryÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦wereÂ¦ Â¦reportedÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦highÂ¦ Â¦caseÂ¦ Â¦f at alityÂ¦ Â¦ofÂ¦ Â¦3 4Â¦ . Â¦4Â¦ % ,â– Â¦ma kingÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦mostÂ¦ Â¦de v as ta tingÂ¦ Â¦vi rusesÂ¦ Â¦knownÂ¦ Â¦toÂ¦ Â¦hum ansÂ¦ .
ğ‹‡ Â¦withinÂ¦ Â¦aÂ¦ Â¦mon thÂ¦ ,â– Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡Â¦h ub e iÂ¦ Â¦g ra d u allyÂ¦ Â¦increasedÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡Â¦organizationÂ¦ Â¦andÂ¦ ğ‹‡ Â¦centersÂ¦ Â¦forÂ¦ ğ‹‡ Â¦diseaseÂ¦ ğ‹‡ Â¦controlÂ¦ Â¦andÂ¦ ğ‹‡ Â¦prev entionÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦ad vi sesÂ¦ Â¦pre gn antÂ¦ Â¦womenÂ¦ Â¦toÂ¦ Â¦doÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦t hi ngsÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦generalÂ¦ Â¦publicÂ¦ Â¦toÂ¦ Â¦avo idÂ¦ Â¦infectionÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦cov eringÂ¦ Â¦c oughÂ¦ ,â– Â¦avo idÂ¦ Â¦inter ac tingÂ¦ Â¦withÂ¦ Â¦s ic kÂ¦ Â¦peopleÂ¦ ,â– Â¦cl ea ningÂ¦ Â¦handsÂ¦ Â¦withÂ¦ Â¦soapÂ¦ Â¦andÂ¦ Â¦waterÂ¦ Â¦orÂ¦ Â¦sa niti zerÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦au stra li aÂ¦ ,â– Â¦theÂ¦ Â¦pandemicÂ¦ Â¦prov idedÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦op por t unityÂ¦ Â¦forÂ¦ Â¦d ai g o uÂ¦ Â¦sho pp ersÂ¦ Â¦toÂ¦ Â¦s ellÂ¦ ğ‹‡Â¦au stra li anÂ¦ Â¦produc tsÂ¦ Â¦intoÂ¦ ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦mo di fic ationsÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦re se ar ch ersÂ¦ Â¦cont in u edÂ¦ Â¦workÂ¦ Â¦thatÂ¦ Â¦toÂ¦ Â¦se ar chÂ¦ Â¦forÂ¦ Â¦anÂ¦ Â¦op ti malÂ¦ Â¦n uc le icÂ¦ Â¦ac idÂ¦ Â¦de te ctionÂ¦ Â¦k itÂ¦ Â¦forÂ¦ Â¦rap idÂ¦ Â¦di a g no sisÂ¦ ,â– Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦samplesÂ¦ Â¦fromÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦includingÂ¦ Â¦bloodÂ¦ Â¦sa mp l ingÂ¦ ,â– Â¦whichÂ¦ Â¦increasedÂ¦ Â¦theÂ¦ Â¦ av a il ab ilityÂ¦ Â¦ofÂ¦ Â¦differentÂ¦ Â¦speci me nsÂ¦ ,â– Â¦andÂ¦ Â¦supp or tedÂ¦ Â¦b ri ng ingÂ¦ Â¦theÂ¦ Â¦speci ficÂ¦ Â¦antib o dyÂ¦ Â¦positiveÂ¦ Â¦resultÂ¦ Â¦intoÂ¦ Â¦theÂ¦ Â¦confirmedÂ¦ Â¦c ri teri aÂ¦ .
ğ‹‡ Â¦cont in u o usÂ¦ Â¦surveillanceÂ¦ Â¦inÂ¦ Â¦m am m alsÂ¦ Â¦isÂ¦ Â¦n ecess aryÂ¦ Â¦forÂ¦ Â¦be tterÂ¦ Â¦under st an dingÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦e co logyÂ¦ Â¦ofÂ¦ ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦andÂ¦ Â¦theirÂ¦ Â¦n atur alÂ¦ Â¦hos tsÂ¦ ,â– Â¦whichÂ¦ Â¦willÂ¦ Â¦pro veÂ¦ Â¦u se f ulÂ¦ Â¦inÂ¦ Â¦prev en tingÂ¦ Â¦ani malÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦andÂ¦ Â¦f ut ureÂ¦ Â¦out b rea ksÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦h ur tsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦m id d leÂ¦ Â¦ofÂ¦ Â¦m yÂ¦ Â¦ch estÂ¦
ğ‹‡Â¦theÂ¦ Â¦ent ireÂ¦ Â¦humanÂ¦ Â¦populationÂ¦ Â¦gen er allyÂ¦ Â¦l ac ksÂ¦ Â¦imm unityÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦andÂ¦ Â¦he nceÂ¦ Â¦isÂ¦ Â¦s us cep ti b leÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦no ve lÂ¦ Â¦virusÂ¦ .
ğ‹‡ Â¦toÂ¦ Â¦conc lu deÂ¦ ,â– Â¦theÂ¦ Â¦mostÂ¦ Â¦effectiveÂ¦ Â¦ wayÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦v iralÂ¦ Â¦ z o o no sisÂ¦ Â¦isÂ¦ Â¦forÂ¦ Â¦hum ansÂ¦ Â¦toÂ¦ Â¦st ayÂ¦ Â¦a wayÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦e co log icalÂ¦ Â¦ ni ch esÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦n atur alÂ¦ Â¦res erv o ir sÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦ z o o no ticÂ¦ Â¦vi rusesÂ¦ .
ğ‹‡Â¦m en talÂ¦ Â¦str essÂ¦ :â– ğ‹‡Â¦asÂ¦ Â¦d es c rib edÂ¦ Â¦ab o veÂ¦ ,â– Â¦duringÂ¦ Â¦theÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦outbreakÂ¦ Â¦manyÂ¦ Â¦patientsÂ¦ Â¦haveÂ¦ Â¦su ff eredÂ¦ Â¦fromÂ¦ Â¦ext ra or d in aryÂ¦ Â¦str essÂ¦ Â¦asÂ¦ Â¦theyÂ¦ Â¦o f tenÂ¦ Â¦e nd ur edÂ¦ Â¦longÂ¦ Â¦per io dsÂ¦ Â¦ofÂ¦ Â¦quarantineÂ¦ Â¦andÂ¦ Â¦ext re meÂ¦ Â¦u nc er ta in tyÂ¦ Â¦andÂ¦ Â¦w it n es sedÂ¦ Â¦theÂ¦ Â¦deathÂ¦ Â¦ofÂ¦ Â¦cl oseÂ¦ Â¦familyÂ¦ Â¦me mb ersÂ¦ Â¦andÂ¦ Â¦f el lowÂ¦ Â¦patientsÂ¦ .
ğ‹‡ Â¦pre t tyÂ¦ Â¦muchÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦feverÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦c oughÂ¦ Â¦h ea d ach eÂ¦ Â¦andÂ¦ Â¦m us c leÂ¦ Â¦pa insÂ¦
ğ‹‡Â¦b es id esÂ¦ Â¦theÂ¦ Â¦high lyÂ¦ Â¦p at ho g en icÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ ,â– Â¦theÂ¦ Â¦ z o o no ticÂ¦ Â¦o ri g inÂ¦ Â¦ofÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - Â¦2 2 9 ğ‹‡ eÂ¦ ,â– ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£Â¦ oc 4 3Â¦ ,â– Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£ Â¦n l ğŠ¼ 6 3Â¦ Â¦andÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£Â¦h k u ğŠ¼ 1Â¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦stu di edÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦studyÂ¦ Â¦p ub lish edÂ¦ Â¦onÂ¦ Â¦1 6Â¦ ğ‹‡Â¦marchÂ¦ Â¦foundÂ¦ Â¦thatÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦upÂ¦ Â¦toÂ¦ Â¦2 3Â¦ ğ‹‡Â¦januaryÂ¦ ,â– Â¦anÂ¦ Â¦es tim atedÂ¦ Â¦8 6Â¦ %â– Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦infectionsÂ¦ Â¦hadÂ¦ Â¦notÂ¦ Â¦beenÂ¦ Â¦det ectedÂ¦ ,â– Â¦andÂ¦ Â¦thatÂ¦ Â¦theseÂ¦ Â¦u nd oc um entedÂ¦ Â¦infectionsÂ¦ Â¦wereÂ¦ Â¦theÂ¦ Â¦infectionÂ¦ Â¦so ur ceÂ¦ Â¦forÂ¦ Â¦7 9Â¦ %â– Â¦ofÂ¦ Â¦d oc um entedÂ¦ Â¦casesÂ¦ .
ğ‹‡ Â¦medicalÂ¦ Â¦sc r ee ningÂ¦ Â¦wasÂ¦ Â¦per formedÂ¦ Â¦pri orÂ¦ Â¦toÂ¦ Â¦dep art ureÂ¦ ,â– Â¦andÂ¦ Â¦fourÂ¦ ğ‹‡Â¦s outhÂ¦ ğ‹‡Â¦a f r ic ansÂ¦ Â¦whoÂ¦ Â¦wereÂ¦ Â¦sh owingÂ¦ Â¦sig nsÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦wereÂ¦ Â¦le f tÂ¦ Â¦be h in dÂ¦ Â¦toÂ¦ Â¦mi tig ateÂ¦ Â¦riskÂ¦ .
ğ‹‡Â¦p har ma ce ut icalÂ¦ Â¦compan iesÂ¦ Â¦areÂ¦ Â¦r ac ingÂ¦ Â¦toÂ¦ Â¦develop Â¦ Â¦antib odiesÂ¦ Â¦andÂ¦ Â¦vaccinesÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡ Â¦itsÂ¦ Â¦s po ra d icÂ¦ Â¦transmissionÂ¦ Â¦toÂ¦ Â¦hum ansÂ¦ Â¦isÂ¦ Â¦anÂ¦ Â¦acc id entÂ¦ Â¦andÂ¦ Â¦hum ansÂ¦ Â¦rem ainÂ¦ Â¦aÂ¦ Â¦de adÂ¦ - Â¦ endÂ¦ Â¦h ostÂ¦ Â¦ofÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦asÂ¦ Â¦itsÂ¦ Â¦transmissionÂ¦ Â¦can no tÂ¦ Â¦beÂ¦ Â¦s us ta inedÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦openÂ¦ Â¦rea dingÂ¦ Â¦f r am esÂ¦ Â¦1 aÂ¦ Â¦andÂ¦ Â¦1 b Â¦ ,â– Â¦whichÂ¦ Â¦occ u p yÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦twoÂ¦ - Â¦th ir dsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦gen omeÂ¦ ,â– Â¦en co deÂ¦ Â¦theÂ¦ Â¦rep lic aseÂ¦ / Â¦trans c ri pt aseÂ¦ Â¦pol y p ro te inÂ¦ .
ğ‹‡Â¦al thoughÂ¦ Â¦theseÂ¦ Â¦ac tionsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦dr am at icallyÂ¦ Â¦d a ma g ingÂ¦ Â¦theÂ¦ Â¦econom yÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦se ct orsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦countryÂ¦ ,â– Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦newÂ¦ Â¦patientsÂ¦ Â¦isÂ¦ Â¦dec li ningÂ¦ ,â– Â¦ind ic a tingÂ¦ Â¦theÂ¦ Â¦s l ow d ownÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epi demicÂ¦ .
ğ‹‡ Â¦byÂ¦ Â¦2 3Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦noÂ¦ Â¦countryÂ¦ Â¦hadÂ¦ Â¦testedÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦3Â¦ %â– Â¦ofÂ¦ Â¦theirÂ¦ Â¦populationÂ¦ ,â– Â¦andÂ¦ Â¦thereÂ¦ Â¦areÂ¦ Â¦m as siveÂ¦ Â¦v ari ationsÂ¦ Â¦inÂ¦ Â¦howÂ¦ Â¦muchÂ¦ Â¦testingÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦doneÂ¦ Â¦acrossÂ¦ Â¦countriesÂ¦ .
ğ‹‡Â¦h ongÂ¦ ğ‹‡Â¦k ongÂ¦ Â¦r ai sedÂ¦ Â¦itsÂ¦ Â¦in fe ct iousÂ¦ Â¦diseaseÂ¦ Â¦responseÂ¦ Â¦levelÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦high estÂ¦ Â¦andÂ¦ Â¦dec l aredÂ¦ Â¦anÂ¦ Â¦emergencyÂ¦ ,â– Â¦clos ingÂ¦ Â¦schoolsÂ¦ Â¦un ti lÂ¦ ğ‹‡Â¦marchÂ¦ Â¦andÂ¦ Â¦can ce llingÂ¦ Â¦itsÂ¦ ğ‹‡ Â¦newÂ¦ ğ‹‡ Â¦yearÂ¦ Â¦ce le b r ationsÂ¦ . ğ‹‡Â¦theÂ¦ Â¦re t ai lÂ¦ Â¦se ctorÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦imp actedÂ¦ Â¦glob allyÂ¦ ,â– Â¦withÂ¦ Â¦reduc tionsÂ¦ Â¦inÂ¦ Â¦st oreÂ¦ Â¦hoursÂ¦ Â¦orÂ¦ Â¦te m por aryÂ¦ Â¦closuresÂ¦ .
ğ‹‡Â¦d esp iteÂ¦ Â¦do ingÂ¦ Â¦soÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦hadÂ¦ Â¦aÂ¦ Â¦s lowÂ¦ Â¦startÂ¦ Â¦inÂ¦ Â¦testingÂ¦ ,â– Â¦whichÂ¦ Â¦ob s c ur edÂ¦ Â¦theÂ¦ Â¦tr ueÂ¦ Â¦ext entÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦timeÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦vi rusesÂ¦ Â¦doÂ¦ Â¦notÂ¦ Â¦needÂ¦ Â¦anÂ¦ Â¦ani malÂ¦ Â¦res erv o irÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦haveÂ¦ Â¦prop osedÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦mayÂ¦ Â¦alsoÂ¦ Â¦beÂ¦ Â¦trans m it tedÂ¦ Â¦byÂ¦ Â¦smallÂ¦ Â¦dr op le tsÂ¦ Â¦thatÂ¦ Â¦st ayÂ¦ Â¦forÂ¦ Â¦moreÂ¦ Â¦pr ol on gedÂ¦ Â¦per io dsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦airÂ¦ ,â– Â¦thatÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦gen er atedÂ¦ Â¦duringÂ¦ Â¦sp ee chÂ¦ . ğ‹‡ Â¦respiratoryÂ¦ Â¦dr op le tsÂ¦ Â¦mayÂ¦ Â¦alsoÂ¦ Â¦beÂ¦ Â¦produc edÂ¦ Â¦duringÂ¦ Â¦brea t hingÂ¦ Â¦outÂ¦ ,â– Â¦includingÂ¦ Â¦whenÂ¦ Â¦t al kingÂ¦ ,â– Â¦ thoughÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦gen er allyÂ¦ Â¦a ir b or n eÂ¦ .
ğ‹‡Â¦w he re asÂ¦ Â¦ ci ve tsÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦ani m alsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦marke tsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦ har b o urÂ¦ Â¦vi rusesÂ¦ Â¦i de nt icalÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦immedi ateÂ¦ Â¦inter medi ateÂ¦ Â¦hos tsÂ¦ Â¦forÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦haveÂ¦ Â¦notÂ¦ Â¦beenÂ¦ Â¦ id enti fiedÂ¦ .
ğ‹‡ Â¦useÂ¦ Â¦ofÂ¦ Â¦s te ro i dsÂ¦ :â– ğ‹‡Â¦asÂ¦ Â¦d es c rib edÂ¦ Â¦ab o veÂ¦ ,â– Â¦s te ro i dsÂ¦ Â¦areÂ¦ Â¦imm un os u pp r ess antÂ¦ Â¦comm on lyÂ¦ Â¦usedÂ¦ Â¦asÂ¦ Â¦anÂ¦ Â¦ad j u nc tiveÂ¦ Â¦the rap yÂ¦ Â¦forÂ¦ Â¦in fe ct iousÂ¦ Â¦dis easesÂ¦ Â¦toÂ¦ Â¦reduceÂ¦ Â¦theÂ¦ Â¦se ver ityÂ¦ Â¦ofÂ¦ Â¦inf l am m atoryÂ¦ Â¦d a ma geÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦com par is onÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epi demicÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦withÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦andÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ Â¦isÂ¦ Â¦prov idedÂ¦ Â¦be lowÂ¦ â–( ğ‹‡ Â¦fi gÂ¦ .â– â€‹ ( ğ‹‡ Â¦fi gÂ¦ . Â¦5 5Â¦ ).
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦wasÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦typ eÂ¦ Â¦ofÂ¦ Â¦be t aÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦withÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦9 9Â¦ . Â¦9 8Â¦ %â– Â¦ge ne ticÂ¦ Â¦i de nt ityÂ¦ Â¦amongÂ¦ Â¦10Â¦ Â¦se que nc edÂ¦ Â¦samplesÂ¦ Â¦coll ectedÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦o ri g in alÂ¦ Â¦s iteÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦h u an anÂ¦ ğ‹‡Â¦s ea f o odÂ¦ ğ‹‡ Â¦marke tÂ¦ Â¦inÂ¦ ğ‹‡Â¦w uhanÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦januaryÂ¦ Â¦2 3Â¦ ,â– Â¦theÂ¦ Â¦cityÂ¦ Â¦ofÂ¦ ğ‹‡Â¦w uhanÂ¦ Â¦wasÂ¦ Â¦loc kedÂ¦ Â¦downÂ¦ Â¦withÂ¦ Â¦allÂ¦ Â¦itsÂ¦ Â¦publicÂ¦ Â¦trans por t ationÂ¦ Â¦sto pp edÂ¦ .
ğ‹‡ Â¦secondÂ¦ ,â– ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - Â¦2 2 9 ğ‹‡ eÂ¦ - Â¦relatedÂ¦ Â¦b atÂ¦ Â¦al p haÂ¦ - ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦areÂ¦ Â¦di ver seÂ¦ Â¦andÂ¦ Â¦n onÂ¦ - Â¦p at ho g en icÂ¦ Â¦inÂ¦ Â¦ba tsÂ¦ ,â– Â¦w he re asÂ¦ Â¦al p ac aÂ¦ Â¦al p haÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦causedÂ¦ Â¦anÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦ Â¦respiratoryÂ¦ Â¦diseaseÂ¦ Â¦inÂ¦ Â¦infectedÂ¦ Â¦ani m alsÂ¦ .
ğ‹‡Â¦butÂ¦ Â¦youÂ¦ ' Â¦r eÂ¦ Â¦brea t hingÂ¦ Â¦allÂ¦ Â¦ri ghtÂ¦ Â¦ri ghtÂ¦ Â¦nowÂ¦ Â¦ri ghtÂ¦ ?
ğ‹‡Â¦inÂ¦ Â¦aÂ¦ Â¦201 6Â¦ Â¦re v iewÂ¦ Â¦ofÂ¦ Â¦1 0 6Â¦ Â¦drugÂ¦ Â¦ca nd id a tesÂ¦ Â¦ass es sedÂ¦ Â¦throughÂ¦ Â¦clinicalÂ¦ Â¦trialsÂ¦ ,â– Â¦theÂ¦ Â¦totalÂ¦ Â¦ca pi talÂ¦ Â¦exp e nd it ureÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦manufactur erÂ¦ Â¦ha vingÂ¦ Â¦aÂ¦ Â¦drugÂ¦ Â¦approvedÂ¦ Â¦throughÂ¦ Â¦s uc c ess f ulÂ¦ ğ‹‡ Â¦phaseÂ¦ ğŠ£Â¦i i i Â¦ğŠ¼ Â¦trialsÂ¦ Â¦wasÂ¦ â– $ Â¦2Â¦ . Â¦6Â¦ Â¦b ill ionÂ¦ â–( Â¦inÂ¦ Â¦201 3Â¦ Â¦do ll ar sÂ¦ ),â– Â¦anÂ¦ Â¦ am oun tÂ¦ Â¦increasingÂ¦ Â¦atÂ¦ Â¦anÂ¦ Â¦an n u alÂ¦ Â¦rateÂ¦ Â¦ofÂ¦ Â¦8Â¦ . Â¦5Â¦ % .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦5Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ğ‹‡Â¦l ab ğ‹‡ c or pÂ¦ Â¦announcedÂ¦ Â¦n ati on w ideÂ¦ Â¦ av a il ab ilityÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦testingÂ¦ Â¦basedÂ¦ Â¦onÂ¦ ğŠ£Â¦r tÂ¦ - Â¦p crÂ¦ğŠ¼ .
ğ‹‡ Â¦testsÂ¦ Â¦usingÂ¦ Â¦twoÂ¦ Â¦com po ne ntsÂ¦ Â¦wereÂ¦ Â¦notÂ¦ Â¦det erm inedÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦re li ableÂ¦ Â¦un ti lÂ¦ Â¦2 8Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ ,â– Â¦andÂ¦ Â¦itÂ¦ Â¦wasÂ¦ Â¦notÂ¦ Â¦un ti lÂ¦ Â¦thenÂ¦ Â¦thatÂ¦ Â¦stateÂ¦ Â¦andÂ¦ Â¦localÂ¦ Â¦labor at oriesÂ¦ Â¦wereÂ¦ Â¦p erm it tedÂ¦ Â¦toÂ¦ Â¦beg inÂ¦ Â¦testingÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦aÂ¦ Â¦h ostÂ¦ Â¦thatÂ¦ Â¦ser vesÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦mi x ingÂ¦ Â¦v es se lÂ¦ ,â– Â¦str andÂ¦ Â¦sw it c hingÂ¦ Â¦occ ur sÂ¦ Â¦fre que ntlyÂ¦ Â¦duringÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ ğŠ£Â¦r na Â¦ğŠ¼ Â¦trans c ri p tionÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦earlyÂ¦ Â¦2020Â¦ ,â– Â¦n u me ro usÂ¦ Â¦ est ab lish edÂ¦ Â¦an tiv iralÂ¦ Â¦comp ou ndsÂ¦ Â¦forÂ¦ Â¦t rea tingÂ¦ Â¦otherÂ¦ Â¦infectionsÂ¦ Â¦wereÂ¦ Â¦beingÂ¦ Â¦rep ur p osedÂ¦ Â¦orÂ¦ Â¦developedÂ¦ Â¦inÂ¦ Â¦newÂ¦ Â¦clinicalÂ¦ Â¦researchÂ¦ Â¦e f for tsÂ¦ Â¦toÂ¦ Â¦al le vi ateÂ¦ Â¦theÂ¦ Â¦ ill nessÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡Â¦theÂ¦ Â¦firstÂ¦ Â¦rec or dedÂ¦ Â¦in ci de ntsÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦infectionÂ¦ Â¦inÂ¦ ğ‹‡ Â¦ba ng la d eshÂ¦ Â¦wereÂ¦ Â¦onÂ¦ ğ‹‡Â¦marchÂ¦ Â¦8Â¦ ,â– Â¦inÂ¦ Â¦twoÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦re tur nedÂ¦ Â¦fromÂ¦ ğ‹‡Â¦ita lyÂ¦ Â¦andÂ¦ Â¦alsoÂ¦ Â¦theÂ¦ Â¦wi feÂ¦ Â¦ofÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦themÂ¦ .
ğ‹‡ Â¦casesÂ¦ Â¦ ref ersÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦testedÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦andÂ¦ Â¦w h oseÂ¦ Â¦testÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦confirmedÂ¦ Â¦positiveÂ¦ Â¦accordingÂ¦ Â¦toÂ¦ Â¦offi cialÂ¦ Â¦prot oc olsÂ¦ .
ğ‹‡Â¦di ar r he aÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦seenÂ¦ Â¦inÂ¦ Â¦someÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦hasÂ¦ Â¦com me ndedÂ¦ Â¦theÂ¦ Â¦e f for tsÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦a u th or itiesÂ¦ Â¦inÂ¦ Â¦ma na g ingÂ¦ Â¦andÂ¦ Â¦cont ainingÂ¦ Â¦theÂ¦ Â¦epi demicÂ¦ .
ğ‹‡Â¦theyÂ¦ Â¦st ayÂ¦ Â¦inÂ¦ Â¦theirÂ¦ Â¦ ownÂ¦ Â¦n atur alÂ¦ Â¦res erv o ir sÂ¦ Â¦un ti lÂ¦ Â¦thereÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦cha nceÂ¦ Â¦forÂ¦ Â¦sp il lo verÂ¦ .
ğ‹‡Â¦w he re asÂ¦ Â¦theÂ¦ Â¦high estÂ¦ Â¦se que nceÂ¦ Â¦h om o logyÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğŠ£Â¦r b d ğŠ¼ sÂ¦ Â¦betweenÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦andÂ¦ Â¦pa ng ol inÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ - Â¦relatedÂ¦ Â¦be t aÂ¦ - ğ‹‡Â¦c oğ‹‡vsÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦andÂ¦ ğ‹‡Â¦ra ğŠ£ t g ğŠ¼ 1 3Â¦ Â¦sh areÂ¦ Â¦theÂ¦ Â¦high estÂ¦ Â¦gen omeÂ¦ - Â¦w ideÂ¦ Â¦se que nceÂ¦ Â¦h om o logyÂ¦ .
ğ‹‡ Â¦secondÂ¦ ,â– Â¦ifÂ¦ Â¦ba tsÂ¦ Â¦pl ayÂ¦ Â¦aÂ¦ Â¦moreÂ¦ Â¦d ir ectÂ¦ Â¦ro leÂ¦ Â¦inÂ¦ Â¦humanÂ¦ Â¦transmissionÂ¦ ,â– Â¦howÂ¦ Â¦hum ansÂ¦ Â¦getÂ¦ Â¦intoÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦ba tsÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦det erm inedÂ¦ .
ğ‹‡Â¦t ha il andÂ¦ ' Â¦sÂ¦ Â¦healthÂ¦ Â¦offi ci alsÂ¦ Â¦areÂ¦ Â¦e nc ou ra g ingÂ¦ Â¦peopleÂ¦ Â¦toÂ¦ Â¦makeÂ¦ Â¦c lo thÂ¦ Â¦fa ce m as ksÂ¦ Â¦atÂ¦ Â¦homeÂ¦ Â¦andÂ¦ Â¦was hÂ¦ Â¦themÂ¦ Â¦d ai lyÂ¦ .
ğ‹‡Â¦theyÂ¦ Â¦shouldÂ¦ ,â– Â¦h ow e verÂ¦ ,â– Â¦beÂ¦ Â¦coll ectedÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦sy s te ma ticÂ¦ Â¦f as h ionÂ¦ Â¦toÂ¦ Â¦comple mentÂ¦ Â¦currentÂ¦ Â¦surveillanceÂ¦ Â¦dataÂ¦ Â¦thatÂ¦ Â¦f oc usÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦reportedÂ¦ Â¦casesÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦deathsÂ¦ .
ğ‹‡ Â¦part icul ar lyÂ¦ ,â– Â¦b atÂ¦ ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦withÂ¦ Â¦ z o o no ticÂ¦ Â¦po t enti alÂ¦ Â¦areÂ¦ Â¦soÂ¦ Â¦di ver seÂ¦ .
ğ‹‡ Â¦perÂ¦ Â¦mediaÂ¦ Â¦re por tsÂ¦ Â¦onÂ¦ Â¦1Â¦ ğ‹‡Â¦aprilÂ¦ ,â– ğ‹‡Â¦s outhÂ¦ ğ‹‡Â¦k o re aÂ¦ Â¦hasÂ¦ Â¦recei vedÂ¦ Â¦re qu es tsÂ¦ Â¦forÂ¦ Â¦virusÂ¦ Â¦testingÂ¦ Â¦ass is ta nceÂ¦ Â¦fromÂ¦ Â¦1 2 1Â¦ Â¦differentÂ¦ Â¦countriesÂ¦ .
ğ‹‡ Â¦supp r ess ionÂ¦ Â¦requir esÂ¦ Â¦moreÂ¦ Â¦ext re meÂ¦ Â¦measuresÂ¦ Â¦soÂ¦ Â¦asÂ¦ Â¦toÂ¦ Â¦re ver seÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦byÂ¦ Â¦reduc ingÂ¦ Â¦theÂ¦ Â¦b as icÂ¦ Â¦rep r od u ctionÂ¦ Â¦numberÂ¦ Â¦toÂ¦ Â¦lessÂ¦ Â¦thanÂ¦ Â¦1Â¦ . ğ‹‡Â¦p artÂ¦ Â¦ofÂ¦ Â¦ma na g ingÂ¦ Â¦anÂ¦ Â¦in fe ct iousÂ¦ Â¦diseaseÂ¦ Â¦outbreakÂ¦ Â¦isÂ¦ Â¦tr yingÂ¦ Â¦toÂ¦ Â¦d ecre aseÂ¦ Â¦theÂ¦ Â¦epi demicÂ¦ Â¦p ea kÂ¦ ,â– Â¦knownÂ¦ Â¦asÂ¦ Â¦fl at te ningÂ¦ Â¦theÂ¦ Â¦epi demicÂ¦ Â¦cur veÂ¦ .
ğ‹‡Â¦t ellÂ¦ Â¦ meÂ¦ Â¦aboutÂ¦ Â¦yourÂ¦ Â¦ch estÂ¦ Â¦p ainÂ¦
ğ‹‡ Â¦mostÂ¦ Â¦b us in es sesÂ¦ Â¦wereÂ¦ Â¦or d eredÂ¦ Â¦toÂ¦ Â¦cl oseÂ¦ ,â– Â¦withÂ¦ Â¦ex cep tionsÂ¦ Â¦forÂ¦ Â¦b us in es sesÂ¦ Â¦d ee medÂ¦ â–" Â¦essentialÂ¦ " ,â– Â¦includingÂ¦ Â¦su p erm ar ke tsÂ¦ ,â– Â¦p har m ac iesÂ¦ ,â– Â¦b an ksÂ¦ ,â– Â¦ har d w areÂ¦ Â¦shopsÂ¦ ,â– Â¦p e tr olÂ¦ Â¦st ationsÂ¦ ,â– Â¦andÂ¦ Â¦g ara gesÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦mi ghtÂ¦ Â¦alsoÂ¦ Â¦guid eÂ¦ Â¦orÂ¦ Â¦facil it ateÂ¦ Â¦theÂ¦ Â¦se ar chÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦res erv o irÂ¦ ,â– Â¦inter medi ateÂ¦ Â¦andÂ¦ Â¦a mp li f yingÂ¦ Â¦ani malÂ¦ Â¦h ostÂ¦ ( Â¦sÂ¦ )â– Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ,â– Â¦withÂ¦ Â¦importantÂ¦ Â¦imp lic ationsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦prev entionÂ¦ Â¦ofÂ¦ Â¦f ut ureÂ¦ Â¦sp ill ov ersÂ¦ .
ğ‹‡Â¦theyÂ¦ Â¦mi ghtÂ¦ Â¦alsoÂ¦ Â¦acc oun tÂ¦ Â¦forÂ¦ Â¦s uc c ess f ulÂ¦ Â¦ad a pt ationÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦inÂ¦ Â¦hum ansÂ¦ Â¦afterÂ¦ Â¦inter s p ec iesÂ¦ Â¦transmissionÂ¦ Â¦fromÂ¦ Â¦theirÂ¦ Â¦ani malÂ¦ Â¦hos tsÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦th oughtÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦ z o o no ticÂ¦ Â¦o ri g inÂ¦ .
ğ‹‡ Â¦anÂ¦ Â¦un as s o ci atedÂ¦ Â¦cl us terÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦casesÂ¦ Â¦wasÂ¦ Â¦la terÂ¦ Â¦det ectedÂ¦ ,â– Â¦st ar tingÂ¦ Â¦withÂ¦ Â¦1 6Â¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡ Â¦lo mb ar dyÂ¦ Â¦onÂ¦ Â¦2 1Â¦ ğ‹‡Â¦februaryÂ¦ . ğ‹‡Â¦onÂ¦ Â¦2 2Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦c oun ci lÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦mi ni st ersÂ¦ Â¦announcedÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦d ecre eÂ¦ - Â¦la wÂ¦ Â¦toÂ¦ Â¦cont ainÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ ,â– Â¦includingÂ¦ Â¦qu ar an ti ningÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦50Â¦ , Â¦000Â¦ Â¦peopleÂ¦ Â¦fromÂ¦ Â¦11Â¦ Â¦differentÂ¦ Â¦mu ni cip al itiesÂ¦ Â¦inÂ¦ Â¦n or th ernÂ¦ ğ‹‡Â¦ita lyÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦us ns Â¦ğŠ¼ ğ‹‡ Â¦com f ortÂ¦ ,â– Â¦aÂ¦ Â¦hospitalÂ¦ Â¦s hi pÂ¦ Â¦withÂ¦ Â¦aboutÂ¦ Â¦1 0 00Â¦ Â¦bedsÂ¦ ,â– Â¦madeÂ¦ Â¦an ch orÂ¦ Â¦inÂ¦ ğ‹‡ Â¦newÂ¦ ğ‹‡Â¦y or kÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦or ga ni z ationsÂ¦ Â¦haveÂ¦ Â¦cre atedÂ¦ Â¦crow d s o ur c edÂ¦ Â¦app sÂ¦ Â¦forÂ¦ Â¦sy nd ro micÂ¦ Â¦surveillanceÂ¦ ,â– Â¦whereÂ¦ Â¦peopleÂ¦ Â¦canÂ¦ Â¦reportÂ¦ Â¦theirÂ¦ Â¦symptomsÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦re se ar ch ersÂ¦ Â¦ma pÂ¦ Â¦areasÂ¦ Â¦withÂ¦ Â¦conc en tr ationÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦symptomsÂ¦ .
ğ‹‡ Â¦schoolsÂ¦ Â¦andÂ¦ Â¦u ni vers itiesÂ¦ Â¦haveÂ¦ Â¦closedÂ¦ Â¦e i therÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦n ati on w ideÂ¦ Â¦orÂ¦ Â¦localÂ¦ Â¦ba sisÂ¦ Â¦inÂ¦ Â¦1 9 3Â¦ Â¦countriesÂ¦ ,â– Â¦a ff ec tingÂ¦ Â¦appro xi ma telyÂ¦ Â¦9 9Â¦ . Â¦4Â¦ Â¦percentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦worldÂ¦ ' Â¦sÂ¦ Â¦stud entÂ¦ Â¦populationÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦develop ingÂ¦ Â¦outbreakÂ¦ Â¦inÂ¦ ğ‹‡Â¦ ir anÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦sentÂ¦ Â¦aÂ¦ ğ‹‡ Â¦jo in tÂ¦ ğ‹‡Â¦ missionÂ¦ ğ‹‡Â¦t ea mÂ¦ Â¦thereÂ¦ Â¦toÂ¦ Â¦ass essÂ¦ Â¦theÂ¦ Â¦situationÂ¦ . ğ‹‡Â¦onÂ¦ Â¦2 8Â¦ ğ‹‡Â¦februaryÂ¦ ,â– ğŠ£Â¦whoÂ¦ğŠ¼ Â¦offi ci alsÂ¦ Â¦saidÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦th reatÂ¦ Â¦ass ess mentÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦g lobalÂ¦ Â¦levelÂ¦ Â¦wouldÂ¦ Â¦beÂ¦ Â¦r ai sedÂ¦ Â¦fromÂ¦ â–" Â¦highÂ¦ "â– Â¦toÂ¦ â–" Â¦veryÂ¦ Â¦highÂ¦ " ,â– Â¦itsÂ¦ Â¦high estÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦al er tÂ¦ Â¦andÂ¦ Â¦riskÂ¦ Â¦ass ess mentÂ¦ .
ğ‹‡ Â¦byÂ¦ Â¦theÂ¦ Â¦timeÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦reportÂ¦ ,â– Â¦theÂ¦ Â¦diseaseÂ¦ Â¦hasÂ¦ Â¦al rea dyÂ¦ Â¦spreadÂ¦ Â¦th r ou g ho utÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦andÂ¦ Â¦ne arÂ¦ Â¦50Â¦ Â¦otherÂ¦ Â¦countriesÂ¦ Â¦allÂ¦ Â¦overÂ¦ Â¦theÂ¦ Â¦worldÂ¦ â–( ğ‹‡ Â¦fi gÂ¦ .â– â€‹ ( ğ‹‡ Â¦fi gÂ¦ . Â¦2Â¦ ). Â¦2Â¦ ).
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦i ra ni anÂ¦ ğ‹‡ Â¦par li a mentÂ¦ Â¦wasÂ¦ Â¦sh utÂ¦ Â¦downÂ¦ ,â– Â¦withÂ¦ Â¦2 3Â¦ Â¦ofÂ¦ Â¦itsÂ¦ Â¦2 9 0Â¦ Â¦me mb ersÂ¦ Â¦reportedÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦hadÂ¦ Â¦testedÂ¦ Â¦positiveÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦onÂ¦ Â¦3Â¦ ğ‹‡Â¦marchÂ¦ .
ğ‹‡Â¦r d ğ‹‡ r pÂ¦ Â¦dire ctlyÂ¦ Â¦ medi a tesÂ¦ Â¦theÂ¦ Â¦sy nt he sisÂ¦ Â¦ofÂ¦ Â¦ne ga tiveÂ¦ - Â¦s en seÂ¦ Â¦ge no micÂ¦ ğŠ£Â¦r na Â¦ğŠ¼ Â¦fromÂ¦ Â¦theÂ¦ Â¦positiveÂ¦ - Â¦s en seÂ¦ Â¦ge no micÂ¦ ğŠ£Â¦r na Â¦ğŠ¼ .
ğ‹‡Â¦am id stÂ¦ Â¦clai msÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦co verÂ¦ - Â¦upÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦ext entÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦inÂ¦ ğ‹‡Â¦ ir anÂ¦ ,â– Â¦moreÂ¦ Â¦thanÂ¦ Â¦ tenÂ¦ Â¦countriesÂ¦ Â¦hadÂ¦ Â¦tr ac edÂ¦ Â¦theirÂ¦ Â¦casesÂ¦ Â¦b ackÂ¦ Â¦toÂ¦ ğ‹‡Â¦ ir anÂ¦ Â¦byÂ¦ Â¦2 8Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦ind ic a tingÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦ext entÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦moreÂ¦ Â¦severeÂ¦ Â¦thanÂ¦ Â¦theÂ¦ Â¦3 8 8Â¦ Â¦casesÂ¦ Â¦reportedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦i ra ni anÂ¦ Â¦governmentÂ¦ Â¦byÂ¦ Â¦thatÂ¦ Â¦d ateÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦l in ea geÂ¦ - Â¦speci ficÂ¦ Â¦acc ess oryÂ¦ Â¦prote insÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦en co dedÂ¦ Â¦byÂ¦ Â¦differentÂ¦ Â¦l in ea gesÂ¦ Â¦ofÂ¦ ğ‹‡Â¦c oğ‹‡vsÂ¦ .
ğ‹‡Â¦allÂ¦ Â¦countriesÂ¦ Â¦canÂ¦ Â¦stillÂ¦ Â¦chan geÂ¦ Â¦theÂ¦ Â¦co ur seÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦areÂ¦ Â¦aÂ¦ Â¦sub f a mi lyÂ¦ Â¦ofÂ¦ Â¦largeÂ¦ Â¦andÂ¦ Â¦en v el op edÂ¦ Â¦vi rusesÂ¦ Â¦cont ainingÂ¦ Â¦aÂ¦ Â¦sing leÂ¦ Â¦str andÂ¦ Â¦ofÂ¦ Â¦s en seÂ¦ ğŠ£Â¦r na Â¦ğŠ¼ .
ğ‹‡Â¦theÂ¦ Â¦testÂ¦ Â¦u sesÂ¦ Â¦re alÂ¦ - Â¦timeÂ¦ Â¦re ver seÂ¦ Â¦trans c ri p tionÂ¦ Â¦pol y mer aseÂ¦ Â¦ch ainÂ¦ Â¦rea ctionÂ¦ â–( Â¦r ğŠ£ r tÂ¦ - Â¦p crÂ¦ğŠ¼ ).
ğ‹‡ Â¦follow ingÂ¦ Â¦theÂ¦ Â¦pro gr ess ionÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦toÂ¦ Â¦newÂ¦ Â¦ho t s po tÂ¦ Â¦countriesÂ¦ ,â– Â¦peopleÂ¦ Â¦fromÂ¦ ğ‹‡Â¦ita lyÂ¦ ,â– Â¦theÂ¦ Â¦firstÂ¦ Â¦countryÂ¦ Â¦inÂ¦ ğ‹‡Â¦e ur op eÂ¦ Â¦toÂ¦ Â¦experie nceÂ¦ Â¦aÂ¦ Â¦ser iousÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦couldÂ¦ Â¦alsoÂ¦ Â¦beÂ¦ Â¦sub j ectedÂ¦ Â¦toÂ¦ Â¦susp ic ionÂ¦ Â¦andÂ¦ Â¦ x en op ho bi aÂ¦ . ğ‹‡ Â¦citizensÂ¦ Â¦inÂ¦ Â¦countriesÂ¦ Â¦includingÂ¦ ğ‹‡Â¦ma la y si aÂ¦ ,â– ğ‹‡ Â¦newÂ¦ ğ‹‡Â¦z e al andÂ¦ ,â– ğ‹‡ Â¦sing ap oreÂ¦ ,â– Â¦andÂ¦ ğ‹‡Â¦s outhÂ¦ ğ‹‡Â¦k o re aÂ¦ Â¦initi allyÂ¦ Â¦sig nedÂ¦ Â¦p e ti tionsÂ¦ Â¦ lob b yingÂ¦ Â¦toÂ¦ Â¦b anÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦peopleÂ¦ Â¦fromÂ¦ Â¦ent eringÂ¦ Â¦theirÂ¦ Â¦countriesÂ¦ Â¦inÂ¦ Â¦anÂ¦ Â¦e ff ortÂ¦ Â¦toÂ¦ Â¦sto pÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ,â– Â¦thisÂ¦ Â¦alsoÂ¦ Â¦app l iesÂ¦ Â¦toÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦whichÂ¦ Â¦isÂ¦ Â¦wellÂ¦ Â¦ad ap tedÂ¦ Â¦toÂ¦ Â¦dr om ed aryÂ¦ Â¦c am elsÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦y est er dayÂ¦ ,â– ğ‹‡ Â¦ba ng la d eshÂ¦ ' Â¦sÂ¦ ğ‹‡Â¦instituteÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦epi dem io logyÂ¦ ,â– ğ‹‡ Â¦diseaseÂ¦ ğ‹‡ Â¦controlÂ¦ Â¦andÂ¦ ğ‹‡ Â¦researchÂ¦ â–( ğŠ£Â¦i ed crÂ¦ğŠ¼ )â– Â¦reportedÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦rec or dedÂ¦ Â¦infectedÂ¦ Â¦casesÂ¦ Â¦inc lu dedÂ¦ Â¦1 1 4Â¦ Â¦ac tiveÂ¦ Â¦casesÂ¦ Â¦andÂ¦ Â¦3 3Â¦ Â¦rec ov eredÂ¦ Â¦casesÂ¦ Â¦whoÂ¦ Â¦wereÂ¦ Â¦sta yingÂ¦ Â¦homeÂ¦ .
ğ‹‡ Â¦mostÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦effectiveÂ¦ Â¦com po ne ntsÂ¦ Â¦rem ainÂ¦ Â¦un k n ownÂ¦ Â¦orÂ¦ Â¦areÂ¦ Â¦v a g ueÂ¦ Â¦asÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦difficul tÂ¦ Â¦toÂ¦ Â¦ex tr actÂ¦ Â¦andÂ¦ Â¦ve ri f yÂ¦ Â¦suchÂ¦ Â¦com po ne ntsÂ¦ Â¦orÂ¦ Â¦theirÂ¦ Â¦op ti malÂ¦ Â¦co mb in ationsÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦possibleÂ¦ ,â– Â¦simil arÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦thatÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦mi ghtÂ¦ Â¦becomeÂ¦ Â¦w ea k erÂ¦ Â¦inÂ¦ Â¦inf ec tiv ityÂ¦ Â¦andÂ¦ Â¦e ve nt u allyÂ¦ Â¦di eÂ¦ Â¦downÂ¦ Â¦orÂ¦ Â¦becomeÂ¦ Â¦aÂ¦ Â¦lessÂ¦ Â¦p at ho g en icÂ¦ Â¦virusÂ¦ Â¦c oÂ¦ - Â¦e xi st entÂ¦ Â¦withÂ¦ Â¦hum ansÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦18Â¦ ,â– Â¦2020Â¦ ,â– Â¦theÂ¦ Â¦firstÂ¦ Â¦p at ho log icalÂ¦ Â¦an al y sisÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦ dem on stra tedÂ¦ Â¦theÂ¦ Â¦d es qu am ationÂ¦ Â¦ofÂ¦ Â¦p ne um oc y tesÂ¦ ,â– Â¦hy a lineÂ¦ Â¦me mb r aneÂ¦ Â¦for m ationÂ¦ ,â– Â¦andÂ¦ Â¦inter s ti ti alÂ¦ Â¦l y mp h oc y teÂ¦ Â¦inf il tr ationÂ¦ ,â– Â¦andÂ¦ Â¦m ul t in uc le atedÂ¦ Â¦sy nc y ti alÂ¦ Â¦ce llsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦ lu ngsÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦patientÂ¦ Â¦whoÂ¦ Â¦diedÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ ,â– Â¦con si st entÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦p at ho logyÂ¦ Â¦ofÂ¦ Â¦v iralÂ¦ Â¦infectionÂ¦ Â¦andÂ¦ ğŠ£ Â¦ar dsÂ¦ ğŠ¼ Â¦andÂ¦ Â¦simil arÂ¦ Â¦toÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦andÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ Â¦patientsÂ¦ .
ğ‹‡Â¦w il d li feÂ¦ Â¦s m u gg l ingÂ¦ Â¦andÂ¦ Â¦ z o o no sesÂ¦ â– â€“ â– ğ‹‡Â¦healthÂ¦ Â¦r is ksÂ¦ Â¦associ atedÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦tra deÂ¦ Â¦inÂ¦ Â¦ex o ticÂ¦ Â¦w il d li feÂ¦
ğ‹‡Â¦forÂ¦ ğŠ£ Â¦cl t Â¦ğŠ¼ Â¦aÂ¦ Â¦sing leÂ¦ Â¦speci m enÂ¦ Â¦ofÂ¦ Â¦per i p h er alÂ¦ Â¦bloodÂ¦ Â¦isÂ¦ Â¦comm on lyÂ¦ Â¦usedÂ¦ ,â– Â¦al thoughÂ¦ Â¦se ri alÂ¦ Â¦speci me nsÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦usedÂ¦ Â¦toÂ¦ Â¦follow Â¦ Â¦theÂ¦ Â¦immuneÂ¦ Â¦responseÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦virusÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦onÂ¦ Â¦itsÂ¦ Â¦ wayÂ¦ Â¦andÂ¦ Â¦youÂ¦ Â¦needÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦rea dyÂ¦ , "â– Â¦ ur g ingÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦ri ghtÂ¦ Â¦responseÂ¦ Â¦measuresÂ¦ Â¦couldÂ¦ Â¦helpÂ¦ Â¦theÂ¦ Â¦worldÂ¦ Â¦avo idÂ¦ â–" Â¦theÂ¦ Â¦wor stÂ¦ Â¦ofÂ¦ Â¦itÂ¦ " .
ğ‹‡ Â¦ourÂ¦ Â¦t ea mÂ¦ Â¦willÂ¦ Â¦alsoÂ¦ Â¦ ti me lyÂ¦ Â¦up d ateÂ¦ Â¦ourÂ¦ Â¦guid e lineÂ¦ Â¦toÂ¦ Â¦off erÂ¦ Â¦helpÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦studyÂ¦ Â¦per formedÂ¦ Â¦inÂ¦ Â¦201 0Â¦ â€“ Â¦11Â¦ Â¦sh ow edÂ¦ Â¦aÂ¦ Â¦largeÂ¦ Â¦v ari ationÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦ av a il ab ilityÂ¦ Â¦ofÂ¦ Â¦int en siveÂ¦ Â¦careÂ¦ Â¦andÂ¦ Â¦inter medi ateÂ¦ Â¦careÂ¦ Â¦bedsÂ¦ Â¦inÂ¦ ğ‹‡Â¦e ur op eÂ¦ ,â– Â¦ra ng ingÂ¦ Â¦fromÂ¦ Â¦2 9Â¦ . Â¦2Â¦ Â¦inÂ¦ ğ‹‡Â¦g erm an yÂ¦ Â¦toÂ¦ Â¦4Â¦ . Â¦2Â¦ Â¦bedsÂ¦ Â¦perÂ¦ Â¦100Â¦ , Â¦000Â¦ Â¦populationÂ¦ Â¦inÂ¦ ğ‹‡Â¦ por t u g alÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦cont ra stÂ¦ ,â– Â¦ifÂ¦ Â¦theÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ Â¦isÂ¦ Â¦ne w lyÂ¦ Â¦in tr od uc edÂ¦ Â¦toÂ¦ Â¦anÂ¦ Â¦inter medi ateÂ¦ Â¦h ostÂ¦ Â¦ri ghtÂ¦ Â¦beforeÂ¦ Â¦orÂ¦ Â¦aroundÂ¦ Â¦itsÂ¦ Â¦in tr od u ctionÂ¦ Â¦toÂ¦ Â¦hum ansÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦wellÂ¦ Â¦ad ap tedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦newÂ¦ Â¦h ostÂ¦ Â¦andÂ¦ Â¦isÂ¦ Â¦o f tenÂ¦ Â¦p at ho g en icÂ¦ .
ğ‹‡Â¦th usÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦muchÂ¦ Â¦moreÂ¦ Â¦ch al le ng ingÂ¦ Â¦toÂ¦ Â¦controlÂ¦ Â¦theÂ¦ Â¦epi demicÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦thanÂ¦ Â¦thoseÂ¦ Â¦ofÂ¦ ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡ Â¦firstÂ¦ ,â– Â¦ifÂ¦ Â¦ba tsÂ¦ Â¦trans m itÂ¦ Â¦anÂ¦ Â¦an ce stra lÂ¦ Â¦virusÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦toÂ¦ Â¦pa ng ol insÂ¦ ,â– Â¦itÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦ofÂ¦ Â¦inter estÂ¦ Â¦toÂ¦ Â¦se eÂ¦ Â¦underÂ¦ Â¦whatÂ¦ Â¦c ir c um st an cesÂ¦ Â¦ba tsÂ¦ Â¦andÂ¦ Â¦pa ng ol insÂ¦ Â¦couldÂ¦ Â¦sh areÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦e co log icalÂ¦ Â¦ ni ch eÂ¦ .
ğ‹‡Â¦ ir anÂ¦ Â¦a ll oc atedÂ¦ Â¦fiveÂ¦ Â¦tr ill ionÂ¦ Â¦ri alsÂ¦ Â¦toÂ¦ Â¦co mb atÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡ Â¦li ke w iseÂ¦ ,â– Â¦aÂ¦ Â¦res erv o irÂ¦ Â¦h ostÂ¦ Â¦ har b o ur sÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ Â¦cont in u o us lyÂ¦ Â¦andÂ¦ Â¦forÂ¦ Â¦longÂ¦ Â¦ter mÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦vi aÂ¦ Â¦s tric tÂ¦ Â¦quarantineÂ¦ Â¦andÂ¦ Â¦isol ationÂ¦ ,â– Â¦theÂ¦ Â¦diseaseÂ¦ Â¦hasÂ¦ Â¦e ve nt u allyÂ¦ Â¦beenÂ¦ Â¦p utÂ¦ Â¦underÂ¦ Â¦controlÂ¦ .
ğŠ£Â¦m ersÂ¦ ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦ser vesÂ¦ Â¦asÂ¦ Â¦anÂ¦ Â¦ex ce ll entÂ¦ Â¦exa mpleÂ¦ Â¦ofÂ¦ Â¦inter s p ec iesÂ¦ Â¦transmissionÂ¦ Â¦fromÂ¦ Â¦ba tsÂ¦ Â¦toÂ¦ Â¦dr om ed aryÂ¦ Â¦c am elsÂ¦ Â¦andÂ¦ Â¦fromÂ¦ Â¦dr om ed aryÂ¦ Â¦c am elsÂ¦ Â¦toÂ¦ Â¦hum ansÂ¦ .
ğ‹‡ Â¦anÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ Â¦canÂ¦ Â¦under g oÂ¦ Â¦aÂ¦ Â¦de adÂ¦ - Â¦ endÂ¦ Â¦infectionÂ¦ Â¦ifÂ¦ Â¦itÂ¦ Â¦can no tÂ¦ Â¦su st ainÂ¦ Â¦itsÂ¦ Â¦transmissionÂ¦ Â¦withinÂ¦ Â¦theÂ¦ Â¦inter medi ateÂ¦ Â¦h ostÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦se ar chÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦ani malÂ¦ Â¦o ri g insÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦isÂ¦ Â¦stillÂ¦ Â¦onÂ¦ .
ğ‹‡ Â¦nowÂ¦ Â¦ourÂ¦ Â¦guid e lineÂ¦ Â¦recei vedÂ¦ Â¦aÂ¦ Â¦com mentÂ¦ Â¦byÂ¦ ğ‹‡Â¦z ho uÂ¦ Â¦ etÂ¦ Â¦ alÂ¦ . ,â– Â¦theyÂ¦ Â¦in tr od uc edÂ¦ Â¦aÂ¦ Â¦si mpleÂ¦ Â¦sc or ingÂ¦ Â¦prop os alÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theirÂ¦ Â¦clinicalÂ¦ Â¦experie nceÂ¦ .
ğ‹‡Â¦n u me ro usÂ¦ Â¦ca nd id ateÂ¦ Â¦d ru gsÂ¦ Â¦underÂ¦ Â¦studyÂ¦ Â¦asÂ¦ â–" Â¦supp or tiveÂ¦ "â– Â¦tre at mentsÂ¦ Â¦toÂ¦ Â¦rel ie veÂ¦ Â¦dis c om f ortÂ¦ Â¦duringÂ¦ Â¦ ill nessÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ ğŠ£Â¦ ns a id ğŠ¼ sÂ¦ Â¦orÂ¦ Â¦br on ch od il atorsÂ¦ ,â– Â¦areÂ¦ Â¦notÂ¦ Â¦inc lu dedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦t ableÂ¦ Â¦be lowÂ¦ .
ğ‹‡Â¦w he re asÂ¦ Â¦aÂ¦ Â¦b atÂ¦ Â¦be t aÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦s har ingÂ¦ Â¦9 5Â¦ %â– Â¦n uc le o t ideÂ¦ Â¦h om o logyÂ¦ Â¦withÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ ,â– Â¦thereÂ¦ Â¦alsoÂ¦ Â¦ex istsÂ¦ Â¦aÂ¦ Â¦b atÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦s har ingÂ¦ Â¦9 6Â¦ %â– Â¦n uc le o t ideÂ¦ Â¦h om o logyÂ¦ Â¦withÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦us u allyÂ¦ Â¦pas sedÂ¦ Â¦fromÂ¦ Â¦mo therÂ¦ Â¦toÂ¦ Â¦fe t usÂ¦ Â¦soÂ¦ Â¦furtherÂ¦ Â¦researchÂ¦ Â¦isÂ¦ Â¦requir edÂ¦ Â¦toÂ¦ Â¦k nowÂ¦ Â¦whetherÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦cr os sedÂ¦ Â¦theÂ¦ Â¦p la ce nt aÂ¦ Â¦orÂ¦ Â¦whetherÂ¦ Â¦p la ce nt asÂ¦ Â¦ofÂ¦ Â¦womenÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦studyÂ¦ Â¦wereÂ¦ Â¦d a ma gedÂ¦ Â¦orÂ¦ Â¦ab n or malÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦11Â¦ ,â– Â¦2020Â¦ ,â– Â¦aÂ¦ Â¦m ul t iÂ¦ - Â¦centerÂ¦ Â¦studyÂ¦ Â¦onÂ¦ Â¦8Â¦ , Â¦8 6 6Â¦ Â¦patientsÂ¦ Â¦includingÂ¦ Â¦4Â¦ , Â¦ 0 2 1Â¦ Â¦confirmedÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦patientsÂ¦ Â¦p res entedÂ¦ Â¦aÂ¦ Â¦moreÂ¦ Â¦up d atedÂ¦ Â¦ ill us tr ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epi demicÂ¦ Â¦asÂ¦ Â¦follow sÂ¦ â–( Â¦h t t psÂ¦ : / / Â¦m pÂ¦ . Â¦we i x inÂ¦ . Â¦ q q Â¦ . Â¦c omÂ¦ / Â¦sÂ¦ / ğ‹‡Â¦ ul ğ‹‡ b iÂ¦ - ğŠ£Â¦h x ğŠ¼ _ r ğŠ£ h p x ğŠ¼ a 1 q ğŠ£ ha ğŠ¼ 2 b h d ğ‹‡ aÂ¦ ).
ğ‹‡Â¦butÂ¦ Â¦alsoÂ¦ Â¦weÂ¦ Â¦sho ul d nÂ¦ ' Â¦tÂ¦ Â¦beÂ¦ Â¦p utÂ¦ Â¦as ideÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦heartÂ¦ Â¦car di ac Â¦ Â¦o ri g inÂ¦ Â¦ch estÂ¦ Â¦p ainÂ¦
ğ‹‡ Â¦severalÂ¦ Â¦loc al itiesÂ¦ Â¦alsoÂ¦ Â¦w it n es sedÂ¦ Â¦p an icÂ¦ Â¦bu yingÂ¦ Â¦thatÂ¦ Â¦l edÂ¦ Â¦toÂ¦ Â¦sh el vesÂ¦ Â¦beingÂ¦ Â¦cle aredÂ¦ Â¦ofÂ¦ Â¦gr oc er yÂ¦ Â¦ ess enti alsÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦fo odÂ¦ ,â– Â¦to il etÂ¦ Â¦p ap erÂ¦ ,â– Â¦andÂ¦ Â¦bo t t l edÂ¦ Â¦waterÂ¦ ,â– Â¦ind uc ingÂ¦ Â¦supplyÂ¦ Â¦sh or ta gesÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦centerÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦ch estÂ¦
ğ‹‡ Â¦econom icallyÂ¦ Â¦si gni fic antÂ¦ Â¦coron a vi rusesÂ¦ Â¦ofÂ¦ Â¦f ar mÂ¦ Â¦ani m alsÂ¦ Â¦includeÂ¦ Â¦ por c ineÂ¦ Â¦coronavirusÂ¦ â–( Â¦trans m is sib leÂ¦ Â¦ga st ro en teri ti sÂ¦ Â¦coronavirusÂ¦ ,â– ğŠ£ Â¦t ge Â¦ğŠ¼ )â– Â¦andÂ¦ Â¦b ov ineÂ¦ Â¦coronavirusÂ¦ ,â– Â¦whichÂ¦ Â¦bothÂ¦ Â¦resultÂ¦ Â¦inÂ¦ Â¦di ar r he aÂ¦ Â¦inÂ¦ Â¦y oun gÂ¦ Â¦ani m alsÂ¦ .
ğ‹‡Â¦iÂ¦ Â¦hadÂ¦ Â¦aÂ¦ Â¦feverÂ¦ Â¦y est er dayÂ¦
ğ‹‡Â¦asÂ¦ Â¦theseÂ¦ Â¦no ti fic ationsÂ¦ Â¦occ ur r edÂ¦ ,â– Â¦doctorsÂ¦ Â¦inÂ¦ ğ‹‡Â¦w uhanÂ¦ Â¦wereÂ¦ Â¦w ar nedÂ¦ Â¦byÂ¦ Â¦policeÂ¦ Â¦forÂ¦ â–" Â¦sprea dingÂ¦ Â¦r um o ur sÂ¦ "â– Â¦aboutÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ .
ğ‹‡Â¦ id enti f yingÂ¦ Â¦theÂ¦ Â¦ani malÂ¦ Â¦hos tsÂ¦ Â¦hasÂ¦ Â¦d ir ectÂ¦ Â¦imp lic ationsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦prev entionÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ Â¦dis easesÂ¦ .
ğ‹‡Â¦ma nd atoryÂ¦ Â¦contactÂ¦ Â¦tr ac ingÂ¦ Â¦andÂ¦ Â¦quarantineÂ¦ ,â– Â¦asÂ¦ Â¦aÂ¦ Â¦p artÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦publicÂ¦ Â¦healthÂ¦ Â¦respon sesÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦outbreakÂ¦ ,â– Â¦canÂ¦ Â¦makeÂ¦ Â¦peopleÂ¦ Â¦moreÂ¦ Â¦an x iousÂ¦ Â¦andÂ¦ Â¦g u il tyÂ¦ Â¦aboutÂ¦ Â¦theÂ¦ Â¦effec tsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦conta g ionÂ¦ ,â– Â¦quarantineÂ¦ ,â– Â¦andÂ¦ Â¦s tig maÂ¦ Â¦onÂ¦ Â¦theirÂ¦ Â¦f am il iesÂ¦ Â¦andÂ¦ Â¦f r ie ndsÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦19Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦sing ap oreÂ¦ ğ‹‡Â¦r edÂ¦ ğ‹‡ Â¦cr os sÂ¦ Â¦announcedÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦wouldÂ¦ Â¦s endÂ¦ â– $ Â¦2Â¦ . Â¦2 6Â¦ Â¦millionÂ¦ Â¦wor thÂ¦ Â¦ofÂ¦ Â¦a idÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ .
ğ‹‡ Â¦simil arÂ¦ Â¦toÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£ Â¦n l 6 3Â¦ ,â– Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - Â¦2 2 9 ğ‹‡ eÂ¦ Â¦andÂ¦ ğŠ£Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£Â¦ oc 4 3Â¦ ,â– Â¦h cğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£Â¦h k u ğŠ¼ 1Â¦ Â¦wasÂ¦ Â¦foundÂ¦ Â¦wor l d w ideÂ¦ ,â– Â¦ca us ingÂ¦ Â¦mi ldÂ¦ Â¦respiratoryÂ¦ Â¦dis easesÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦sp ec ul atedÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦fl uÂ¦ Â¦pandemicÂ¦ Â¦ofÂ¦ Â¦1 8 9 0Â¦ Â¦mayÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦thisÂ¦ Â¦sp il lo verÂ¦ Â¦e v entÂ¦ ,â– Â¦andÂ¦ Â¦notÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦inf lu en z aÂ¦ Â¦virusÂ¦ ,â– Â¦becauseÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦relatedÂ¦ Â¦ tim ingÂ¦ ,â– Â¦ne u ro log icalÂ¦ Â¦symptomsÂ¦ ,â– Â¦andÂ¦ Â¦un k n ownÂ¦ Â¦ca us a tiveÂ¦ Â¦ag entÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦allÂ¦ Â¦se v enÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦ z o o no ticÂ¦ Â¦o ri g inÂ¦ Â¦fromÂ¦ Â¦ba tsÂ¦ ,â– Â¦m iceÂ¦ Â¦orÂ¦ Â¦d om es ticÂ¦ Â¦ani m alsÂ¦ .
ğ‹‡ Â¦doÂ¦ Â¦youÂ¦ Â¦haveÂ¦ Â¦someÂ¦ Â¦sh or t nessÂ¦ Â¦ofÂ¦ Â¦brea thÂ¦ Â¦go esÂ¦ Â¦withÂ¦ Â¦thatÂ¦ ?
ğ‹‡Â¦thisÂ¦ ,â– Â¦h ow e verÂ¦ ,â– Â¦v ar iesÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦hum id ityÂ¦ Â¦andÂ¦ Â¦te mp er at ureÂ¦ . ğ‹‡Â¦p e tsÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦ani m alsÂ¦ Â¦haveÂ¦ Â¦testedÂ¦ Â¦positiveÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡ Â¦qu estÂ¦ ğ‹‡Â¦di a g no st icsÂ¦ Â¦simil ar lyÂ¦ Â¦madeÂ¦ Â¦n ati on w ideÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦testingÂ¦ Â¦availableÂ¦ Â¦asÂ¦ Â¦ofÂ¦ Â¦9Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ .
ğ‹‡Â¦asÂ¦ Â¦aÂ¦ Â¦no ve lÂ¦ Â¦diseaseÂ¦ ,â– ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦hasÂ¦ Â¦j ustÂ¦ Â¦startedÂ¦ Â¦toÂ¦ Â¦ma ni f estÂ¦ Â¦itsÂ¦ Â¦f ul lÂ¦ Â¦clinicalÂ¦ Â¦co ur seÂ¦ Â¦th r ou g ho utÂ¦ Â¦t ho us a ndsÂ¦ Â¦ofÂ¦ Â¦patientsÂ¦ .
ğ‹‡ Â¦byÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦14Â¦ ,â– Â¦theÂ¦ Â¦mor t alityÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦wasÂ¦ Â¦2Â¦ %â– Â¦whenÂ¦ Â¦theÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦re ach edÂ¦ Â¦6 6Â¦ , Â¦5 7 6Â¦ Â¦glob allyÂ¦ .
ğ‹‡ Â¦mostÂ¦ Â¦imp res si ve lyÂ¦ ,â– Â¦theÂ¦ Â¦rateÂ¦ Â¦forÂ¦ Â¦sy m pt o ma ticÂ¦ Â¦wor se ningÂ¦ â–( Â¦fromÂ¦ Â¦li ghtÂ¦ Â¦toÂ¦ Â¦severeÂ¦ )â– Â¦wasÂ¦ Â¦rem ar k ab lyÂ¦ Â¦l ow erÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğŠ£ Â¦w mÂ¦ + Â¦t c m Â¦ğŠ¼ Â¦groupÂ¦ Â¦thanÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğŠ£ Â¦w m Â¦ğŠ¼ Â¦onlyÂ¦ Â¦groupÂ¦ â–( Â¦7Â¦ . Â¦4Â¦ %â– Â¦ vers usÂ¦ Â¦4 6Â¦ . Â¦2Â¦ % )â– Â¦andÂ¦ Â¦theÂ¦ Â¦mor t alityÂ¦ Â¦wasÂ¦ Â¦l ow erÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğŠ£ Â¦w mÂ¦ + Â¦t c m Â¦ğŠ¼ Â¦groupÂ¦ Â¦thanÂ¦ ğŠ£ Â¦w m Â¦ğŠ¼ Â¦onlyÂ¦ Â¦groupÂ¦ â–( Â¦8Â¦ . Â¦8Â¦ %â– Â¦ vers usÂ¦ Â¦3 9Â¦ % ).
ğ‹‡ Â¦drugÂ¦ Â¦ca nd id a tesÂ¦ Â¦inÂ¦ ğ‹‡ Â¦phaseÂ¦ ğ‹‡Â¦iÂ¦ - ğŠ£Â¦i i Â¦ğŠ¼ Â¦trialsÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦lowÂ¦ Â¦rateÂ¦ Â¦ofÂ¦ Â¦s uc c essÂ¦ â–( Â¦underÂ¦ Â¦12Â¦ % )â– Â¦toÂ¦ Â¦pas sÂ¦ Â¦throughÂ¦ Â¦allÂ¦ Â¦tri alÂ¦ Â¦p ha sesÂ¦ Â¦toÂ¦ Â¦g ainÂ¦ Â¦e ve nt u alÂ¦ Â¦appro v alÂ¦ .
ğ‹‡ Â¦cy t o k ineÂ¦ Â¦st or mÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦for mÂ¦ Â¦ofÂ¦ Â¦sy s te micÂ¦ Â¦inf l am m atoryÂ¦ Â¦responseÂ¦ Â¦fe atur edÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦re le aseÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦ser iesÂ¦ Â¦ofÂ¦ Â¦cy t o k inesÂ¦ Â¦includingÂ¦ ğŠ£ Â¦t n f ğŠ¼ Î± Â¦ ,â– ğŠ£Â¦ il Â¦ğŠ¼ - Â¦1 Î² Â¦ ,â– ğŠ£Â¦i lÂ¦ - Â¦2Â¦ ,â– Â¦i lÂ¦ - Â¦6Â¦ ,â– Â¦i f n ğŠ¼ Î± Â¦ ,â– ğŠ£Â¦i f n ğŠ¼ Î² Â¦ ,â– ğŠ£Â¦i f n ğŠ¼ Î³ Â¦ ,â– Â¦andÂ¦ ğŠ£Â¦m c pÂ¦ğŠ¼ - Â¦1Â¦ .
ğ‹‡ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦comp ara tiveÂ¦ Â¦an al y sisÂ¦ Â¦betweenÂ¦ Â¦isol a tesÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ Â¦andÂ¦ Â¦ ci v etÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦c oğ‹‡vsÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦isÂ¦ Â¦th oughtÂ¦ Â¦toÂ¦ Â¦under g oÂ¦ Â¦rap idÂ¦ Â¦ad a pt ationÂ¦ Â¦inÂ¦ Â¦differentÂ¦ Â¦hos tsÂ¦ ,â– Â¦part icul ar lyÂ¦ Â¦withÂ¦ Â¦mut ationsÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğŠ£Â¦r b d Â¦ğŠ¼ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦sÂ¦ Â¦prote inÂ¦ .
ğ‹‡ Â¦part icul ar lyÂ¦ ,â– Â¦pa ng ol inÂ¦ Â¦be t aÂ¦ - ğ‹‡Â¦c oğ‹‡vsÂ¦ Â¦areÂ¦ Â¦high lyÂ¦ Â¦p at ho g en icÂ¦ Â¦inÂ¦ Â¦pa ng ol insÂ¦ .
ğ‹‡ Â¦faceÂ¦ Â¦masksÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦wi de lyÂ¦ Â¦usedÂ¦ Â¦inÂ¦ ğ‹‡Â¦j ap anÂ¦ ,â– ğ‹‡Â¦s outhÂ¦ ğ‹‡Â¦k o re aÂ¦ ,â– ğ‹‡Â¦ma la y si aÂ¦ ,â– Â¦andÂ¦ ğ‹‡ Â¦sing ap oreÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦thisÂ¦ Â¦reg ardÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦follow sÂ¦ Â¦theÂ¦ Â¦generalÂ¦ Â¦tr endÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦otherÂ¦ Â¦sixÂ¦ ğŠ£Â¦h cğŠ¼ oğ‹‡vsÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– Â¦theÂ¦ Â¦m ainÂ¦ Â¦prote aseÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦virusÂ¦ Â¦wasÂ¦ Â¦ id enti fiedÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦t ar g etÂ¦ Â¦forÂ¦ Â¦p ostÂ¦ - Â¦infectionÂ¦ Â¦d ru gsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦firstÂ¦ Â¦knownÂ¦ Â¦caseÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦no ve lÂ¦ Â¦coronavirusÂ¦ Â¦mayÂ¦ Â¦tr aceÂ¦ Â¦b ackÂ¦ Â¦toÂ¦ Â¦1Â¦ ğ‹‡Â¦de ce mberÂ¦ Â¦2019Â¦ Â¦inÂ¦ ğ‹‡Â¦w uhanÂ¦ ,â– ğ‹‡Â¦h ub e iÂ¦ ,â– ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦allÂ¦ Â¦fe at uresÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦no ve lÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦virusÂ¦ Â¦occ urÂ¦ Â¦inÂ¦ Â¦relatedÂ¦ Â¦coron a vi rusesÂ¦ Â¦inÂ¦ Â¦n at ureÂ¦ . ğ‹‡ Â¦out s ideÂ¦ Â¦theÂ¦ Â¦humanÂ¦ Â¦bodyÂ¦ ,â– Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦ki lledÂ¦ Â¦byÂ¦ Â¦h ou se ho ldÂ¦ Â¦soapÂ¦ ,â– Â¦whichÂ¦ Â¦dis s ol vesÂ¦ Â¦itsÂ¦ Â¦prot ec tiveÂ¦ Â¦en v el op eÂ¦ . ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦isÂ¦ Â¦clos e lyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦o ri g in alÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡ Â¦andÂ¦ Â¦canÂ¦ Â¦youÂ¦ Â¦t ellÂ¦ Â¦ meÂ¦ Â¦whatÂ¦ Â¦otherÂ¦ Â¦symptomsÂ¦ Â¦areÂ¦ Â¦youÂ¦ Â¦ha vingÂ¦ Â¦al ongÂ¦ Â¦withÂ¦ Â¦thisÂ¦ ?
ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦hasÂ¦ Â¦higherÂ¦ Â¦mor t alityÂ¦ Â¦thanÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ â–( Â¦10Â¦ . Â¦9 1Â¦ %â– Â¦ vers usÂ¦ Â¦1Â¦ . Â¦4 4Â¦ % ).
ğ‹‡ Â¦anyÂ¦ Â¦otherÂ¦ Â¦symptomsÂ¦ Â¦orÂ¦ Â¦proble msÂ¦ Â¦thatÂ¦ Â¦youÂ¦ Â¦no t iceÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦m us c leÂ¦ Â¦ ach esÂ¦ ?
ğ‹‡Â¦theÂ¦ Â¦expertsÂ¦ Â¦under s c or edÂ¦ Â¦thatÂ¦ Â¦everyÂ¦ Â¦in di v id u alÂ¦ Â¦hasÂ¦ Â¦theÂ¦ Â¦ri ghtÂ¦ Â¦toÂ¦ Â¦healthÂ¦ ,â– Â¦includingÂ¦ Â¦peopleÂ¦ Â¦withÂ¦ Â¦dis ab il itiesÂ¦ ,â– Â¦be lo ng ingÂ¦ Â¦toÂ¦ Â¦min or ityÂ¦ Â¦gr ou psÂ¦ ,â– Â¦ ol derÂ¦ Â¦peopleÂ¦ ,â– Â¦intern allyÂ¦ Â¦dis p l ac edÂ¦ Â¦peopleÂ¦ ,â– Â¦theÂ¦ Â¦h om el essÂ¦ ,â– Â¦thoseÂ¦ Â¦li vingÂ¦ Â¦inÂ¦ Â¦ext re me lyÂ¦ Â¦po orÂ¦ Â¦conditionsÂ¦ ,â– Â¦peopleÂ¦ Â¦inÂ¦ Â¦det entionÂ¦ ,â– Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦ ref u ge esÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦u ns p eci fiedÂ¦ Â¦gr ou psÂ¦ Â¦inÂ¦ Â¦needÂ¦ Â¦ofÂ¦ Â¦governmentÂ¦ Â¦supp ortÂ¦ .
